Document:

Amended and Restated Credit Agreement

 Exhibit 10.1 
 CONFIDENTIAL TREATMENT REQUESTED – REDACTED COPY 
  
  
  
 AMENDED AND RESTATED CREDIT AGREEMENT 
 Dated as of November 10, 2008 
 between 
 VARIAN MEDICAL SYSTEMS, INC. 
 and 
 BANK OF AMERICA, N.A. 
  
  
  
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 

 TABLE OF CONTENTS 
  

					
	 Section
	  	 	  	Page
			
	ARTICLE I.	  	DEFINITIONS AND ACCOUNTING TERMS	  	1
			
	 1.01
	  	Defined Terms	  	1
	 1.02
	  	Other Interpretive Provisions	  	19
	 1.03
	  	Accounting Terms	  	20
	 1.04
	  	Rounding	  	21
	 1.05
	  	Times of Day	  	21
	 1.06
	  	Letter of Credit Amounts	  	21
			
	ARTICLE II.	  	THE COMMITMENT AND CREDIT EXTENSIONS	  	21
			
	 2.01
	  	Loans	  	21
	 2.02
	  	Borrowings, Conversions and Continuations of Loans	  	21
	 2.03
	  	Letters of Credit	  	22
	 2.04
	  	Prepayments	  	27
	 2.05
	  	Termination or Reduction of Commitment	  	28
	 2.06
	  	Repayment of Loans	  	28
	 2.07
	  	Interest	  	28
	 2.08
	  	Fees	  	29
	 2.09
	  	Computation of Interest and Fees	  	29
	 2.10
	  	Evidence of Debt	  	29
	 2.11
	  	Payments Generally	  	29
			
	ARTICLE III.	  	TAXES, YIELD PROTECTION AND ILLEGALITY	  	30
			
	 3.01
	  	Taxes	  	30
	 3.02
	  	Illegality	  	32
	 3.03
	  	Inability to Determine Eurodollar Rate	  	32
	 3.04
	  	Increased Costs; Reserves on Eurodollar Rate Loans	  	33
	 3.05
	  	Compensation for Losses	  	34
	 3.06
	  	Requests for Compensation; Mitigation	  	35
	 3.07
	  	Survival	  	35
			
	ARTICLE IV.	  	CONDITIONS PRECEDENT TO CREDIT EXTENSIONS	  	35
			
	 4.01
	  	Conditions of Initial Credit Extension	  	35
	 4.02
	  	Conditions to all Credit Extensions	  	37
			
	ARTICLE V.	  	REPRESENTATIONS AND WARRANTIES	  	38
			
	 5.01
	  	Existence, Qualification and Power; Compliance with Laws	  	38
	 5.02
	  	Authorization; No Contravention	  	38

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 i 

					
	 5.03
	  	Governmental Authorization; Other Consents	  	38
	 5.04
	  	Binding Effect	  	39
	 5.05
	  	Financial Statements; No Material Adverse Effect	  	39
	 5.06
	  	Litigation	  	39
	 5.07
	  	No Default	  	39
	 5.08
	  	Ownership of Property; Liens	  	40
	 5.09
	  	Regulatory Compliance	  	40
	 5.10
	  	Insurance	  	40
	 5.11
	  	Taxes	  	40
	 5.12
	  	ERISA Compliance	  	40
	 5.13
	  	Subsidiaries	  	41
	 5.14
	  	Margin Regulations; Investment Company Act	  	41
	 5.15
	  	Disclosure	  	41
	 5.16
	  	Intellectual Property; Licenses, Etc.	  	42
	 5.17
	  	Solvency	  	42
			
	ARTICLE VI.	  	AFFIRMATIVE COVENANTS	  	42
			
	 6.01
	  	Financial Statements	  	42
	 6.02
	  	Certificates; Other Information	  	43
	 6.03
	  	Notices	  	44
	 6.04
	  	Payment of Obligations	  	45
	 6.05
	  	Preservation of Existence, Etc.	  	45
	 6.06
	  	Maintenance of Properties	  	45
	 6.07
	  	Maintenance of Insurance	  	45
	 6.08
	  	Intellectual Property	  	45
	 6.09
	  	Books and Records	  	45
	 6.10
	  	Inspection Rights	  	46
	 6.11
	  	Use of Proceeds	  	46
	 6.12
	  	Depository Bank	  	46
	 6.13
	  	Additional Guarantors; Pledge	  	46
	 6.14
	  	Further Assurances	  	47
			
	ARTICLE VII.	  	NEGATIVE COVENANTS	  	47
			
	 7.01
	  	Liens	  	47
	 7.02
	  	Investments	  	49
	 7.03
	  	Subsidiary Guaranties	  	50
	 7.04
	  	Fundamental Changes	  	51
	 7.05
	  	Dispositions	  	51
	 7.06
	  	Restricted Payments	  	52
	 7.07
	  	Change in Nature of Business	  	53
	 7.08
	  	Transactions with Affiliates	  	53
	 7.09
	  	Burdensome Agreements	  	53
	 7.10
	  	Use of Proceeds	  	53
	 7.11
	  	Financial Covenants	  	53
	 7.12
	  	Capital Expenditures	  	54

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 ii 

					
	 7.13
	  	Fiscal Periods	  	54
			
	ARTICLE VIII.	  	EVENTS OF DEFAULT AND REMEDIES	  	54
			
	 8.01
	  	Events of Default	  	54
	 8.02
	  	Remedies Upon Event of Default	  	56
	 8.03
	  	Application of Funds	  	56
			
	ARTICLE IX.	  	MISCELLANEOUS	  	57
			
	 9.01
	  	Amendments; Etc.	  	57
	 9.02
	  	Notices and Other Communications; Facsimile Copies	  	57
	 9.03
	  	No Waiver; Cumulative Remedies	  	58
	 9.04
	  	Expenses; Indemnity; Damage Waiver	  	58
	 9.05
	  	Payments Set Aside	  	59
	 9.06
	  	Successors and Assigns	  	60
	 9.07
	  	Treatment of Certain Information; Confidentiality	  	62
	 9.08
	  	Right of Setoff	  	62
	 9.09
	  	Interest Rate Limitation	  	63
	 9.10
	  	Counterparts; Integration; Effectiveness	  	63
	 9.11
	  	Survival of Representations and Warranties	  	63
	 9.12
	  	Severability	  	63
	 9.13
	  	Governing Law; Jurisdiction; Etc.	  	64
	 9.14
	  	Waiver of Jury Trial	  	65
	 9.15
	  	USA PATRIOT Act Notice	  	65
	 9.16
	  	Time of the Essence	  	65
	 9.17
	  	ENTIRE AGREEMENT	  	65
	 9.18
	  	Effect of Amendment and Restatement	  	65
	 9.19
	  	Post-Closing Matters	  	65
			
	SIGNATURES	  		  	S-1

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 iii 

 SCHEDULES 
  

			
	5.05	  	Supplement to Financial Statements
		
	5.06	  	Litigation
		
	5.09	  	Environmental Matters
		
	5.13	  	Subsidiaries, Other Equity Investments
		
	5.16	  	Intellectual Property Matters
		
	7.01	  	Existing Liens
		
	7.03	  	Existing Subsidiary Guarantees
		
	7.11	  	Covenant Information
		
	9.02	  	Notice Addresses and Lending Office

 EXHIBITS 
 Form of 
  

			
	A	  	Loan Notice
	B	  	Note
	C	  	Compliance Certificate
	D	  	Guaranty
	E	  	Opinion Matters

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 iv 

 AMENDED AND RESTATED CREDIT AGREEMENT 
 This AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of November 10, 2008 by and between Varian Medical
Systems, Inc., a Delaware corporation (the “Borrower”) and Bank of America, N.A. (the “Lender”). 
 The
Borrower and the Lender have entered into that Credit Agreement dated as of July 27, 2007 (the “Existing Credit Agreement”), pursuant to which the Lender has provided the Borrower a revolving credit facility. 
 The Borrower had requested the Lender to amend and restate the Existing Credit Agreement, and the Lender is willing to do so, on the terms and conditions
set forth herein. 
 In consideration of the mutual covenants and agreements herein contained, the parties hereto covenant and agree as
follows: 
 ARTICLE I. 
 DEFINITIONS AND ACCOUNTING TERMS 
 1.01 Defined Terms. As used in this Agreement, the following terms shall
have the meanings set forth below: 
 “Acquired Entity” means (a) any Person that becomes a Subsidiary of the Borrower
as a result of an Acquisition or (b) any business entity or division of a Person, all or substantially all of the assets and business of which are acquired by the Borrower or a Subsidiary of the Borrower pursuant to an Acquisition. 

“Acquisition” means any transaction or series of related transactions for the purpose of or resulting, directly or indirectly, in
(a) the acquisition of all or substantially all of the assets of a Person, or of any business or division of a Person (other than a Person that is a Subsidiary), (b) the acquisition of in excess of 50% of the capital stock, partnership
interests, membership interests or equity of any Person (other than a Person that is a Subsidiary), or otherwise causing any Person to become a Subsidiary, or (c) a merger or consolidation or any other combination with another Person (other
than a Person that is a Subsidiary). 
 “Adjusted Commitment” means, at any time, the Commitment at such time, provided that
for such purpose the entirety of clause (i) and the phrase “(ii) thereafter” shall be deemed deleted from such definition. 
 “Adjusted Repurchases” means in respect of the Borrower for any period, total repurchases, redemptions and acquisitions by the Borrower of its Equity Interests during such period (“gross repurchases”);
provided that if as of the last day of such period Total Liquidity equals or exceeds 25% of gross repurchases, then “Adjusted Repurchases” for such period shall be equal to 75% of gross repurchases. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 1 

 “Affiliate” means, with respect to any Person, another Person that directly, or
indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified. 
 “Agreement” means this Credit Agreement. 
 “Applicable Period” means, as of any date of
determination, the period of 12 months ending on such date. 
 “Applicable Rate” means the following percentages per annum,
based upon the Consolidated Leverage Ratio as set forth in the most recent Compliance Certificate received by the Lender pursuant to Section 6.02(b): 
 Applicable Rate 
  

												
	 Pricing
Level
	  	 Consolidated Leverage Ratio
	  	Commitment
Fee	 	 	Eurodollar
Rate/
Letter of
Credit
Fee+	 	 	Base
Rate+	 
	1	  	Less than or equal to 0.50:1.00	  	0.20	%	 	1.25	%	 	-0.50	%
	2	  	Greater than 0.50:1.00, but less than or equal to 1.00:1.00	  	0.25	%	 	1.375	%	 	-0.25	%
	3	  	Greater than 1.00:1.00	  	0.30	%	 	1.50	%	 	0.0	%

 Any increase or decrease in the Applicable Rate resulting from a change in the Consolidated
Leverage Ratio shall become effective as of the first Business Day immediately following the date a Compliance Certificate is delivered pursuant to Section 6.02(b); provided, however, that if a Compliance Certificate is not
delivered when due in accordance with such Section, then Pricing Level 3 shall apply as of the first Business Day after the date on which such Compliance Certificate was required to have been delivered and shall continue until the date such
Compliance Certificate is delivered. The Applicable Rate in effect from the Closing Date through the date of delivery of the Compliance Certificate in respect of the fiscal quarter ending on or about September 30, 2008 shall be determined based
upon Pricing Level 1. 
 “Approved Fund” has the meaning specified in Section 9.06(f). 
 “Attributable Indebtedness” means, on any date, (a) in respect of any capital lease of any Person, the capitalized amount thereof
that would appear on a balance sheet of such Person prepared as of such date in accordance with GAAP, and (b) in respect of any Synthetic Lease Obligation, the capitalized amount of the remaining lease payments under the relevant lease that
would appear on a balance sheet of such Person prepared as of such date in accordance with GAAP if such lease were accounted for as a capital lease. 
 “Audited Financial Statements” means the audited consolidated balance sheet of the Borrower and its Subsidiaries for the fiscal year ended September 28, 2007, and the related consolidated
statements of income or operations, shareholders’ equity and cash flows for such fiscal year of the Borrower and its Subsidiaries, including the notes thereto. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 2 

 “Availability Period” means the period from and including the Closing Date to the
earlier of (a) the Maturity Date and (b) the date of termination of the Commitment. 
 “Bankruptcy Code” means
Title 11 of the United States Code (11 U.S.C. §101, et seq.). 
 “Base Rate” means for any day a fluctuating rate per
annum equal to the higher of (a) the Federal Funds Rate plus 1/2 of 1% and (b) the rate of interest in effect for such day as publicly announced from time to time by the Lender as its “prime rate.” The “prime rate” is a
rate set by the Lender based upon various factors including the Lender’s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below
such announced rate. Any change in such rate announced by the Lender shall take effect at the opening of business on the day specified in the public announcement of such change. 
 “Base Rate Loan” means a Loan that bears interest based on the Base Rate. 
 “Borrower” has the meaning specified in the introductory paragraph hereto. 
 “Borrowing” means a borrowing consisting of simultaneous Loans of the same Type and, in the case of Eurodollar Rate Loans, having the
same Interest Period made by the Lender pursuant to Section 2.01. 
 “Business Day” means any day other than a
Saturday, Sunday or other day on which commercial banks are authorized to close under the Laws of, or are in fact closed in, the state where the Lending Office is located and, if such day relates to any Eurodollar Rate Loan, means any such day on
which dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar market. 
 “Capital
Expenditures” has the meaning specified in Section 7.12. 
 “Cash Collateralize” has the meaning
specified in Section 2.03(f). 
 “Change in Law” means the occurrence, after the date of this Agreement, of any
of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation or application thereof by any Governmental Authority
or (c) the making or issuance of any request, guideline or directive (whether or not having the force of law) by any Governmental Authority. 
 “Change of Control” means an event or series of events by which: 
 (a) any “person” or
“group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but excluding any employee benefit plan of such person or its subsidiaries, and any person or entity acting in its capacity as trustee,
agent or other fiduciary or administrator of any such plan) becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, except that a person or group shall be deemed to have
“beneficial ownership” of all securities that such person or group has the right to acquire (such right, an “option right”), whether such right is exercisable immediately or only after the 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 3 

 
passage of time), directly or indirectly, of 35% or more of the equity securities of the Borrower entitled to vote for members of the board of directors or
equivalent governing body of the Borrower on a fully-diluted basis (and taking into account all such securities that such person or group has the right to acquire pursuant to any option right); 
 (b) during any period of 12 consecutive months, a majority of the members of the board of directors or other equivalent governing body of
the Borrower cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by
individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or other equivalent
governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body (excluding, in the case of both
clause (ii) and clause (iii), any individual whose initial nomination for, or assumption of office as, a member of that board or equivalent governing body occurs as a result of an actual or threatened solicitation of proxies or consents for the
election or removal of one or more directors by any person or group other than a solicitation for the election of one or more directors by or on behalf of the board of directors); or 
 (c) any Person or two or more Persons acting in concert shall have acquired by contract or otherwise, or shall have entered into a
contract or arrangement that, upon consummation thereof, will result in its or their acquisition of the power to exercise, directly or indirectly, a controlling influence over the management or policies of the Borrower, or control over the equity
securities of the Borrower entitled to vote for members of the board of directors or equivalent governing body of the Borrower on a fully-diluted basis (and taking into account all such securities that such Person or group has the right to acquire
pursuant to any option right) representing 35% or more of the combined voting power of such securities. 
 “Closing Date”
means the first date all the conditions precedent in Section 4.01 are satisfied or waived by the Lender. 
 “Code” means the Internal Revenue Code of 1986. 
 “Commitment” means the obligation of the Lender
to make Loans and L/C Credit Extensions hereunder in an aggregate principal amount at any one time not to exceed (i) at any date prior to the Supplemental Authorization Date, One Hundred Million Dollars ($100,000,000) and (ii) thereafter,
One Hundred Fifty Million Dollars ($150,000,000), as such amount may be adjusted from time to time in accordance with this Agreement. 
 “Compliance Certificate” means a certificate substantially in the form of Exhibit C. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 4 

 “Consolidated EBITDA” means, for any period, for the Borrower and its Subsidiaries on a
consolidated basis, an amount equal to Consolidated Net Income for such period plus (a) the following to the extent deducted in calculating such Consolidated Net Income: (i) Consolidated Interest Charges for such period,
(ii) the provision for Federal, state, local and foreign income taxes payable by the Borrower and its Subsidiaries for such period (net of tax credits), (iii) depreciation and amortization expense, and (iv) other non-recurring
expenses of the Borrower and its Subsidiaries reducing such Consolidated Net Income which do not represent a cash item in such period or any future period and minus (b) to the extent included in calculating such Consolidated Net Income,
all non-cash items increasing Consolidated Net Income for such period. 
 “Consolidated Funded Indebtedness” means, as of
any date of determination, for the Borrower and its Subsidiaries on a consolidated basis, the sum of (a) the outstanding principal amount of all obligations, whether current or long-term, for borrowed money (including Obligations hereunder) and
all obligations evidenced by bonds, debentures, notes, loan agreements or other similar instruments, (b) all purchase money Indebtedness, (c) all direct obligations arising under letters of credit (including standby and commercial),
bankers’ acceptances, bank guaranties, surety bonds and similar instruments, (d) all obligations in respect of the deferred purchase price of property or services (other than trade accounts payable in the ordinary course of business),
(e) Attributable Indebtedness in respect of capital leases and Synthetic Lease Obligations, (f) without duplication, all Guarantees with respect to outstanding Indebtedness of the types specified in clauses (a) through (e) above
of Persons other than the Borrower or any Subsidiary, and (g) all Indebtedness of the types referred to in clauses (a) through (f) above of any partnership or joint venture (other than a joint venture that is itself a corporation or
limited liability company) in which the Borrower or a Subsidiary is a general partner or joint venturer, unless such Indebtedness is expressly made non-recourse to the Borrower or such Subsidiary. Notwithstanding the foregoing, in no event shall
“Consolidated Funded Indebtedness” include or be deemed to include the obligations or Indebtedness resulting from the consolidation of FIN 46 Entities, except to the extent that such Indebtedness and obligations at any time exceed in the
aggregate $[****]. 
 “Consolidated Fixed Charge Coverage Ratio” means, as of any date of determination, the ratio of
(a) Consolidated EBITDA for the period of the four prior fiscal quarters ending on such date less (i) Capital Expenditures for such period less (ii) dividends in respect of Equity Interests of the Borrower and Adjusted Repurchases for
such period, less (iii) cash taxes paid for such period, to (b) Consolidated Fixed Charges for such period. 
 “Consolidated Fixed Charges” means, for any period, for the Borrower and its Subsidiaries on a consolidated basis, the sum of (a) Consolidated Interest Charges for such period, and (b) all scheduled principal
payments in respect of Indebtedness for the four fiscal quarter period following the last day of such period. 
 “Consolidated
Interest Charges” means, for any period, for the Borrower and its Subsidiaries on a consolidated basis, interest expense determined in accordance with GAAP, consistently applied, less the amount of interest expense resulting from the
consolidation of FIN 46 Entities, to the extent the related Indebtedness is disregarded pursuant to the last sentence of “Consolidated Funded Indebtedness”. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 5 

 “Consolidated Leverage Ratio” means, as of any date of determination, the ratio of
(a) Consolidated Funded Indebtedness as of such date to (b) Consolidated EBITDA for the period of the four fiscal quarters most recently ended. 
 “Consolidated Net Income” means, for any period, for the Borrower and its Subsidiaries on a consolidated basis, the net income of the Borrower and its Subsidiaries (excluding extraordinary gains but
including extraordinary losses) for that period; provided, however, Consolidated Net Income shall exclude income resulting from the consolidation of FIN 46 Entities. 
 “Consolidated Tangible Net Worth” means, as of any date of determination, for the Borrower and its Subsidiaries on a consolidated basis,
Shareholders’ Equity of the Borrower and its Subsidiaries on that date minus the Intangible Assets of the Borrower and its Subsidiaries on that date. Notwithstanding the foregoing, Consolidated Tangible Net Worth shall be calculated
without reference to the effect of consolidation of FIN 46 Entities. 
 “Contractual Obligation” means, as to any Person,
any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound. 
 “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a
Person, whether through the ability to exercise voting power, by contract or otherwise. “Controlling” and “Controlled” have meanings correlative thereto. 
 “Credit Extension” means each of the following: (a) a borrowing of a Loan and (b) an L/C Credit Extension. 
 “Debtor Relief Laws” means the Bankruptcy Code of the United States, and all other liquidation, conservatorship, bankruptcy, assignment
for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief Laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors
generally. 
 “Default” means any event or condition that constitutes an Event of Default or that, with the giving of any
notice, the passage of time, or both, would be an Event of Default. 
 “Default Rate” means (a) when used with respect
to Obligations other than Letter of Credit Fees, an interest rate equal to the Base Rate plus 2% per annum; provided, however, that with respect to a Eurodollar Rate Loan, the Default Rate shall be an interest rate equal to
the interest rate (including any Applicable Rate) otherwise applicable to such Loan plus 2% per annum, and (b) when used with respect to Letter of Credit Fees, a rate equal to the Applicable Rate plus 2% per annum. 

“Disposition” or “Dispose” means the sale, transfer, license, lease or other disposition (including any sale and
leaseback transaction) of any property by any Person, including any sale, assignment, transfer or other disposal, with or without recourse, of any notes or accounts receivable or any rights and claims associated therewith. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 6 

 “Dollar” and “$” mean lawful money of the United States. 
 “Domestic Subsidiary” means any Subsidiary that is organized under the laws of any political subdivision of the United States.

 “Eligible Assignee” has the meaning specified in Section 9.06(f). 
 “Environmental Laws” means any and all Federal, state, local, and foreign statutes, laws, regulations, ordinances, rules, judgments,
orders, decrees, permits, concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution and the protection of the environment or the release of any materials into the environment, including those related to
hazardous substances or wastes, air emissions and discharges to waste or public systems. 
 “Equity Interests” means, with
respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or
other ownership or profit interests in) such Person, all of the securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in) such Person or warrants, rights or options for the purchase or
acquisition from such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting, and whether or not such
shares, warrants, options, rights or other interests are outstanding on any date of determination. 
 “ERISA” means the
Employee Retirement Income Security Act of 1974. 
 “ERISA Affiliate” means any trade or business (whether or not
incorporated) under common control with the Borrower within the meaning of Section 414(b) or (c) of the Code (and Sections 414(m) and (o) of the Code for purposes of provisions relating to Section 412 of the Code). 
 “ERISA Event” means (a) a Reportable Event with respect to a Pension Plan; (b) a withdrawal by the Borrower or any ERISA
Affiliate from a Pension Plan subject to Section 4063 of ERISA during a plan year in which it was a substantial employer (as defined in Section 4001(a)(2) of ERISA) or a cessation of operations that is treated as such a withdrawal under
Section 4062(e) of ERISA; (c) a complete or partial withdrawal by the Borrower or any ERISA Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan is in reorganization; (d) the filing of a notice of intent to
terminate, the treatment of a Plan amendment as a termination under Sections 4041 or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a Pension Plan or Multiemployer Plan; (e) an event or condition which constitutes
grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan or Multiemployer Plan; or (f) the imposition of any liability under Title IV of ERISA, other than for PBGC premiums
due but not delinquent under Section 4007 of ERISA, upon the Borrower or any ERISA Affiliate. 
 “Eurocurrency
liabilities” has the meaning specified in Section 3.04(e). 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 7 

 “Eurodollar Rate” means, for any Interest Period with respect to a Eurodollar Rate Loan,
the rate per annum equal to the British Bankers Association LIBOR Rate (“BBA LIBOR”), as published by Reuters (or other commercially available source providing quotations of BBA LIBOR as designated by the Lender from time to time)
at approximately 11:00 a.m., London time, two Business Days prior to the commencement of such Interest Period, for Dollar deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period. If such rate
is not available at such time for any reason, then the “Eurodollar Rate” for such Interest Period shall be the rate per annum determined by the Lender to be the rate at which deposits in Dollars for delivery on the first day of such
Interest Period in same day funds in the approximate amount of the Eurodollar Rate Loan being made, continued or converted by the Lender and with a term equivalent to such Interest Period would be offered by Lender’s London Branch to major
banks in the London interbank eurodollar market at their request at approximately 11:00 a.m. (London time) two Business Days prior to the commencement of such Interest Period. 
 “Eurodollar Rate Loan” means a Loan that bears interest at a rate based on the Eurodollar Rate. 
 “Event of Default” has the meaning specified in Section 8.01. 
 “Excluded Taxes” means, with respect to the Lender or any other recipient of any payment to be made by or on account of any obligation
of the Borrower hereunder, (a) taxes imposed on or measured by its overall net income (however denominated), and franchise taxes imposed on it (in lieu of net income taxes), by the jurisdiction (or any political subdivision thereof) under the
laws of which such recipient is organized or in which its principal office is located or, in the case of the Lender, in which its applicable Lending Office is located, and (b) any branch profits taxes imposed by the United States or any similar
tax imposed by any other jurisdiction in which the Borrower is located. 
 “Exempt Subsidiary” has the meaning specified in
Section 6.13. 
 “Existing Credit Agreement” has the meaning specified in the recitals hereto. 
 “Extension Effective Date” has the meaning specified in Section 2.12(b). 
 “FDA” means the U.S. Food and Drug Administration, together with any comparable regulatory agency or other Governmental Authority
existing under the laws of any non-U.S. jurisdiction. 
 “FDA Regulations” means any Laws relating to or administered by the
FDA. 
 “Federal Funds Rate” means, for any day, the rate per annum equal to the weighted average of the rates on overnight
Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, as published by the Federal Reserve Bank of New York on the Business Day next succeeding such day; provided that (a) if
such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next succeeding Business Day, and (b) if no such rate is so published on such
next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate (rounded upward, if necessary, to a whole multiple of 1/100 of 1%) charged to the Lender on such day on such transactions as determined by the Lender.

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 8 

 “FIN 46 Entity” means any Person, that is not otherwise a Subsidiary of the Borrower,
whose assets or liabilities are required to be consolidated with Borrower under FIN 46(R)- “Consolidation of Variable Interest Entities” published by the Financial Accounting Standards Board. 
 “First Tier Foreign Subsidiary” means a Foreign Subsidiary that is a direct Subsidiary of the Borrower or of a Domestic Subsidiary.

 “Foreign Lender” means any Eligible Assignee that becomes an assignee of Loans hereunder and is organized under the laws
of a jurisdiction other than that in which the Borrower is resident for tax purposes. For purposes of this definition, the United States, each State thereof and the District of Columbia shall be deemed to constitute a single jurisdiction.

 “Foreign Subsidiary” means any Subsidiary other than a Domestic Subsidiary. 
 “Foreign Subsidiary Holding Company” means, as of any time of determination, a Domestic Subsidiary that at such time (i) holds
Equity Interests of one or more Foreign Subsidiaries, (ii) conducts no business or financial operations, (iii) has no Indebtedness, (iv) holds no assets other than assets incidental to the ownership of such Equity Interests of such
Foreign Subsidiaries, and (v) has no Liens on any of its assets . 
 “FRB” means the Board of Governors of the Federal
Reserve System of the United States. 
 “Fund” has the meaning specified in Section 9.06(f). 
 “GAAP” means generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the
Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the
accounting profession in the United States, that are applicable to the circumstances as of the date of determination, consistently applied. 
 “Governmental Authority” means the government of the United States or any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court,
central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central
Bank). 
 “Guarantee” means, as to any Person, (a) any obligation, contingent or otherwise, of such Person guaranteeing
or having the economic effect of guaranteeing any Indebtedness or other obligation payable or performable by another Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of such Person,
direct or 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 9 

 
indirect, (i) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation, (ii) to
purchase or lease property, securities or services for the purpose of assuring the obligee in respect of such Indebtedness or other obligation of the payment or performance of such Indebtedness or other obligation, (iii) to maintain working
capital, equity capital or any other financial statement condition or liquidity or level of income or cash flow of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation, or (iv) entered into for
the purpose of assuring in any other manner the obligee in respect of such Indebtedness or other obligation of the payment or performance thereof or to protect such obligee against loss in respect thereof (in whole or in part), or (b) any Lien
on any assets of such Person securing any Indebtedness or other obligation of any other Person, whether or not such Indebtedness or other obligation is assumed by such Person (or any right, contingent or otherwise, of any holder of such Indebtedness
to obtain any such Lien). The amount of any Guarantee shall be deemed to be an amount equal to the stated or determinable amount of the related primary obligation, or portion thereof, in respect of which such Guarantee is made or, if not stated or
determinable, the maximum reasonably anticipated liability in respect thereof as determined by the guaranteeing Person in good faith. The term “Guarantee” as a verb has a corresponding meaning. 
 “Guarantor Assessment Date” means each of (i) any date on which the Borrower delivers or is obligated to deliver to the Lender its
annual financial statements under Section 6.01(a), (ii) any date on which the Borrower consummates any Acquisition, or acquires or creates any new or additional Subsidiary, (iii) any date on which the Borrower sells, transfers,
divests or otherwise disposes of any Subsidiary or all or substantially of the assets of any Subsidiary, and (iv) any date on which a Domestic Subsidiary previously deemed a Foreign Subsidiary Holding Company ceases to be a Foreign Subsidiary
Holding Company. 
 “Guarantors” means any and all Persons that have executed or are required to execute the Guaranty
pursuant to Section 6.13(a), other than Persons deemed released from the Guaranty pursuant to Section 6.13(b). 
 “Guaranty” means the Guaranty made by the Guarantor in favor of the Lender, substantially in the form of Exhibit D. 
 “Honor Date” has the meaning specified in Section 2.03(c)(i). 
 “Indebtedness” means, as to any Person at a particular time, without duplication, all of the following, whether or not included as indebtedness or liabilities in accordance with GAAP: 
 (a) all obligations of such Person for borrowed money and all obligations of such Person evidenced by bonds, debentures, notes, loan
agreements or other similar instruments; 
 (b) all direct or contingent obligations of such Person arising under letters of
credit (including standby and commercial), bankers’ acceptances, bank guaranties, surety bonds and similar instruments; 
 (c) net obligations of such Person under any Swap Contract; 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 10 

 (d) all obligations of such Person to pay the deferred purchase price of property or
services (other than trade accounts payable in the ordinary course of business and, in each case, not past due for more than 120 days after the date on which such trade account payable was created); 
 (e) indebtedness (excluding prepaid interest thereon) secured by a Lien on property owned or being purchased by such Person (including
indebtedness arising under conditional sales or other title retention agreements), whether or not such indebtedness shall have been assumed by such Person or is limited in recourse; 
 (f) capital leases and Synthetic Lease Obligations; 
 (g) all obligations of such Person to purchase, redeem, retire, defease or otherwise make any payment in respect of any Equity Interest in
such Person or any other Person, valued, in the case of a redeemable preferred interest, at the greater of its voluntary or involuntary liquidation preference plus accrued and unpaid dividends; and 
 (h) all Guarantees of such Person in respect of any of the foregoing. 
 For all purposes hereof, the Indebtedness of any Person shall include the Indebtedness of any partnership or joint venture (other than a joint venture
that is itself a corporation or limited liability company) in which such Person is a general partner or a joint venturer, unless such Indebtedness is expressly made non-recourse to such Person. The amount of any net obligation under any Swap
Contract on any date shall be deemed to be the Swap Termination Value thereof as of such date. The amount of any capital lease or Synthetic Lease Obligation as of any date shall be deemed to be the amount of Attributable Indebtedness in respect
thereof as of such date. 
 “Indemnified Taxes” means Taxes other than Excluded Taxes. 
 “Indemnitees” has the meaning specified in Section 9.04(b). 
 “Information” has the meaning specified in Section 9.07(b). 
 “Intangible Assets” means assets that are considered to be intangible assets under GAAP, including customer lists, goodwill, computer
software, copyrights, trade names, trademarks, patents, franchises, licenses, unamortized deferred charges, unamortized debt discount and capitalized research and development costs. 
 “Interest Payment Date” means, (a) as to any Loan other than a Base Rate Loan, the last day of each Interest Period applicable to
such Loan and the Maturity Date; provided, however, that if any Interest Period for a Eurodollar Rate Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period shall also
be Interest Payment Dates; and (b) as to any Base Rate Loan, the last Business Day of each March, June, September and December and the Maturity Date. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 11 

 “Interest Period” means, as to each Eurodollar Rate Loan, the period commencing on the
date such Eurodollar Rate Loan is disbursed or converted to or continued as a Eurodollar Rate Loan and ending on the date one, two, three or six months thereafter, as selected by the Borrower in its Loan Notice; provided that: 
 (i) any Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business Day
unless such Business Day falls in another calendar month, in which case such Interest Period shall end on the next preceding Business Day; 
 (ii) any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on
the last Business Day of the calendar month at the end of such Interest Period; and 
 (iii) no Interest Period shall extend
beyond the Maturity Date. 
 “Investment” means, as to any Person, any direct or indirect acquisition or investment by such
Person, whether by means of (a) the purchase or other acquisition of capital stock or other securities of another Person, (b) a loan, advance or capital contribution to, Guarantee or assumption of debt of, or purchase or other acquisition
of any other debt or equity participation or interest in, another Person, including any partnership or joint venture interest in such other Person and any arrangement pursuant to which the investor Guarantees Indebtedness of such other Person, or
(c) the purchase or other acquisition (in one transaction or a series of transactions) of assets of another Person that constitute a business unit. For purposes of covenant compliance, the amount of any Investment shall be the amount actually
invested, without adjustment for subsequent increases or decreases in the value of such Investment. 
 “IP Rights” has the
meaning specified in Section 5.16. 
 “IRS” means the United States Internal Revenue Service. 
 “ISP” means, with respect to any Letter of Credit, the “International Standby Practices 1998” published by the Institute of
International Banking Law & Practice (or such later version thereof as may be in effect at the time of issuance). 
 “Issuer
Documents” means with respect to any Letter of Credit, the Letter of Credit Application, and any other document, agreement and instrument entered into by the Lender and the Borrower (or any Subsidiary) or in favor the Lender and relating to
any such Letter of Credit. 
 “Laws” means, collectively, all international, foreign, Federal, state and local statutes,
treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation
or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 12 

 “L/C Borrowing” means an extension of credit resulting from a drawing under any Letter
of Credit which has not been reimbursed on the date when made or refinanced as a Borrowing. 
 “L/C Credit Extension” means,
with respect to any Letter of Credit, the issuance thereof or extension of the expiry date thereof, or the increase of the amount thereof. 
 “L/C Obligations” means, as at any date of determination, the aggregate amount available to be drawn under all outstanding Letters of Credit plus the aggregate of all Unreimbursed Amounts, including all L/C
Borrowings. For purposes of computing the amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with Section 1.06. For all purposes of this Agreement, if on any
date of determination a Letter of Credit has expired by its terms but any amount may still be drawn thereunder by reason of the operation of Rule 3.14 of the ISP, such Letter of Credit shall be deemed to be “outstanding” in the amount so
remaining available to be drawn. 
 “Lender” has the meaning specified in the introductory paragraph hereto. 
 “Lending Office” means the office or offices of the Lender described as such on Schedule 9.02, or such other office or
offices as the Lender may from time to time notify the Borrower. 
 “Letter of Credit” means any standby letter of credit
issued hereunder. 
 “Letter of Credit Application” means an application and agreement for the issuance or amendment of a
Letter of Credit in the form from time to time in use by the Lender. 
 “Letter of Credit Expiration Date” means the day
that is seven days prior to the Maturity Date then in effect (or, if such day is not a Business Day, the next preceding Business Day). 
 “Letter of Credit Fee” has the meaning specified in Section 2.03(h). 
 “Letter of Credit
Sublimit” means an amount equal to $25,000,000. The Letter of Credit Sublimit is part of, and not in addition to, the Commitment. 
 “Lien” means any mortgage, pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or other), charge, or preference, priority or other security interest or preferential arrangement in the nature
of a security interest of any kind or nature whatsoever (including any conditional sale or other title retention agreement, any easement, right of way or other encumbrance on title to real property, and any financing lease having substantially the
same economic effect as any of the foregoing). 
 “Loan” has the meaning specified in Section 2.01. 

“Loan Documents” means this Agreement, any Note, each Issuer Document, the Guaranty and each Pledge Agreement. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 13 

 “Loan Notice” means a notice of (a) a borrowing of a Loan, (b) a conversion of
a Loan from one Type to the other, or (c) a continuation of a Eurodollar Rate Loan as the same Type, pursuant to Section 2.02(a), which, if in writing, shall be substantially in the form of Exhibit A. 
 “Loan Parties” means, collectively, the Borrower, each Guarantor and each “Grantor” or “Pledgor” under and as
defined in any Pledge Agreement. 
 “Material Adverse Effect” means (a) a material adverse change in, or a material
adverse effect upon, the operations, business, properties, liabilities (actual or contingent), condition (financial or otherwise) of the Borrower and its Subsidiaries taken as a whole; (b) a material impairment of the ability of any Loan Party
to perform its obligations under any Loan Document to which it is a party; or (c) a material adverse effect upon the legality, validity, binding effect or enforceability against any Loan Party of any Loan Document to which it is a party.

 “Material Subsidiary” means (a) as of the last day of any fiscal year of the Borrower, any Subsidiary that has
(i) total revenues for the four fiscal quarter period ending on such date equal to or greater than 15% of the consolidated total revenues of the Borrower and its Subsidiaries during such four fiscal quarter period or (ii) holds assets as
of such date equal to or greater than 15% of the consolidated total assets of the Borrower and its Subsidiaries; and (b) as of any other Guarantor Assessment Date, any Subsidiary that has, on a pro forma basis, based upon the then-most recently
delivered financial statements provided to the Lender under Section 6.01(a) or (b) and giving effect to such acquisition, divestiture or creation, as though occurring on the first day of the four fiscal quarter period ending
on the effective date of such delivered financial statements, (i) total revenues during the immediately preceding four fiscal quarter period then-most recently ended equal to or greater than 15% of the consolidated total revenues of the
Borrower and its Subsidiaries for such period, or (ii) total assets equal to or greater than 15% of the consolidated total assets of the Borrower and its Subsidiaries on such date. 
 “Maturity Date” means November 10, 2011. 
 “Maximum Rate” has the meaning specified in Section 9.09. 
 “Multiemployer Plan” means any employee benefit plan of the type described in Section 4001(a)(3) of ERISA, to which the Borrower or any ERISA Affiliate makes or is obligated to make contributions, or during the
preceding five plan years, has made or been obligated to make contributions. 
 “Note” means a promissory note made by the
Borrower in favor of the Lender evidencing Loans made by the Lender, substantially in the form of Exhibit B. 
 “Note
Purchase Agreement” means that Amended and Restated Note Purchase and Private Shelf Agreement dated as of April 2, 1999 between the Borrower and The Prudential Insurance Company of America. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 14 

 “Obligations” means all advances to, and debts, liabilities, obligations, covenants and
duties of, any Loan Party arising under any Loan Document or otherwise with respect to any Loan or Letter of Credit, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or
hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party or any Affiliate thereof of any proceeding under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless
of whether such interest and fees are allowed claims in such proceeding. 
 “Organization Documents” means, (a) with
respect to any corporation, the certificate or articles of incorporation and the bylaws (or equivalent or comparable constitutive documents with respect to any non-U.S. jurisdiction); (b) with respect to any limited liability company, the
certificate or articles of formation or organization and operating agreement; and (c) with respect to any partnership, joint venture, trust or other form of business entity, the partnership, joint venture or other applicable agreement of
formation or organization and any agreement, instrument, filing or notice with respect thereto filed in connection with its formation or organization with the applicable Governmental Authority in the jurisdiction of its formation or organization
and, if applicable, any certificate or articles of formation or organization of such entity. 
 “Original Closing Date”
means July 27, 2007, the “Closing Date” under and as defined in the Existing Credit Agreement. 
 “Other
Taxes” means all present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies arising from any payment made hereunder or under any other Loan Document or from the execution, delivery or
enforcement of, or otherwise with respect to, this Agreement or any other Loan Document. 
 “Outstanding Amount” means
(i) with respect to Loans on any date, the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of Loans occurring on such date; and (ii) with respect to any L/C Obligations on
any date, the amount of such L/C Obligations on such date after giving effect to any L/C Credit Extension occurring on such date and any other changes in the aggregate amount of the L/C Obligations as of such date, including as a result of any
reimbursements by the Borrower of Unreimbursed Amounts. 
 “Participant” has the meaning specified in
Section 9.06(c). 
 “PBGC” means the Pension Benefit Guaranty Corporation. 
 “Pension Plan” means any “employee pension benefit plan” (as such term is defined in Section 3(2) of ERISA), other than a
Multiemployer Plan, that is subject to Title IV of ERISA and is sponsored or maintained by the Borrower or any ERISA Affiliate or to which the Borrower or any ERISA Affiliate contributes or has an obligation to contribute, or in the case of a
multiple employer or other plan described in Section 4064(a) of ERISA, has made contributions at any time during the immediately preceding five plan years. 
 “Permitted Liens” has the meaning specified in Section 7.01. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 15 

 “Person” means any natural person, corporation, limited liability company, trust, joint
venture, association, company, partnership, Governmental Authority or other entity. 
 “Plan” means any “employee
benefit plan” (as such term is defined in Section 3(3) of ERISA) established by the Borrower or, with respect to any such plan that is subject to Section 412 of the Code or Title IV of ERISA, any ERISA Affiliate. 
 “Pledge Agreement” means a pledge agreement in favor of the Lender, in form and substance satisfactory to the Lender. 
 “Pledged Collateral” has the meaning specified in each Pledge Agreement. 
 “Registered Public Accounting Firm” has the meaning specified in the Securities Laws and shall be independent of the Borrower as
prescribed by the Securities Laws. 
 “Related Parties” means, with respect to any Person, such Person’s Affiliates and
the partners, directors, officers, employees, agents and advisors of such Person and of such Person’s Affiliates. 
 “Reportable
Event” means any of the events set forth in Section 4043(c) of ERISA, other than events for which the 30-day notice period has been waived. 
 “Request for Credit Extension” means (a) with respect to a Borrowing, conversion or continuation of a Loan, a Loan Notice, and (b) with respect to an L/C Credit Extension, a Letter of Credit
Application. 
 “Responsible Officer” means the chief executive officer, president, chief financial officer, treasurer,
assistant treasurer, controller or secretary of a Loan Party. Any document delivered hereunder that is signed by a Responsible Officer of a Loan Party shall be conclusively presumed to have been authorized by all necessary corporate, partnership
and/or other action on the part of such Loan Party and such Responsible Officer shall be conclusively presumed to have acted on behalf of such Loan Party. 
 “Restricted Payment” means any dividend or other distribution (whether in cash, securities or other property) with respect to any capital stock or other Equity Interest of the Borrower or any
Subsidiary, or any payment (whether in cash, securities or other property), including any sinking fund or similar deposit, on account of the purchase, redemption, retirement, acquisition, cancellation or termination of any such capital stock or
other Equity Interest, or on account of any return of capital to the Borrower’s stockholders, partners or members (or the equivalent Person thereof). 
 “Sarbanes-Oxley” means the Sarbanes-Oxley Act of 2002. 
 “SEC” means the
Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 16 

 “Securities Laws” means the Securities Act of 1933, the Securities Exchange Act of 1934,
Sarbanes-Oxley and the applicable accounting and auditing principles, rules, standards and practices promulgated, approved or incorporated by the SEC or the Public Company Accounting Oversight Board, as each of the foregoing may be amended and in
effect on any applicable date hereunder. 
 “Shareholders’ Equity” means, as of any date of determination, consolidated
shareholders’ equity of the Borrower and its Subsidiaries as of that date determined in accordance with GAAP. 
 “Significant
Subsidiary” means, as of any date of determination, any Subsidiary having, as of the then-most recent fiscal quarter-end end date for which financial statements are available, total assets of not less than $10,000,000. 
 “Single Transaction Limit” means $[****]. 
 “Solvent” means, with respect to any Person as of a particular date, that on such date (a) such Person is able to pay its debts and other liabilities, contingent obligations and other commitments
as they mature in the normal course of business, (b) such Person does not intend to, and does not believe that it will, incur debts or liabilities beyond such Person’s ability to pay as such debts and liabilities mature in their ordinary
course, (c) such Person is not engaged in a business or transaction, and is not about to engage in a business or a transaction, for which such Person’s assets would constitute unreasonably small capital after giving due consideration to
the prevailing practice in the industry in which such Person is engaged or is to engage, (d) the fair value of the assets of such Person is greater than the total amount of liabilities, including contingent liabilities, of such Person, and
(e) the aggregate fair saleable value (i.e., the amount that may be realized within a reasonable time, considered to be six months to one year, either through collection or sale at the regular market value, conceiving the latter as the amount
that could be obtained for the assets in question within such period by a capable and diligent businessman from an interested buyer who is willing to purchase under ordinary selling conditions) of the assets of such Person will exceed its debts and
other liabilities (including contingent, subordinated, unmatured and unliquidated debts and liabilities). For purposes of this definition, “debt” means any liability on a claim, and “claim” means (i) a right to payment,
whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured, or (ii) a right to an equitable remedy for breach of performance
if such breach gives rise to a payment, whether or not such right is an equitable remedy, is reduced judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, secured or unsecured. 
 “Specified Period” means, as of any date of determination, the most recent four-fiscal quarter period prior to such date for which
financial statements have been delivered hereunder. 
 “Subsidiary” of a Person means a corporation, partnership, joint
venture, limited liability company or other business entity of which a majority of the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other than securities or interests
having such power only by reason of the happening of a contingency) are at the time beneficially owned, or the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person. Unless
otherwise specified, all references herein to a “Subsidiary” or to “Subsidiaries” shall refer to a Subsidiary or Subsidiaries of the Borrower. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 17 

 “Supplemental Authorization Date” means the date the Borrower delivers to the Lender the
Supplemental Authorization Documents. 
 “Supplemental Authorization Documents” means, collectively the following, each in
form and substance satisfactory to the Lender: (i) certified resolutions of the Borrower’s board of directors authorizing Borrowings and Credit Extensions hereunder to the amount of $150,000,000, and (ii) a favorable opinion of
counsel to the Loan Parties, addressed to the Lender, as to the matters set forth in Exhibit E and such other matters concerning the Loan Parties and the Loan Documents as the Lender may reasonably request. 
 “Swap Contract” means (a) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate
transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions,
interest rate options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, or any other similar
transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement, and (b) any and all transactions of any
kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master
Agreement, or any other master agreement (any such master agreement, together with any related schedules, a “Master Agreement”), including any such obligations or liabilities under any Master Agreement. 
 “Swap Termination Value” means, in respect of any one or more Swap Contracts, after taking into account the effect of any legally
enforceable netting agreement relating to such Swap Contracts, (a) for any date on or after the date such Swap Contracts have been closed out and termination value(s) determined in accordance therewith, such termination value(s), and
(b) for any date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market value(s) for such Swap Contracts, as determined based upon one or more mid-market or other readily available quotations provided by any
recognized dealer in such Swap Contracts (which may include the Lender or any Affiliate of the Lender). 
 “Synthetic Lease
Obligation” means the monetary obligation of a Person under (a) a so-called synthetic, off-balance sheet or tax retention lease, or (b) an agreement for the use or possession of property creating obligations that do not appear on
the balance sheet of such Person but which, upon the insolvency or bankruptcy of such Person, would be characterized as the indebtedness of such Person (without regard to accounting treatment). 
 “Taxes” means all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges imposed
by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 18 

 “Threshold Amount” means $[****]. 
 “Total Consideration” means, in respect of any Acquisition undertaken by the Borrower or its Subsidiaries, total consideration paid or
agreed to be paid by the Borrower or its Subsidiaries in connection therewith, including consideration consisting of (i) cash and cash equivalents, (ii) Equity Interests of the Borrower, (iii) licenses granted or received in
connection therewith in respect of IP Rights, (iv) the assumption of Indebtedness or other obligations or liabilities of the Acquired Entity existing prior to such Acquisition, and (v) earn-out and similar payments contingent on future
performance or revenues. 
 “Total Liquidity” means, as of any date of determination for the Borrower and its Subsidiaries
on a consolidated basis, the sum, without duplication, of (i) cash, (ii) cash-equivalents, and (iii) marketable securities. 
 “Total Outstandings” means, as of any date of determination, the aggregate Outstanding Amount of all Loans and all L/C Obligations as of such date. 
 “Type” means, with respect to a Loan, its character as a Base Rate Loan or a Eurodollar Rate Loan. 
 “Unfunded Pension Liability” means the excess of a Pension Plan’s benefit liabilities under Section 4001(a)(16) of ERISA, over
the current value of that Pension Plan’s assets, determined in accordance with the assumptions used for funding the Pension Plan pursuant to Section 412 of the Code for the applicable plan year. 
 “United States” and “U.S.” mean the United States of America. 
 “Unreimbursed Amount” has the meaning specified in Section 2.03(c)(i). 
 “Voting Stock” means securities, ownership interests or membership interests of any class or classes of a business entity, the holders
of which are ordinarily, in the absence of contingencies, (a) entitled to elect a majority of the corporate directors (or Persons performing similar functions), if such entity is a corporation, (b) entitled to cast a majority of the votes
on the general business matters of such entity, or (c) entitled to act as the sole general partner or sole manager, or entitled to elect the manager or managing partner of such entity. 
 1.02 Other Interpretive Provisions. With reference to this Agreement and each other Loan Document, unless otherwise specified herein or in
such other Loan Document: 
 (a) The definitions of terms herein shall apply equally to the singular and plural forms of the
terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include,” “includes” and “including” shall be deemed to
be followed by the phrase “without limitation.” The word “will” shall be construed to have the same meaning and effect as the word “shall.” Unless the context requires otherwise, (i) any definition of
or reference to any agreement, instrument or other document (including any Organization Document) shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified
(subject to any restrictions on such amendments, 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 19 

 
supplements or modifications set forth herein or in any other Loan Document), (ii) any reference herein to any Person shall be construed to include such
Person’s successors and assigns, (iii) the words “herein,” “hereof” and “hereunder,” and words of similar import when used in any Loan Document, shall be construed to refer to such Loan
Document in its entirety and not to any particular provision thereof, (iv) all references in a Loan Document to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to,
the Loan Document in which such references appear, (v) any reference to any law shall include all statutory and regulatory provisions consolidating, amending, replacing or interpreting such law and any reference to any law or regulation shall,
unless otherwise specified, refer to such law or regulation as amended, modified or supplemented from time to time, and (vi) the words “asset” and “property” shall be construed to have the same meaning and
effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights. 
 (b) In the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including;” the words “to” and
“until” each mean “to but excluding;” and the word “through” means “to and including.” 
 (c) Section headings herein and in the other Loan Documents are included for convenience of reference only and shall not affect the interpretation of this Agreement or any other Loan Document. 
 1.03 Accounting Terms. 
 (a) Generally. All accounting terms not specifically or completely defined herein shall be construed in conformity with, and all financial data (including financial ratios and other financial calculations) required to be submitted
pursuant to this Agreement shall be prepared in conformity with, GAAP applied on a consistent basis, as in effect from time to time, applied in a manner consistent with that used in preparing the Audited Financial Statements, except as
otherwise specifically prescribed herein. 
 (b) Changes in GAAP. If at any time any change in GAAP would affect the
computation of any financial ratio or requirement set forth in any Loan Document, and either the Borrower or the Lender shall so request, the Lender and the Borrower shall negotiate in good faith to amend such ratio or requirement to preserve the
original intent thereof in light of such change in GAAP (subject to the approval of the Lender), provided that, until so amended, (i) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein
and (ii) the Borrower shall provide to the Lender financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made
before and after giving effect to such change in GAAP. 
 (c) Consolidation of Variable Interest Entities. All
references herein to consolidated financial statements of the Borrower and its Subsidiaries or to the determination of any amount for the Borrower and its Subsidiaries on a consolidated basis or any similar reference shall, in each case, unless
otherwise expressly provided, be deemed to include each variable interest entity that the Borrower is required to consolidate pursuant to FASB Interpretation No. 46 – Consolidation of Variable Interest Entities: an interpretation of ARB
No. 51 (January 2003) as if such variable interest entity were a Subsidiary as defined herein. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 20 

 1.04 Rounding. Any financial ratios required to be maintained by the Borrower pursuant to
this Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the
nearest number (with a rounding-up if there is no nearest number). 
 1.05 Times of Day. Unless otherwise specified, all
references herein to times of day shall be references to Pacific time (daylight or standard, as applicable). 
 1.06 Letter of Credit
Amounts. Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the stated amount of such Letter of Credit in effect at such time; provided, however, that with respect to any Letter of
Credit that, by its terms or the terms of any Issuer Document related thereto, provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed to be the maximum stated amount of such
Letter of Credit after giving effect to all such increases, whether or not such maximum stated amount is in effect at such time. 
 ARTICLE
II. 
 THE COMMITMENT AND CREDIT EXTENSIONS 
 2.01 Loans. Subject to the terms and conditions set forth herein, the Lender agrees to make loans (each such loan, a “Loan”) to the Borrower from time to time, on any Business Day during the
Availability Period, in an aggregate amount not to exceed at any time outstanding the amount of the Commitment; provided, however, that after giving effect to any borrowing, the Total Outstandings shall not exceed the Commitment.
Within the limits of the Commitment, and subject to the other terms and conditions hereof, the Borrower may borrow under this Section 2.01, prepay under Section 2.04, and reborrow under this Section 2.01. A Loan
may be a Base Rate Loan or a Eurodollar Rate Loan, as further provided herein. 
 2.02 Borrowings, Conversions and Continuations of Loans.

 (a) Each borrowing, each conversion of Loans from one Type to the other, and each continuation of Eurodollar Rate Loans
shall be made upon the Borrower’s irrevocable notice to the Lender, which may be given by telephone. Each such notice must be received by the Lender not later than 8:00 a.m. (i) three Business Days prior to the requested date of any
Borrowing of, conversion to or continuation of Eurodollar Rate Loans or of any conversion of Eurodollar Rate Loans to a Base Rate Loans, and (ii) on the requested date of any Borrowing of Base Rate Loans. Each telephonic notice by the Borrower
pursuant to this Section 2.02(a) must be confirmed promptly by delivery to the Lender of a written Loan Notice, appropriately completed and signed by a Responsible Officer of the Borrower. Each Borrowing of, conversion to or continuation
of Eurodollar Rate Loans shall be in a minimum principal amount of $1,000,000. Except as provided in Section 2.03(c), each Borrowing of or conversion to Base Rate Loans shall be in a minimum principal amount of $100,000. Each Loan Notice
(whether telephonic or written) shall specify (A) whether the Borrower is 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 21 

 
requesting a Borrowing, a conversion of Loans from one Type to the other, or a continuation of Eurodollar Rate Loans, (B) the requested date of the
Borrowing, conversion or continuation, as the case may be (which shall be a Business Day), (C) the principal amount of the Loans to be borrowed, converted or continued, (D) the Type of Loans to be borrowed or to which existing Loans are to
be converted, and (E) if applicable, the duration of the Interest Period with respect thereto. If the Borrower fails to specify a Type of Loan in a Loan Notice or if the Borrower fails to give a timely notice requesting a conversion or
continuation, then the applicable Loans shall be made as, or converted to, Base Rate Loans. Any such automatic conversion to Base Rate Loans shall be effective as of the last day of the Interest Period then in effect with respect to the applicable
Eurodollar Rate Loan. If the Borrower requests a borrowing of, conversion to, or continuation of Eurodollar Rate Loans in any such Loan Notice, but fails to specify an Interest Period, it will be deemed to have specified an Interest Period of one
month. 
 (b) Upon satisfaction of the applicable conditions set forth in Section 4.02 (and, if such Borrowing is
the initial Credit Extension, Section 4.01), the Lender shall make the proceeds of each Loan available to the Borrower either by (i) crediting the account of the Borrower on the books of the Lender with the amount of such proceeds
or (ii) wire transfer of such proceeds, in each case in accordance with instructions provided to (and reasonably acceptable to) the Lender by the Borrower; provided, however, that if, on the date of the Loan Notice given with
respect to such Borrowing, there are L/C Borrowings outstanding, then the proceeds of such Borrowing, first, shall be applied to the payment in full of any such unreimbursed drawings, and second, to the Borrower as provided above. 

(c) Except as otherwise provided herein, Eurodollar Rate Loans may be continued or converted only on the last day of an Interest Period
for such Eurodollar Rate Loans. During the existence of a Default, no Loans may be requested as, converted to or continued as Eurodollar Rate Loans without the consent of the Lender. 
 (d) The Lender shall promptly notify the Borrower of the interest rate applicable to any Interest Period for Eurodollar Rate Loans upon
determination of such interest rate. At any time that Base Rate Loans are outstanding, the Lender shall notify the Borrower of any change in the Lender’s prime rate used in determining the Base Rate promptly following the public announcement of
such change. 
 2.03 Letters of Credit. 
 (a) The Letter of Credit Commitment. 
 (i) Subject to the terms and conditions set
forth herein, the Lender agrees (A) from time to time on any Business Day during the period from the Closing Date until the Letter of Credit Expiration Date, to issue Letters of Credit for the account of the Borrower, and to amend or extend
Letters of Credit previously issued by it, in accordance with subsection (b) below, and (B) to honor drawings under the Letters of Credit; provided that the Lender shall not be obligated to make any L/C Credit Extension with respect
to any Letter of Credit if as of the date of such L/C Credit Extension, (y) the Total Outstandings would exceed the Commitment or (z) the Outstanding Amount of the L/C Obligations would exceed the Letter of Credit 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 22 

 
Sublimit. Each request by the Borrower for the issuance or amendment of a Letter of Credit shall be deemed to be a representation by the Borrower that the
L/C Credit Extension so requested complies with the conditions set forth in the proviso to the preceding sentence. Within the foregoing limits, and subject to the terms and conditions hereof, the Borrower’s ability to obtain Letters of Credit
shall be fully revolving, and accordingly the Borrower may, during the foregoing period, obtain Letters of Credit to replace Letters of Credit that have expired or that have been drawn upon and reimbursed. 
 (ii) The Lender shall not issue any Letter of Credit if: 
 (A) the expiry date of such requested Letter of Credit would occur more than twelve months after the date of issuance, unless the Lender
has approved such expiry date; or 
 (B) the expiry date of such requested Letter of Credit would occur after the Letter of
Credit Expiration Date, unless the Lender has approved such expiry date. 
 (iii) The Lender shall not be under any obligation
to issue any Letter of Credit if: 
 (A) any order, judgment or decree of any Governmental Authority or arbitrator shall by
its terms purport to enjoin or restrain the Lender from issuing such Letter of Credit, or any Law applicable to the Lender or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over
the Lender shall prohibit, or request that the Lender refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon the Lender with respect to such Letter of Credit any restriction, reserve or
capital requirement (for which the Lender is not otherwise compensated hereunder) not in effect on the Original Closing Date, or shall impose upon the Lender any unreimbursed loss, cost or expense which was not applicable on the Original Closing
Date and which the Lender in good faith deems material to it; or 
 (B) the issuance of such Letter of Credit would violate
one or more policies of the Lender; or 
 (C) except as otherwise agreed by the Lender, such Letter of Credit is in an
initial stated amount less than $100,000; or 
 (D) such Letter of Credit is to be denominated in a currency other than
Dollars; or 
 (E) such Letter of Credit contains any provisions for automatic reinstatement of the stated amount after any
drawing thereunder. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 23 

 (iv) The Lender shall not amend any Letter of Credit if the Lender would not be permitted
at such time to issue such Letter of Credit in its amended form under the terms hereof. 
 (v) The Lender shall be under no
obligation to amend any Letter of Credit if (A) the Lender would have no obligation at such time to issue such Letter of Credit in its amended form under the terms hereof, or (B) the beneficiary of such Letter of Credit does not accept the
proposed amendment to such Letter of Credit. 
 (b) Procedures for Issuance and Amendment of Letters of Credit.

 (i) Each Letter of Credit shall be issued or amended, as the case may be, upon the request of the Borrower delivered to the
Lender in the form of a Letter of Credit Application, appropriately completed and signed by a Responsible Officer of the Borrower. Such Letter of Credit Application must be received by the Lender not later than 8:00 a.m., at least two Business Days
(or such later date and time as the Lender may agree in a particular instance in its sole discretion) prior to the proposed issuance date or date of amendment, as the case may be. In the case of a request for an initial issuance of a Letter of
Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the Lender: (A) the proposed issuance date of the requested Letter of Credit (which shall be a Business Day); (B) the amount thereof; (C) the
expiry date thereof; (D) the name and address of the beneficiary thereof; (E) the documents to be presented by such beneficiary in case of any drawing thereunder; (F) the full text of any certificate to be presented by such
beneficiary in case of any drawing thereunder; and (G) such other matters as the Lender may require. In the case of a request for an amendment of any outstanding Letter of Credit, such Letter of Credit Application shall specify in form and
detail satisfactory to the Lender (I) the Letter of Credit to be amended; (II) the proposed date of amendment thereof (which shall be a Business Day); (III) the nature of the proposed amendment; and (IV) such other matters as the
Lender may require. Additionally, the Borrower shall furnish to the Lender such other documents and information pertaining to such requested Letter of Credit issuance or amendment, including any Issuer Documents, as the Lender may require.

 (ii) Upon the Lender’s determination that the requested issuance or amendment is permitted in accordance with the
terms hereof, then, subject to the terms and conditions hereof, the Lender shall, on the requested date, issue a Letter of Credit for the account of the Borrower or enter into the applicable amendment, as the case may be, in each case in accordance
with the Lender’s usual and customary business practices. 
 (iii) Promptly after its delivery of any Letter of Credit or
any amendment to a Letter of Credit to an advising bank with respect thereto or to the beneficiary thereof, the Lender will also deliver to the Borrower a true and complete copy of such Letter of Credit or amendment. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 24 

 (c) Drawings and Reimbursements. 
 (i) Upon receipt from the beneficiary of any Letter of Credit of any notice of a drawing under such Letter of Credit, the Lender shall
notify the Borrower thereof. Not later than 8:00 a.m. on the date of any payment by the Lender under a Letter of Credit (each such date, an “Honor Date”), the Borrower shall reimburse the Lender in an amount equal to the amount of
such drawing. If the Borrower fails to so reimburse the Lender (any such unreimbursed amount, an “Unreimbursed Amount”), the Borrower shall be deemed to have requested a Borrowing of Base Rate Loans to be disbursed on the Honor Date
in an amount equal to such Unreimbursed Amount, without regard to the minimum and multiples specified in Section 2.02 for the principal amount of Base Rate Loans, but subject to the amount of the unutilized portion of the Commitment and
the conditions set forth in Section 4.02 (other than the delivery of a Loan Notice). 
 (ii) With respect to any
Unreimbursed Amount that is not fully refinanced by a Borrowing of Base Rate Loans because the conditions set forth in Section 4.02 cannot be satisfied or for any other reason, the Borrower shall be deemed to have incurred from the
Lender an L/C Borrowing in the amount of the Unreimbursed Amount that is not so refinanced, which L/C Borrowing shall be due and payable on demand (together with interest) and shall bear interest at the Default Rate. 
 (d) Obligations Absolute. The obligation of the Borrower to reimburse the Lender for each drawing under each Letter of Credit and
to repay each L/C Borrowing shall be absolute, unconditional and irrevocable, and shall be paid strictly in accordance with the terms of this Agreement under all circumstances, including the following: 
 (i) any lack of validity or enforceability of such Letter of Credit, this Agreement, or any other Loan Document; 
 (ii) the existence of any claim, counterclaim, setoff, defense or other right that the Borrower or any Subsidiary may have at any time
against any beneficiary or any transferee of such Letter of Credit (or any Person for whom any such beneficiary or any such transferee may be acting), the Lender or any other Person, whether in connection with this Agreement, the transactions
contemplated hereby or by such Letter of Credit or any agreement or instrument relating thereto, or any unrelated transaction; 
 (iii) any draft, demand, certificate or other document presented under such Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect; or any
loss or delay in the transmission or otherwise of any document required in order to make a drawing under such Letter of Credit; 
 (iv) any payment by the Lender under such Letter of Credit against presentation of a draft or certificate that does not strictly comply with the terms of such Letter of Credit; or any payment made by the Lender under such Letter of Credit
to any Person purporting to be a trustee in bankruptcy, debtor-in-possession, assignee for the benefit of creditors, liquidator, receiver or other representative of or successor to any beneficiary or any transferee of such Letter of Credit,
including any arising in connection with any proceeding under any Debtor Relief Law; or 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 25 

 (v) any other circumstance or happening whatsoever, whether or not similar to any of the
foregoing, including any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Borrower or any Subsidiary. 
 The Borrower shall promptly examine a copy of each Letter of Credit and each amendment thereto that is delivered to it and, in the event of any claim of noncompliance with the Borrower’s instructions or other
irregularity, the Borrower will promptly notify the Lender. The Borrower shall be conclusively deemed to have waived any such claim against the Lender and its correspondents unless such notice is given as aforesaid. 
 (e) Role of Lender. The Borrower agrees that, in paying any drawing under a Letter of Credit, the Lender shall not have any
responsibility to obtain any document (other than any sight draft, certificates and documents expressly required by the Letter of Credit) or to ascertain or inquire as to the validity or accuracy of any such document or the authority of the Person
executing or delivering any such document. The Borrower hereby assumes all risks of the acts or omissions of any beneficiary or transferee with respect to its use of any Letter of Credit; provided, however, that this assumption is not
intended to, and shall not, preclude the Borrower’s pursuing such rights and remedies as it may have against the beneficiary or transferee at law or under any other agreement. None of the Lender, any of its Affiliates, any of the respective
officers, directors, employees, agents or attorneys-in-fact of the Lender and its Affiliates, nor any of the respective correspondents, participants or assignees of the Lender shall be liable or responsible for any of the matters described in
clauses (i) through (v) of Section 2.03(d); provided, however, that anything in such clauses to the contrary notwithstanding, the Borrower may have a claim against the Lender, and the Lender may be liable to the
Borrower, to the extent, but only to the extent, of any direct, as opposed to consequential or exemplary, damages suffered by the Borrower which the Borrower proves were caused by the Lender’s willful misconduct or gross negligence or the
Lender’s willful failure to pay under any Letter of Credit after the presentation to it by the beneficiary of a sight draft and certificate(s) strictly complying with the terms and conditions of a Letter of Credit. In furtherance and not in
limitation of the foregoing, the Lender may accept documents that appear on their face to be in order, without responsibility for further investigation, regardless of any notice or information to the contrary, and the Lender shall not be responsible
for the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign a Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, which may prove to be invalid or
ineffective for any reason. 
 (f) Cash Collateral. Upon the request of the Lender, (i) if the Lender has honored
any full or partial drawing request under any Letter of Credit and such drawing has resulted in an L/C Borrowing, or (ii) if, as of the Letter of Credit Expiration Date, any L/C Obligation for any reason remains outstanding, the Borrower shall,
in each case, immediately Cash Collateralize the then Outstanding Amount of all L/C Obligations. Sections 2.04 and 8.02(c) set forth additional requirements to deliver Cash Collateral hereunder. For purposes of this
Section 2.03 and Sections 2.04(b) and 8.02(c), “Cash Collateralize” means to pledge and 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 26 

 
deposit with or deliver to the Lender, as collateral for the L/C Obligations, cash or deposit account balances pursuant to documentation in form and
substance satisfactory to the Lender. Derivatives of such term have corresponding meanings. The Borrower hereby grants to the Lender a security interest in all such cash, deposit accounts and all balances therein and all proceeds of the foregoing.
Cash Collateral shall be maintained in blocked, non-interest bearing deposit accounts at the Lender. 
 (g) Applicability
of ISP. Unless otherwise expressly agreed by the Lender and the Borrower when a Letter of Credit is issued the rules of the ISP shall apply to each Letter of Credit. 
 (h) Letter of Credit Fees. The Borrower shall pay to the Lender a Letter of Credit fee (the “Letter of Credit
Fee”) for each Letter of Credit equal to the Applicable Rate times the daily amount available to be drawn under such Letter of Credit. For purposes of computing the daily amount available to be drawn under any Letter of Credit, the
amount of such Letter of Credit shall be determined in accordance with Section 1.06. Letter of Credit Fees shall be (A) computed on a quarterly basis in arrears and (B) due and payable on the first Business Day after the end of
each March, June, September and December, commencing with the first such date to occur after the issuance of such Letter of Credit, on the Letter of Credit Expiration Date and thereafter on demand. If there is any change in the Applicable Rate
during any quarter, the daily amount available to be drawn under each Letter of Credit shall be computed and multiplied by the Applicable Rate separately for each period during such quarter that such Applicable Rate was in effect. Notwithstanding
anything to the contrary contained herein, while any Event of Default exists, all Letter of Credit Fees shall accrue at the Default Rate. 
 (i) Documentary and Processing Charges Payable to Lender. The Borrower shall pay directly to the Lender for its own account the customary issuance, presentation, amendment and other processing fees, and other
standard costs and charges, of the Lender relating to letters of credit as from time to time in effect. Such customary fees and standard costs and charges are due and payable on demand and are nonrefundable. 
 (j) Conflict with Issuer Documents. In the event of any conflict between the terms hereof and the terms of any Issuer Document, the
terms hereof shall control. 
 2.04 Prepayments. 
 (a) The Borrower may, upon notice to the Lender, at any time or from time to time voluntarily prepay any Loan in whole or in part without
premium or penalty; provided that (i) such notice must be received by the Lender not later than 8:00 a.m. (A) three Business Days prior to any date of prepayment of Eurodollar Rate Loans, and (B) on the date of prepayment of
Base Rate Loans; (ii) any prepayment of Eurodollar Rate Loans shall be in a minimum principal amount of $1,000,000; and (iii) any prepayment of Base Rate Loans shall be in a minimum principal amount of $100,000 or, in each case, if less,
the entire principal amount thereof then outstanding. Each such notice shall specify the date and amount of such prepayment and the Type(s) of Loans to be prepaid. If such notice is given by the Borrower, the Borrower shall make such prepayment and
the payment amount specified in such notice shall be due and payable on the date specified therein. Any prepayment of Eurodollar Rate Loans shall be accompanied by all accrued interest on the amount repaid, together with any additional amounts
required pursuant to Section 3.05. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 27 

 (b) If for any reason the Total Outstandings at any time exceed the Commitment then in
effect, the Borrower shall immediately prepay Loans and/or Cash Collateralize the L/C Obligations in an aggregate amount equal to such excess; provided, however, that the Borrower shall not be required to Cash Collateralize the L/C
Obligations pursuant to this Section 2.04(b) unless after the prepayment in full of the Loans the Total Outstandings exceed the Commitment then in effect. 
 2.05 Termination or Reduction of Commitment. The Borrower may, upon notice to the Lender, terminate the Commitment, or from time to time permanently reduce the Commitment; provided that
(i) any such notice shall be received by the Lender not later than 8:00 a.m., five Business Days prior to the date of termination or reduction, (ii) any such partial reduction shall be in a minimum amount of $1,000,000, (iii) the
Borrower shall not terminate or reduce the Commitment if, after giving effect thereto and to any concurrent prepayments hereunder, the Total Outstandings would exceed the Commitment, and (iv) if, after giving effect to any reduction of the
Commitment, the Letter of Credit Sublimit exceeds the amount of the Commitment, such Letter of Credit Sublimit shall be automatically reduced by the amount of such excess. All commitment fees accrued until the effective date of any termination of
the Commitment shall be paid on the effective date of such termination. 
 2.06 Repayment of Loans. The Borrower shall repay to
the Lender on the Maturity Date the aggregate principal amount of Loans outstanding on such date. 
 2.07 Interest. 
 (a) Subject to the provisions of subsection (b) below, (i) each Eurodollar Rate Loan shall bear interest on the outstanding
principal amount thereof for each Interest Period at a rate per annum equal to the Eurodollar Rate for such Interest Period plus the Applicable Rate; and (ii) each Base Rate Loan shall bear interest on the outstanding principal amount
thereof from the applicable borrowing date at a rate per annum equal to the Base Rate plus the Applicable Rate. 
 (b)
While any Event of Default exists, the Borrower shall pay interest on the principal amount of all outstanding Obligations hereunder at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by
applicable Laws. 
 (c) Interest on each Loan shall be due and payable in arrears on each Interest Payment Date applicable
thereto and at such other times as may be specified herein. Interest hereunder shall be due and payable in accordance with the terms hereof before and after judgment, and before and after the commencement of any proceeding under any Debtor Relief
Law. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 28 

 2.08 Fees. In addition to certain fees described in subsections (h) and (i) of
Section 2.03: 
 (a) Commitment Fee. The Borrower shall pay to the Lender a commitment fee equal to the
Applicable Rate times the actual daily amount by which the Adjusted Commitment exceeds the Total Outstandings. The commitment fee shall accrue at all times during the Availability Period, including at any time during which one or more of the
conditions in Article IV is not met, and shall be due and payable quarterly in arrears on the last Business Day of each March, June, September and December, commencing with the first such date to occur after the Closing Date, and on the
Maturity Date. The commitment fee shall be calculated quarterly in arrears. 
 (b) Up-front Fee. The Borrower shall pay
to the Lender an up-front fee of 0.25% times the Commitment, payable on the Closing Date. Such fee shall be fully earned when paid and shall not be refundable for any reason whatsoever. 
 2.09 Computation of Interest and Fees. All computations of interest for Base Rate Loans when the Base Rate is determined by the
Lender’s “prime rate” shall be made on the basis of a year of 365 or 366 days, as the case may be, and actual days elapsed. All other computations of fees and interest shall be made on the basis of a 360-day year and actual days
elapsed (which results in more fees or interest, as applicable, being paid than if computed on the basis of a 365-day year). Interest shall accrue on each Loan for the day on which the Loan is made, and shall not accrue on a Loan, or any portion
thereof, for the day on which the Loan or such portion is paid, provided that any Loan that is repaid on the same day on which it is made shall, subject to Section 2.11(a), bear interest for one day. Each determination by the
Lender of an interest rate or fee hereunder shall be conclusive and binding for all purposes, absent manifest error. 
 2.10
Evidence of Debt. The Credit Extensions made by the Lender shall be evidenced by one or more accounts or records maintained by the Lender in the ordinary course of business. The accounts or records maintained by the Lender shall be conclusive
absent manifest error of the amount of the Credit Extensions made by the Lender to the Borrower and the interest and payments thereon. Any failure to so record or any error in doing so shall not, however, limit or otherwise affect the obligation of
the Borrower hereunder to pay any amount owing with respect to the Obligations. Upon the request of the Lender, the Borrower shall execute and deliver to the Lender a Note, which shall evidence the Lender’s Loans in addition to such accounts or
records. The Lender may attach schedules to the Note and endorse thereon the date, Type (if applicable), amount and maturity of Loans and payments with respect thereto. 
 2.11 Payments Generally. 
 (a) All payments to be made by the Borrower shall be made
without condition or deduction for any counterclaim, defense, recoupment or setoff. Except as otherwise expressly provided herein, all payments by the Borrower hereunder shall be made to the Lender at the applicable Lending Office in Dollars and in
immediately available funds not later than 11:00 a.m. on the date specified herein. All payments received by the Lender after 11:00 a.m. shall be deemed received on the next succeeding Business Day and any applicable interest or fee shall continue
to accrue. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 29 

 (b) If any payment to be made by the Borrower shall come due on a day other than a
Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected in computing interest or fees, as the case may be. 
 (c) Nothing herein shall be deemed to obligate the Lender to obtain the funds for any Loan in any particular place or manner or to
constitute a representation by the Lender that it has obtained or will obtain the funds for any Loan in any particular place or manner. 
 ARTICLE III. 
 TAXES, YIELD PROTECTION AND ILLEGALITY 
 3.01 Taxes. 
 (a)
Payments Free of Taxes. Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall be made free and clear of and without reduction or withholding for any Indemnified Taxes or Other
Taxes, provided that if the Borrower shall be required by applicable law to deduct any Indemnified Taxes (including any Other Taxes) from such payments, then (i) the sum payable shall be increased as necessary so that after making all
required deductions (including deductions applicable to additional sums payable under this Section) the Lender receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower shall make such
deductions and (iii) the Borrower shall timely pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law. 
 (b) Payment of Other Taxes by the Borrower. Without limiting the provisions of subsection (a) above, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with
applicable law. 
 (c) Indemnification by the Borrower. The Borrower shall indemnify the Lender within 120 days after
demand therefor, for the full amount of any Indemnified Taxes or Other Taxes (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this Section) paid by the Lender and any penalties, interest and
reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment
or liability delivered to the Borrower by the Lender shall be conclusive absent manifest error. 
 (d) Evidence of
Payments. As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower to a Governmental Authority, the Borrower shall deliver to the Lender the original or a certified copy of a receipt issued by such
Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Lender. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 30 

 (e) Status of Foreign Lenders. 
 (i) Any Foreign Lender that is entitled to an exemption from or reduction of withholding tax under the law of the jurisdiction in which
the Borrower is resident for tax purposes, or any treaty to which such jurisdiction is a party, with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower, at the time or times prescribed by applicable law or
reasonably requested by the Borrower, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Foreign Lender,
if requested by the Borrower, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower as will enable the Borrower to determine whether or not such Foreign Lender is subject to backup withholding or
information reporting requirements. 
 (ii) Without limiting the generality of the foregoing, in the event that the Borrower
is resident for tax purposes in the United States, any Foreign Lender shall deliver to the Borrower (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes an assignee of Loans
under this Agreement (and from time to time thereafter upon the request of the Borrower, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable: 
 (A) duly completed copies of Internal Revenue Service Form W-8BEN claiming eligibility for benefits of an income tax treaty to which the
United States is a party, 
 (B) duly completed copies of Internal Revenue Service Form W-8ECI, 
 (C) in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code,
(x) a certificate to the effect that such Foreign Lender is not (1) a “bank” within the meaning of Section 881(c)(3)(A) of the Code, (2) a “10 percent shareholder” of the Borrower within the meaning of
Section 881(c)(3)(B) of the Code, or (3) a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Code and (y) duly completed copies of Internal Revenue Service Form W-8BEN, or 
 (D) any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in United States Federal
withholding tax duly completed together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower to determine the withholding or deduction required to be made. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 31 

 (f) Treatment of Certain Refunds. If the Lender determines, in its sole
discretion, that it has received a refund of any Taxes or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this Section, it shall pay to the Borrower an
amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section with respect to the Taxes or Other Taxes giving rise to such refund), net of all out-of-pocket expenses of
the Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund), provided that the Borrower, upon the request of the Lender, agrees to repay the amount so paid over to the
Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Lender in the event the Lender is required to repay such refund to such Governmental Authority. This subsection shall not be construed to
require the Lender to make available its tax returns (or any other information relating to its taxes that it deems confidential) to the Borrower or any other Person. 
 3.02 Illegality. If the Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for the Lender or its Lending Office to make, maintain or
fund Eurodollar Rate Loans, or to determine or charge interest rates based upon the Eurodollar Rate, or any Governmental Authority has imposed material restrictions on the authority of the Lender to purchase or sell, or to take deposits of, Dollars
in the London interbank market, then, on notice thereof by the Lender to the Borrower, any obligation of the Lender to make or continue Eurodollar Rate Loans or to convert Base Rate Loans to Eurodollar Rate Loans shall be suspended until the Lender
notifies the Borrower that the circumstances giving rise to such determination no longer exist. Upon receipt of such notice, the Borrower shall, upon demand from the Lender, prepay or, if applicable, convert all Eurodollar Rate Loans to Base Rate
Loans, either on the last day of the Interest Period therefor, if the Lender may lawfully continue to maintain such Eurodollar Rate Loans to such day, or immediately, if the Lender may not lawfully continue to maintain such Eurodollar Rate Loans.
Upon any such prepayment or conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted. The Lender agrees to designate a different Lending Office if such designation will avoid the need for such notice and will
not, in the good faith judgment of the Lender, otherwise be materially disadvantageous to the Lender. 
 3.03 Inability to
Determine Eurodollar Rate. If the Lender determines that for any reason in connection with any request for Eurodollar Rate Loans or a conversion to or continuation thereof that (a) Dollar deposits are not being offered to banks in the
London interbank eurodollar market for the applicable amount and Interest Period of such Eurodollar Rate Loans, (b) adequate and reasonable means do not exist for determining the Eurodollar Rate for any requested Interest Period with respect to
a proposed Eurodollar Rate Loan, or (c) the Eurodollar Rate for any requested Interest Period with respect to a proposed Eurodollar Rate Loan does not adequately and fairly reflect the cost to the Lender of funding such Loan, the Lender will
promptly so notify the Borrower. Thereafter, the obligation of the Lender to make or maintain Eurodollar Rate Loans shall be suspended until the Lender revokes such notice. Upon receipt of such notice, the Borrower may revoke any pending request for
a Borrowing of, conversion to or continuation of Eurodollar Rate Loans or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans in the amount specified therein. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 32 

 3.04 Increased Costs; Reserves on Eurodollar Rate Loans. 
 (a) Increased Costs Generally. If any Change in Law shall: 
 (i) impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against
assets of, deposits with or for the account of, or credit extended or participated in by, the Lender (except any reserve requirement contemplated by Section 3.04(e)); 
 (ii) subject the Lender to any tax of any kind whatsoever with respect to this Agreement, any Letter of Credit or any Eurodollar Rate Loan
made by it, or change the basis of taxation of payments to the Lender in respect thereof (except for Indemnified Taxes or Other Taxes covered by Section 3.01 and the imposition of, or any change in the rate of, any Excluded Tax payable
by the Lender); or 
 (iii) impose on the Lender or the London interbank market any other condition, cost or expense affecting
this Agreement or Eurodollar Rate Loans made by the Lender or any Letter of Credit; 
 and the result of any of the foregoing shall be to increase the cost
to the Lender of making or maintaining any Eurodollar Rate Loan (or of maintaining its obligation to make any such Loan), or to increase the cost to the Lender of issuing or maintaining any Letter of Credit (or of maintaining its obligation to issue
any Letter of Credit), or to reduce the amount of any sum received or receivable by the Lender hereunder (whether of principal, interest or any other amount) then, upon request of the Lender, the Borrower will pay to the Lender such additional
amount or amounts as will compensate the Lender for such additional costs incurred or reduction suffered. 
 (b) Capital
Requirements. If the Lender determines that any Change in Law affecting the Lender or any Lending Office of the Lender or the Lender’s holding company, if any, regarding capital requirements has or would have the effect of reducing the rate
of return on the Lender’s capital or on the capital of the Lender’s holding company, if any, as a consequence of this Agreement, the Commitment of the Lender or the Loans made by, or the Letters of Credit issued by, the Lender, to a level
below that which the Lender or such Lender’s holding company could have achieved but for such Change in Law (taking into consideration the Lender’s policies and the policies of the Lender’s holding company with respect to capital
adequacy), then from time to time the Borrower will pay to the Lender such additional amount or amounts as will compensate the Lender or such Lender’s holding company for any such reduction suffered. 
 (c) Certificates for Reimbursement. A certificate of the Lender setting forth the amount or amounts necessary to compensate the
Lender or its holding company, as the case may be, as specified in subsection (a) or (b) of this Section and delivered to the Borrower shall be conclusive absent manifest error. The Borrower shall pay the Lender the amount shown as due on
any such certificate within 10 days after receipt thereof. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 33 

 (d) Delay in Requests. Failure or delay on the part of the Lender to demand
compensation pursuant to the foregoing provisions of this Section shall not constitute a waiver of the Lender’s right to demand such compensation, provided that the Borrower shall not be required to compensate the Lender pursuant to the
foregoing provisions of this Section for any increased costs incurred or reductions suffered more than nine months prior to the date that the Lender notifies the Borrower of the Change in Law giving rise to such increased costs or reductions and of
the Lender’s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the nine-month period referred to above shall be extended to include the period of
retroactive effect thereof). 
 (e) Reserves on Eurodollar Rate Loans. The Borrower shall pay to the Lender, as long as
the Lender shall be required to maintain reserves with respect to liabilities or assets consisting of or including Eurocurrency funds or deposits (currently known as “Eurocurrency liabilities”), additional interest on the unpaid
principal amount of each Eurodollar Rate Loan equal to the actual costs of such reserves allocated to such Loan by such Lender (as determined by such Lender in good faith, which determination shall be conclusive), which shall be due and payable on
each date on which interest is payable on such Loan, provided the Borrower shall have received at least 10 days’ prior notice of such additional interest from such Lender. If a Lender fails to give notice 10 days prior to the relevant
Interest Payment Date, such additional interest shall be due and payable 10 days from receipt of such notice. 
 3.05 Compensation
for Losses. Upon demand of the Lender from time to time, the Borrower shall promptly compensate the Lender for and hold the Lender harmless from any loss, cost or expense incurred by it as a result of: 
 (a) any continuation, conversion, payment or prepayment of any Loan other than a Base Rate Loan on a day other than the last day of the
Interest Period for such Loan (whether voluntary, mandatory, automatic, by reason of acceleration, or otherwise); or 
 (b)
any failure by the Borrower (for a reason other than the failure of the Lender to make a Loan) to prepay, borrow, continue or convert any Loan other than a Base Rate Loan on the date or in the amount notified by the Borrower, 
 including any loss of anticipated profits and any loss or expense arising from the liquidation or reemployment of funds obtained by it to maintain such Loan or from fees
payable to terminate the deposits from which such funds were obtained. The Borrower shall also pay any customary administrative fees charged by the Lender in connection with the foregoing. 
 For purposes of calculating amounts payable by the Borrower to the Lender under this Section 3.05, the Lender shall be deemed to have funded each Eurodollar
Rate Loan at the Eurodollar base rate used in determining the Eurodollar Rate for such Loan by a matching deposit or other borrowing in the London interbank eurodollar market for a comparable amount and for a comparable period, whether or not such
Eurodollar Rate Loan was in fact so funded. 
  
  

*** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version
of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 34 

 3.06 Requests for Compensation; Mitigation. 
 (a) A certificate of the Lender claiming compensation under this Article III and setting forth the additional amount or
amounts to be paid to it hereunder shall be conclusive in the absence of manifest error. In determining such amount, the Lender may use any reasonable averaging and attribution methods. 
 (b) If the Lender requests compensation under Section 3.04, or the Borrower is required to pay any additional amount to the
Lender or any Governmental Authority for the account of the Lender pursuant to Section 3.01, or if the Lender gives a notice pursuant to Section 3.02, then the Lender shall use reasonable efforts to designate a different
Lending Office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of the Lender, such designation or assignment (i) would eliminate
or reduce amounts payable pursuant to Section 3.01 or 3.04, as the case may be, in the future, or eliminate the need for the notice pursuant to Section 3.02, as applicable, and (ii) in each case, would not subject
the Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to the Lender. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by the Lender in connection with any such designation or
assignment. 
 3.07 Survival. All of the Borrower’s obligations under this Article III shall survive
termination of the Commitment and repayment of all other Obligations hereunder. 
 ARTICLE IV. 
 CONDITIONS PRECEDENT TO CREDIT EXTENSIONS 
 4.01 Conditions of Initial Credit Extension. The obligation of the Lender to make its initial Credit Extension hereunder is subject to satisfaction of the following conditions precedent: 
 (a) The Lender’s receipt of the following, each of which shall be originals or telecopies (followed promptly by originals) unless
otherwise specified, each properly executed by a Responsible Officer of the signing Loan Party, each dated the Closing Date (or, in the case of certificates of governmental officials, a recent date before the Closing Date) and each in form and
substance satisfactory to the Lender and its legal counsel: 
 (i) executed counterparts of this Agreement, each sufficient in
number for distribution to the Lender and the Borrower; 
 (ii) if requested by the Lender, a Note executed by the Borrower in
favor of the Lender; 
 (iii) executed counterparts of a Pledge Agreement by (x) each Person holding Equity Interests in
any Foreign Subsidiary Holding Company, and (y) the Borrower and each Domestic Subsidiary (other than a Foreign Subsidiary Holding Company) holding Equity Interests in any First Tier Foreign Subsidiary that is a Material Subsidiary and an
Exempt Subsidiary, sufficient in number for distribution to the Lender and the Borrower, together with: 
 (A) written advice
relating to such Lien searches as the Lender shall have requested, and such termination statements or other documents as may be necessary to confirm that the Pledged Collateral is subject to no other Liens in favor of any Persons (other than
Permitted Liens); 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 35 

 (B) all certificates and instruments, if any, representing the Pledged Collateral, with
stock transfer powers executed in blank with signatures guaranteed, as the Lender may specify; 
 (C) evidence that all other
actions necessary or in the opinion of the Lender desirable to perfect and protect the first prior Lien created by the Pledge Agreement have been taken; 
 (D) funds sufficient to pay any filing tax or fee in connection with any and all UCC-1 financing statements deemed in the opinion of the Lender necessary or desirable; and 
 (E) evidence that all other actions necessary or in the opinion of the Lender desirable to perfect and protect the first priority Lien
created by the Pledge Agreement, and to enhance the ability to preserve and protect its interest in and access to the Pledged Collateral, have been taken; 
 (iv) such certificates of resolutions or other action, incumbency certificates and/or other certificates of Responsible Officers of each Loan Party as the Lender may require evidencing the identity, authority and
capacity of each Responsible Officer thereof authorized to act as a Responsible Officer in connection with this Agreement and the other Loan Documents to which such Loan Party is a party; 
 (v) such documents and certifications as the Lender may reasonably require to evidence that each Loan Party is duly organized or formed,
and that each Loan Party is validly existing, in good standing and qualified to engage in business in each jurisdiction where its ownership, lease or operation of properties or the conduct of its business requires such qualification, except to the
extent that failure to do so could not reasonably be expected to have a Material Adverse Effect; 
 (vi) a certificate of a
Responsible Officer of each Loan Party either (A) attaching copies of all consents, licenses and approvals required in connection with the execution, delivery and performance by such Loan Party and the validity against such Loan Party of the
Loan Documents to which it is a party, and such consents, licenses and approvals shall be in full force and effect, or (B) stating that no such consents, licenses or approvals are so required; 
 (vii) a certificate signed by a Responsible Officer of the Borrower certifying (A) that the conditions specified in Sections
4.02(a) and (b) have been satisfied, (B) that there has been no event or circumstance since June 27, 2008 that has had or could be reasonably expected to have, either individually or in the aggregate, a Material Adverse
Effect; and (C) a calculation of the Consolidated Leverage Ratio as of the last day of the fiscal quarter of the Borrower most recently ended prior to the Closing Date; 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 36 

 (viii) satisfactory evidence that the Borrower has terminated and paid all amounts owing
in respect of that overdraft facility in the amount of JPY [****] extended by Bank of America to Varian Medical Systems K.K.; and 
 (ix) such other assurances, certificates, documents, consents or opinions as the Lender reasonably may require. 
 (b) Any fees required to be paid on or before the Closing Date shall have been paid. 
 (c) the Borrower shall have
paid all accrued and unpaid interest and commitment fees outstanding in respect of the Existing Credit Agreement. 
 (d) The
Borrower shall have paid all fees, charges and disbursements of counsel to the Lender to the extent invoiced prior to or on the Closing Date, plus such additional amounts of such fees, charges and disbursements as shall constitute its reasonable
estimate of such fees, charges and disbursements incurred or to be incurred by it through the closing proceedings (provided that such estimate shall not thereafter preclude a final settling of accounts between the Borrower and the Lender).

 (e) The Borrower shall have executed and delivered to the Lender the Lender’s standard International Foreign Exchange
Master Agreement, together with any and all documents required thereunder. 
 (f) The Closing Date shall have occurred on or
before November 10, 2008. 
 4.02 Conditions to all Credit Extensions. The obligation of the Lender to honor any Request
for Credit Extension (other than a Loan Notice requesting only a conversion of Loans to the other Type, or a continuation of Eurodollar Rate Loans) is subject to the following conditions precedent: 
 (a) The representations and warranties of the Borrower and each other Loan Party contained in Article V or any other Loan
Document, or which are contained in any document furnished at any time under or in connection herewith or therewith, shall be true and correct on and as of the date of such Credit Extension, except to the extent that such representations and
warranties specifically refer to an earlier date, in which case they shall be true and correct as of such earlier date, and except that for purposes of this Section 4.02, the representations and warranties contained in subsections
(a) and (b) of Section 5.05 shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of Section 6.01. 
 (b) No Default shall exist, or would result from such proposed Credit Extension or from the application of the proceeds thereof.

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 37 

 (c) The Lender shall have received a Request for Credit Extension in accordance with the
requirements hereof. 
 Each Request for Credit Extension (other than a Loan Notice requesting only a conversion of Loans to the other Type
or a continuation of Eurodollar Rate Loans) submitted by the Borrower shall be deemed to be a representation and warranty that the conditions specified in Sections 4.02(a) and (b) have been satisfied on and as of the date of the
applicable Credit Extension. 
 ARTICLE V. 
 REPRESENTATIONS AND WARRANTIES 
 The Borrower represents and warrants to the Lender that: 

5.01 Existence, Qualification and Power; Compliance with Laws. Each Loan Party (a) is duly organized or formed, validly existing
and in good standing under the Laws of the jurisdiction of its incorporation or organization, (b) has all requisite power and authority and all requisite governmental licenses, authorizations, consents and approvals to (i) own or lease its
assets and carry on its business and (ii) execute, deliver and perform its obligations under the Loan Documents to which it is a party, (c) is duly qualified and is licensed and in good standing under the Laws of each jurisdiction where
its ownership, lease or operation of properties or the conduct of its business requires such qualification or license, and (d) is in compliance with all Laws; except in each case referred to in clause (b)(i), (c) or (d), to the extent that
failure to do so could not reasonably be expected to have a Material Adverse Effect. 
 5.02 Authorization; No Contravention.
The execution, delivery and performance by each Loan Party of each Loan Document to which such Person is party, have been duly authorized by all necessary corporate or other organizational action, and do not and will not
(a) contravene the terms of any of such Person’s Organization Documents; (b) conflict with or result in any breach or contravention of, or the creation of any Lien under, or require any payment to be made under
(i) any Contractual Obligation to which such Person is a party or affecting such Person or the properties of such Person or any of its Subsidiaries or (ii) any material order, injunction, writ or decree of any Governmental
Authority or any arbitral award to which such Person or its property is subject; or (c) violate any material Law. Each Loan Party and each Subsidiary thereof is in compliance with all Contractual Obligations referred to in clause (b)(i),
except to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect. 
 5.03 Governmental
Authorization; Other Consents. No approval, consent, exemption, authorization, or other action by, or notice to, or filing with, any Governmental Authority or any other Person is necessary or required in connection with the execution, delivery
or performance by, or enforcement against, any Loan Party of this Agreement or any other Loan Document. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 38 

 5.04 Binding Effect. This Agreement has been, and each other Loan Document, when delivered
hereunder, will have been, duly executed and delivered by each Loan Party that is party thereto. This Agreement constitutes, and each other Loan Document when so delivered will constitute, a legal, valid and binding obligation of such Loan Party,
enforceable against each Loan Party that is party thereto in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally or by
equitable principles relating to enforceability. 
 5.05 Financial Statements; No Material Adverse Effect. 
 (a) The Audited Financial Statements (i) were prepared in accordance with GAAP consistently applied throughout the period covered
thereby, except as otherwise expressly noted therein; (ii) fairly present the financial condition of the Borrower and its Subsidiaries as of the date thereof and their results of operations for the period covered thereby in accordance with GAAP
consistently applied throughout the period covered thereby, except as otherwise expressly noted therein; and (iii) show all material indebtedness and other liabilities, direct or contingent, of the Borrower and its Subsidiaries as of the date
thereof, including liabilities for taxes, material commitments and Indebtedness. 
 (b) The unaudited consolidated and
consolidating balance sheets of the Borrower and its Subsidiaries dated June 30, 2008, and the related consolidated and consolidating statements of income or operations, shareholders’ equity and cash flows for the fiscal quarter ended on
that date (i) were prepared in accordance with GAAP consistently applied throughout the period covered thereby, except as otherwise expressly noted therein, and (ii) fairly present the financial condition of the Borrower and its
Subsidiaries as of the date thereof and their results of operations for the period covered thereby, subject, in the case of clauses (i) and (ii), to the absence of footnotes and to normal year-end audit adjustments. Schedule 5.05
sets forth all material indebtedness and other liabilities, direct or contingent, of the Borrower and its consolidated Subsidiaries as of the date of such financial statements, including liabilities for taxes, material commitments and Indebtedness.

 (c) Since June 27, 2008, there has been no event or circumstance, either individually or in the aggregate, that has
had or could reasonably be expected to have a Material Adverse Effect. 
 5.06 Litigation. There are no actions, suits,
proceedings, claims or disputes pending or, to the knowledge of the Borrower after due and diligent investigation, threatened or contemplated, at law, in equity, in arbitration or before any Governmental Authority, by or against the Borrower or any
of its Subsidiaries or against any of their properties or revenues that (a) purport to affect or pertain to this Agreement or any other Loan Document, or any of the transactions contemplated hereby, or (b) except as
specifically disclosed in Schedule 5.06, either individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. 
 5.07 No Default. Neither the Borrower nor any Subsidiary is in default under or with respect to any Contractual Obligation that could, either individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect. No Default has occurred and is continuing or would result from the consummation of the transactions contemplated by this Agreement or any other Loan Document. As of the Closing Date, there exists no
“Default” under and as defined in the Existing Credit Agreement. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 39 

 5.08 Ownership of Property; Liens. Each of the Borrower and each Subsidiary has good record
and marketable title in fee simple to, or valid leasehold interests in, all real property necessary or used in the ordinary conduct of its business, except for such defects in title as could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. The property of the Borrower and its Subsidiaries is subject to no Liens, other than Liens permitted by Section 7.01. 
 5.09 Regulatory Compliance. The Borrower and its Subsidiaries conduct in the ordinary course of business a review of the effect of
(i) existing Environmental Laws and claims alleging potential liability or responsibility for violation of any Environmental Law and (ii) existing FDA Regulations, on their respective businesses, operations and properties, and as a result
thereof the Borrower has reasonably concluded that, except as specifically disclosed in Schedule 5.09, such Environmental Laws and claims and FDA Regulations could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect. 
 5.10 Insurance. The properties of the Loan Parties are insured with financially sound and reputable
insurance companies not Affiliates of the Borrower, in such amounts (after giving effect to any self-insurance compatible with the following standards), with such deductibles and covering such risks as are customarily carried by companies engaged in
similar businesses and owning similar properties in localities where the Borrower or the applicable Subsidiary operates. 
 5.11
Taxes. The Borrower and its Subsidiaries have filed (or obtained appropriate extensions in respect of) all Federal, state and other material tax returns and reports required to be filed, and have paid (or obtained appropriate extensions in
respect of) all Federal, state and other material taxes, assessments, fees and other governmental charges levied or imposed upon them or their properties, income or assets otherwise due and payable, except those which are being contested in good
faith by appropriate proceedings diligently conducted and for which adequate reserves have been provided in accordance with GAAP. To Borrower’s knowledge, there is no proposed tax assessment against the Borrower or any Subsidiary that would, if
made, have a Material Adverse Effect. 
 5.12 ERISA Compliance. 
 (a) Each Plan is in compliance in all material respects with the applicable provisions of ERISA, the Code and other Federal or state Laws.
Each Plan that is intended to qualify under Section 401(a) of the Code has received a favorable determination letter from the IRS or an application for such a letter is currently being processed by the IRS with respect thereto and, to the best
knowledge of the Borrower, nothing has occurred which would prevent, or cause the loss of, such qualification. The Borrower and each ERISA Affiliate have made all required contributions to each Plan subject to Section 412 of the Code, and no
application for a funding waiver or an extension of any amortization period pursuant to Section 412 of the Code has been made with respect to any Plan. 
 (b) There are no pending or, to the best knowledge of the Borrower, threatened claims, actions or lawsuits, or action by any Governmental
Authority, with respect to any Plan that could be reasonably be expected to have a Material Adverse Effect. There has been no prohibited transaction or violation of the fiduciary responsibility rules with respect to any Plan that has resulted or
could reasonably be expected to result in a Material Adverse Effect. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 40 

 (c) (i) No ERISA Event has occurred or is reasonably expected to occur; (ii) no
Pension Plan has any Unfunded Pension Liability; (iii) neither the Borrower nor any ERISA Affiliate has incurred, or reasonably expects to incur, any liability under Title IV of ERISA with respect to any Pension Plan (other than premiums due
and not delinquent under Section 4007 of ERISA); (iv) neither the Borrower nor any ERISA Affiliate has incurred, or reasonably expects to incur, any liability (and no event has occurred which, with the giving of notice under
Section 4219 of ERISA, would result in such liability) under Sections 4201 or 4243 of ERISA with respect to a Multiemployer Plan; and (v) neither the Borrower nor any ERISA Affiliate has engaged in a transaction that could be subject to
Sections 4069 or 4212(c) of ERISA. 
 5.13 Subsidiaries. As of the Closing Date, the Borrower has no Subsidiaries other than
those specifically disclosed in Part (a) of Schedule 5.13, and all of the outstanding Equity Interests in such Subsidiaries are owned by the Borrower or its Subsidiaries (as so indicated) free and clear of all Liens other than
Permitted Liens. The Borrower has no equity investments in any other corporation or entity other than those specifically disclosed in Part (b) of Schedule 5.13. Part (a) of such Schedule further specifies or identifies
(i) all Significant Subsidiaries as of the Closing Date, (ii) all Material Subsidiaries as of the Closing Date, and (iii) whether each Material Subsidiary is an Exempt Subsidiary. 
 5.14 Margin Regulations; Investment Company Act. 
 (a) The Borrower is not engaged and will not engage, principally or as one of its important activities, in the business of purchasing or carrying margin stock (within the meaning of Regulation U issued by the FRB), or
extending credit for the purpose of purchasing or carrying margin stock. Following the application of the proceeds of each Borrowing or drawing under each Letter of Credit, not more than 25% of the value of the assets (either of the Borrower only or
of the Borrower and its Subsidiaries on a consolidated basis) subject to the provisions of Section 7.01 or Section 7.05 or subject to any restriction contained in any agreement or instrument between the Borrower and the
Lender or any Affiliate of the Lender relating to Indebtedness and within the scope of Section 8.01(e) will be margin stock. 
 (b) None of the Borrower, any Person Controlling the Borrower, or any Subsidiary is or is required to be registered as an “investment company” under the Investment Company Act of 1940. 
 5.15 Disclosure. The Borrower has disclosed to the Lender all agreements, instruments and corporate or other restrictions to which it or
any of its Subsidiaries is subject, and all other matters known to it, that, individually or in the aggregate, could reasonably be expected to result in a Material Adverse Effect. All of Borrower’s publicly-filed reports and registration
statements are in compliance with all applicable Securities Laws and securities regulations. No other report, financial statement, certificate or other information furnished (whether in writing or orally) by or on behalf of any Loan Party to the
Lender in connection 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 41 

 
with the transactions contemplated hereby and the negotiation of this Agreement or delivered hereunder (as modified or supplemented by other information so
furnished) contains to the Borrower’s knowledge any material misstatement of fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;
provided that, with respect to projected financial information, the Borrower represents only that such information was prepared in good faith based upon assumptions believed to be reasonable at the time. 
 5.16 Intellectual Property; Licenses, Etc. Except as disclosed in Schedule 5.16, to the Borrower’s knowledge, the Borrower and
its Subsidiaries own, or possess the right to use, all of the trademarks, service marks, trade names, copyrights, patents, patent rights, franchises, licenses and other intellectual property rights (collectively, “IP Rights”) that
are reasonably necessary for the operation of the business of the Borrower and its Subsidiaries, taken as a whole, except as would not reasonably be expected to have Material Adverse Effect. No claim or litigation regarding any of the IP Rights is
pending or, to the Borrower’s knowledge, threatened, which, either individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. All material patents and patent applications owned by the Borrower as of the
Closing Date, and all material patent licenses relating to third party patents as to which the Borrower is licensee, together with their respective expiry or termination dates, are set forth on Schedule 5.16. 
 5.17 Solvency. Each Loan Party is Solvent. 
 ARTICLE VI. 
 AFFIRMATIVE COVENANTS 
 So long as the Commitment shall be in effect, any Loan or other Obligation hereunder shall remain unpaid or unsatisfied (other than contingent
indemnification obligations), or any Letter of Credit shall remain outstanding, the Borrower shall, and shall (except in the case of the covenants set forth in Sections 6.01, 6.02 and 6.03) cause each Subsidiary to: 

6.01 Financial Statements. Deliver to the Lender, in form and detail satisfactory to the Lender: 
 (a) as soon as available, but in any event within 90 days after the end of each fiscal year of the Borrower (commencing with the fiscal
year ended September 26, 2008), a consolidated and consolidating balance sheet of the Borrower and its Subsidiaries as at the end of such fiscal year, and the related consolidated and consolidating statements of income or operations,
shareholders’ equity and cash flows for such fiscal year, setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail and prepared in accordance with GAAP, such consolidating statements to
be audited and accompanied by (i) a report and opinion of a Registered Public Accounting Firm of nationally recognized standing reasonably acceptable to the Lender, which report and opinion shall be prepared in accordance with generally
accepted auditing standards and applicable Securities Laws and shall not be subject to any “going concern” or like qualification or exception or any qualification or exception as to the scope of such audit; and 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 42 

 (b) as soon as available, but in any event within 45 days after the end of each of the
first three fiscal quarters of each fiscal year of the Borrower, a consolidated balance sheet of the Borrower and its Subsidiaries as at the end of such fiscal quarter, and the related consolidated statements of income or operations,
shareholders’ equity and cash flows for such fiscal quarter and for the portion of the Borrower’s fiscal year then ended, setting forth in each case in comparative form the figures for the corresponding fiscal quarter of the previous
fiscal year and the corresponding portion of the previous fiscal year, all in reasonable detail, such statements to be certified by a Responsible Officer of the Borrower as fairly presenting the financial condition, results of operations,
shareholders’ equity and cash flows of the Borrower and its Subsidiaries in accordance with GAAP, subject only to normal year-end audit adjustments and the absence of footnotes. 
 As to any information contained in materials furnished pursuant to Section 6.02(d), the Borrower shall not be separately required to furnish such information under clause (a) or (b) above, but
the foregoing shall not be in derogation of the obligation of the Borrower to furnish the information and materials described in clauses (a) and (b) above at the times specified therein. 
 6.02 Certificates; Other Information. Deliver to the Lender, in form and detail satisfactory to the Lender: 
 (a) [Reserved]; 
 (b) concurrently with the delivery of the financial statements referred to in Sections 6.01(a) and (b) (commencing with the delivery of the financial statements for the fiscal year ended September 26, 2008), a
duly completed Compliance Certificate signed by a Responsible Officer of the Borrower; 
 (c) promptly after any request by
the Lender, copies of any detailed audit reports, management letters or recommendations submitted to the board of directors (or the audit committee of the board of directors) of the Borrower by independent accountants in connection with the accounts
or books of the Borrower or any Subsidiary, or any audit of any of them; 
 (d) promptly after the same are available, copies
of each annual report, proxy or financial statement or other report or communication sent to the stockholders of the Borrower, and copies of all annual, regular, periodic and special reports and registration statements which the Borrower may file or
be required to file with the SEC under Section 13 or 15(d) of the Securities Exchange Act of 1934, and not otherwise required to be delivered to the Lender pursuant hereto; 
 (e) [Reserved]; 
 (f) promptly, and in any event within ten Business Days after receipt thereof by any Loan Party or any Subsidiary thereof, copies of each notice or other correspondence received from the SEC (or comparable agency in any applicable non-U.S.
jurisdiction) concerning any investigation or possible investigation or other inquiry by such agency regarding financial or other operational results of any Loan Party or any Subsidiary thereof; and 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 43 

 (g) promptly, such additional information regarding the business, financial or corporate
affairs of the Borrower or any Subsidiary, or compliance with the terms of the Loan Documents, as the Lender may from time to time reasonably request. 
 Documents required to be delivered pursuant to Section 6.01(a) or (b) or Section 6.02(d) (to the extent any such documents are included in materials otherwise filed with the SEC)
may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i) on which the Borrower posts such documents, or provides a link thereto on the Borrower’s website on the Internet at the website
address listed on Schedule 9.02; or (ii) on which such documents are posted on the Borrower’s behalf on an Internet or intranet website, if any, to which the Lender has access (whether a commercial, third-party website);
provided that the Borrower shall notify the Lender (by telecopier or electronic mail) of the posting of any such documents and provide to the Lender by electronic mail electronic versions (i.e., soft copies) of such documents.
Notwithstanding anything contained herein, in every instance the Borrower shall be required to provide paper copies of the Compliance Certificates required by Section 6.02(b) to the Lender. Except for such Compliance Certificates, the
Lender shall have no obligation to request the delivery or to maintain copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery, and the Lender
shall be solely responsible for requesting delivery to it or maintaining its copies of such documents. 
 6.03 Notices.
Promptly notify the Lender: 
 (a) of the occurrence of any Default; 
 (b) of any matter (other than general economic trends) that has resulted or could reasonably be expected to result in a Material Adverse
Effect, including (i) breach or non-performance of, or any default under, a Contractual Obligation of the Borrower or any Subsidiary; (ii) any dispute, litigation, investigation, proceeding or suspension between the Borrower or any
Subsidiary and any Governmental Authority; or (iii) the commencement of, or any material development in, any litigation or proceeding affecting the Borrower or any Subsidiary, including pursuant to any applicable FDA Regulations; 
 (c) of the occurrence of any ERISA Event; 
 (d) of any material change in accounting policies or financial reporting practices by the Borrower; and 
 (e) of any amendment, modification or waiver to or under the Note Purchase Agreement, or any notes from time to time issued and outstanding thereunder. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 44 

 Each notice pursuant to this Section shall be accompanied by a statement of a Responsible Officer of the
Borrower setting forth details of the occurrence referred to therein and stating what action the Borrower has taken and proposes to take with respect thereto. Each notice pursuant to Section 6.03(a) shall describe with particularity any
and all provisions of this Agreement and any other Loan Document that have been breached. 
 6.04 Payment of Obligations. Pay
and discharge as the same shall become due and payable (a) all material tax liabilities, assessments and governmental charges or levies upon it or its properties or assets, unless the same are being contested in good faith by appropriate
proceedings diligently conducted and adequate reserves in accordance with GAAP are being maintained by the Borrower or such Subsidiary; and (b) all lawful claims which, if unpaid, would by law become a Lien upon its property (other than an
inchoate Lien permitted by Section 7.01); in each case, where a failure to so pay and discharge could reasonably be expected to have a Material Adverse Effect. 
 6.05 Preservation of Existence, Etc. (a) Preserve, renew and maintain in full force and effect its legal existence and good standing
under the Laws of the jurisdiction of its organization except in a transaction permitted by Section 7.04 or 7.05; (b) take all reasonable action to maintain all rights, privileges, permits, licenses and franchises necessary
or desirable in the normal conduct of its business, except to the extent that failure to do so could not reasonably be expected to have a Material Adverse Effect; and (c) preserve or renew all of its registered patents, trademarks, trade names
and service marks, the non-preservation of which could reasonably be expected to have a Material Adverse Effect. 
 6.06
Maintenance of Properties. (a) Maintain, preserve and protect all of its material properties and equipment necessary in the operation of its business in good working order and condition, ordinary wear and tear excepted, and (b) use
the standard of care typical in the industry in the operation and maintenance of its facilities; in each case except where the failure to do so could not reasonably be expected to have a Material Adverse Effect. 
 6.07 Maintenance of Insurance. Maintain with financially sound and reputable insurance companies not Affiliates of the Borrower, insurance
with respect to its properties and business against loss or damage of the kinds customarily insured against by Persons engaged in the same or similar business, of such types and in such amounts (after giving effect to any self-insurance compatible
with the following standards) as are customarily carried under similar circumstances by such other Persons. 
 6.08 Intellectual
Property. Ensure that at all times the Borrower shall continue to own all or substantially all material patents, patent applications and patent rights relating to any material business of the Borrower and its Subsidiaries, to the extent that it
held such patents, patent applications and patent rights on the Closing Date. 
 6.09 Books and Records. (a) Maintain
proper books of record and account, in which full, true and correct entries in conformity with GAAP consistently applied shall be made of all financial transactions and matters involving the assets and business of the Borrower or such Subsidiary, as
the case may be; and (b) maintain such books of record and account in material conformity with all applicable requirements of any Governmental Authority having regulatory jurisdiction over the Borrower or such Subsidiary, as the case may be.

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 45 

 6.10 Inspection Rights. Permit representatives and independent contractors of the Lender to
visit and inspect any of its properties, to examine its corporate, financial and operating records, and make copies thereof or abstracts therefrom, and to discuss its affairs, finances and accounts with its directors, officers, and independent
public accountants, all at such reasonable times during normal business hours and as often as may be reasonably desired, upon reasonable advance notice to the Borrower; provided, however, that (i) the Borrower shall not be
obligated to reimburse the expenses associated with more than one visit and inspection per calendar year (subject to clause (ii) below) and (ii) when an Event of Default exists the Lender (or any of its representatives or independent
contractors) may do any of the foregoing at the expense of the Borrower at any time during normal business hours and without advance notice. 
 6.11 Use of Proceeds. Use the proceeds of the Credit Extensions for working capital, capital expenditures, acquisitions, stock purchases and other general corporate purposes, not in contravention of any Law or of any Loan
Document. 
 6.12 Depository Bank. At all times from and after the Closing Date, cause the Lender and its affiliates to be the
primary depository bank for both U.S. and foreign (non-U.S.) deposit accounts maintained by the Borrower and its Subsidiaries. To the extent the Lender does not operate a branch or have an Affiliate accepting deposits in any foreign jurisdiction in
which a Subsidiary is located, such Subsidiary shall maintain its accounts at a correspondent bank of the Lender. 
 6.13 Additional
Guarantors; Pledge. 
 (a) On each Guarantor Assessment Date, the Borrower shall determine whether there exists any new or
additional Material Subsidiaries, and if so, shall promptly notify the Lender of such fact and promptly thereafter: 
 (i)
unless such Subsidiary is unable to execute such document without contravening local law and without causing any non-de minimis adverse tax effect as to the Borrower (and the Borrower provides a certificate to such effect) (any Subsidiary subject to
either such inability, an “Exempt Subsidiary”), become a Guarantor by executing and delivering to the Lender a counterpart of the Guaranty; 
 (ii) if such Subsidiary is an Exempt Subsidiary, unless prohibited by local law, and unless already provided, cause (x) each holder
of Equity Interests in any Foreign Subsidiary Holding Company as to which such Subsidiary is a Subsidiary, and (y) the Borrower and each Domestic Subsidiary (other than a Foreign Subsidiary Holding Company) as to which such Subsidiary is a
Subsidiary, to pledge 65% of the voting Equity Interests and all non-voting Equity Interests in such Subsidiary or Foreign Subsidiary Holding Company (or any intervening First Tier Foreign Subsidiary) to the Lender pursuant to a Pledge Agreement
containing a limitation on the obligations secured thereby similar to that set forth in the Pledge Agreement delivered on the Closing Date; 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 46 

 (iii) deliver to the Lender favorable opinions of counsel to such Person, which opinions
shall (i) cover, among other things, the legality, validity, binding effect and enforceability of the documentation referred to in this Section 6.13, and (ii) be in form and substance reasonably satisfactory to the Lender; and

 (iv) deliver to the Lender documents of the types referred to in clauses (iii), (iv), (v) and (vi) of
Section 4.01(a), which documents shall be in form and substance satisfactory to the Lender. 
 (b) If the Borrower
shall determine on any Guarantor Assessment Date in respect of any Subsidiary previously deemed not to be an Exempt Subsidiary and that is at such time a Guarantor, that, due to a change in Laws, such Subsidiary has become an Exempt Subsidiary, the
Borrower may deliver to the Lender a certificate to such effect, certifying also the absence of any Default or Event of Default, whereupon the Lender shall execute such instruments of release as shall be reasonably satisfactory to the parties,
confirming the release of such Subsidiary from the Guaranty. 
 6.14 Further Assurances. Promptly upon request by the Lender,
the Borrower shall (and shall cause any of its Subsidiaries to) do, execute, acknowledge, deliver, record, re-record, file, re-file, register and re-register, any and all such further acts, deeds, conveyances, security agreements, mortgages,
assignments, estoppel certificates, financing statements and continuation thereof, termination statements, notices of assignment, transfers, certificates, control agreements, assurances and other instruments the Lender may reasonably require from
time to time in order (i) to carry out more effectively the purposes of this Agreement or any other Loan Document, (ii) to subject to the Liens created by the Pledge Agreement any of the properties, rights or interests covered by the
Pledge Agreement, (iii) to perfect and maintain the validity, effectiveness and priority of the Pledge Agreement and the Liens intended to be created thereby, and (iv) to better assure, convey, grant, assign, transfer, preserve, protect
and confirm to the Lender the rights granted or now or hereafter intended to be granted to the Lenders under any Loan Document or under any other document executed in connection therewith. 
 ARTICLE VII. 
 NEGATIVE COVENANTS 
 So long as the Commitment shall be in effect, any Loan or other Obligation hereunder shall remain unpaid or unsatisfied (other than contingent
indemnification Obligations), or any Letter of Credit shall remain outstanding, the Borrower shall not, nor shall it permit any Subsidiary to, directly or indirectly: 
 7.01 Liens. Create, incur, assume or suffer to exist any Lien upon any of its property, assets or revenues, whether now owned or hereafter acquired, other than the following (“Permitted
Liens”): 
 (a) Liens pursuant to any Loan Document; 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 47 

 (b) Liens existing on the date hereof and listed on Schedule 7.01 and any
renewals or extensions thereof, provided that (i) the property covered thereby is not changed, (ii) the amount secured or benefited thereby is not increased, (iii) the direct or any contingent obligor with respect thereto is
not changed, and (iv) any renewal or extension of the obligations secured or benefited thereby is permitted by Section 7.03(b); 
 (c) Liens for taxes not yet due or which are being contested in good faith and by appropriate proceedings diligently conducted, if adequate reserves with respect thereto are maintained on the books of the applicable
Person in accordance with GAAP; 
 (d) carriers’, warehousemen’s, mechanics’, materialmen’s,
landlord’s, repairmen’s or other like Liens arising in the ordinary course of business which are not overdue for a period of more than 60 days or which are being contested in good faith and by appropriate proceedings diligently conducted,
if adequate reserves with respect thereto are maintained on the books of the applicable Person; 
 (e) pledges or deposits in
the ordinary course of business on assets other than Equity Interests issued by any First Tier Foreign Subsidiary, in connection with workers’ compensation, unemployment insurance and other social security legislation, other than any Lien
imposed by ERISA; 
 (f) deposits (other than Equity Interests issued by any First Tier Foreign Subsidiary) to secure the
performance of bids, trade contracts and leases (other than Indebtedness), statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business; 
 (g) easements, rights-of-way, restrictions and other similar encumbrances affecting real property which, in the aggregate, are not
substantial in amount, and which do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the applicable Person; 
 (h) Liens on assets other than Equity Interests issued by any First Tier Foreign Subsidiary, securing judgments for the payment of money
not constituting an Event of Default under Section 8.01(h); 
 (i) Liens on assets other than Equity Interests
issued by any First Tier Foreign Subsidiary, securing purchase money Indebtedness and capital leases in respect of such assets; 
 (j) Interests of lessors under operating leases; 
 (k) Liens consisting of leases or subleases of tangible property
granted to others not interfering in any material respect with the business of the Borrower and its Subsidiaries, taken as a whole, and licenses and sublicenses of IP Rights permitted under Section 7.05(f); 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 48 

 (l) Liens in favor of customs and revenue authorities arising as a matter of law to
secure payment of customs duties in connection with the importation of goods; 
 (m) Liens on cash collateral securing
reimbursement obligations to issuing banks under letters of credit otherwise permitted hereunder; 
 (n) Liens on assets
acquired in any Investment not prohibited hereunder (other than Equity Interests issued by any First Tier Foreign Subsidiary) to the extent such Liens were in existence at the time of acquisition and not incurred in anticipation thereof; 

(o) Liens upon such accounts and the financial assets therein in favor of other financial institutions arising in connection with
Borrower’s or any Subsidiary’s deposit or securities accounts held at such institutions and not securing Indebtedness; 
 (p) Liens on earnest money deposits required under a letter of intent or purchase agreement in connection with Acquisitions and other transactions otherwise permitted hereunder; 
 (q) Liens on assets other than Equity Interests issued by any First Tier Foreign Subsidiary, representing part of the proceeds of a sale
or other disposition of property otherwise permitted hereunder, to secure post closing obligations to the buyer in connection with such sale or other disposition; 
 (r) Liens on cash representing proceeds from the issuance of Indebtedness solely for the purpose of making interest payments in connection
with such Indebtedness; 
 (s) Liens on insurance proceeds securing the payment of financed insurance premiums; and

 (t) other Liens on assets other than Equity Interests issued by any First Tier Foreign Subsidiary, securing Indebtedness
not in excess of the Threshold Amount in the aggregate at any time outstanding. 
 7.02 Investments. Make any Investments,
except: 
 (a) Investments held by the Borrower or such Subsidiary in the form of cash equivalents, or short-term marketable
securities and other Investments permitted by the Borrower’s board-approved investment policy in effect from time to time; 
 (b) advances to officers, directors and employees of the Borrower and Subsidiaries for travel, entertainment, relocation and analogous ordinary business purposes; 
  

  
 *** Confidential Treatment has been
requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 49 

 (c) Investments consisting of extensions of credit in the nature of accounts receivable,
prepaid royalties or notes receivable arising from the grant of trade credit in the ordinary course of business, and Investments received in satisfaction or partial satisfaction thereof from financially troubled account debtors to the extent
reasonably necessary in order to prevent or limit loss; 
 (d) Guarantees permitted by Section 7.03; 

(e) Acquisitions by the Borrower or any of its wholly-owned Subsidiaries, provided that (i) the Total Consideration for any
Acquisition does not exceed $[****], and (ii) after giving effect to such Acquisition, the Total Consideration for all Acquisitions together consummated by the Borrower or its Subsidiaries from and after the Closing Date does not exceed
$[****]; 
 (f) Investments as to which the Lender has provided its prior written consent; 
 (g) Investments acquired in exchange for any other Investments in connection with or as a result of a bankruptcy, workout, reorganization
or recapitalization; and 
 (h) and other Investments (including joint ventures), other than Acquisitions, provided that, the
aggregate amount of all such Investments together during the term of this Agreement does not exceed $[****]. 
 7.03 Subsidiary
Guaranties. Create, incur, assume or suffer to exist any Guaranties issued by Subsidiaries, except: 
 (a) the Guaranty;

 (b) Guarantees outstanding on the date hereof and listed on Schedule 7.03; 
 (c) Guarantees issued by a Subsidiary other than a Domestic Subsidiary or a First Tier Foreign Subsidiary with respect to Indebtedness or
other obligations of any other Subsidiary; 
 (d) Guarantees of First Tier Foreign Subsidiaries in respect of ordinary course
real estate lease, vendor and other ordinary course transactions not constituting financings and entered into by Subsidiaries of any such First Tier Foreign Subsidiary; and 
 (e) Indebtedness arising from any refinancings, refundings, renewals or extensions of items (b) and (c) above; provided
that the amount of such Indebtedness is not increased at the time of such refinancing, refunding, renewal or extension except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in
connection therewith and by an amount equal to any existing commitments unutilized thereunder. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 50 

 7.04 Fundamental Changes. Merge, dissolve, liquidate, consolidate with or into another
Person, or Dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired) to or in favor of any Person, except that, so long as no Default exists or would
result therefrom: 
 (a) any Subsidiary may merge or consolidate with (i) the Borrower, provided that the Borrower
shall be the continuing or surviving Person, or (ii) any one or more other Subsidiaries, provided that when any Guarantor is merging with another Subsidiary, a Guarantor shall be the continuing or surviving Person; 
 (b) Subsidiaries of Borrower may merge or consolidate with any Person as necessary to consummate Acquisitions permitted hereunder;

 (c) any Loan Party may merge or consolidate with any Person so long as (i) such Loan Party is the continuing or
surviving Person, (ii) the merger or consolidation does not result in a decrease of more than [****] in Borrower’s Consolidated Tangible Net Worth, based upon the then-most recently delivered financial statements hereunder, and
(iii) no Change of Control results therefrom; 
 (d) any Subsidiary may Dispose of all or substantially all of its assets
(upon voluntary liquidation or otherwise) to the Borrower or to another Subsidiary; and 
 (e) Dispositions of all or
substantially all assets of any Subsidiary of Borrower (other than Guarantor) not otherwise permitted under this Section 7.04; provided that (i) at the time of such Disposition, no Default shall exist or would result from such
Disposition, (ii) no such Disposition or related series of Dispositions shall entail assets having combined book value in excess of the Single Transaction Limit, and (iii) after giving effect to such Disposition, the Borrower is in
compliance, on a projected pro forma basis, with Section 7.11 for the subsequent four fiscal quarters. 
 7.05
Dispositions. Make any Disposition or enter into any agreement to make any Disposition, except: 
 (a) Dispositions of
obsolete or worn out property, whether now owned or hereafter acquired, in the ordinary course of business; 
 (b)
Dispositions of inventory in the ordinary course of business; 
 (c) Dispositions of equipment or real property to the extent
that (i) such property is exchanged for credit against the purchase price of similar replacement property or (ii) the proceeds of such Disposition are reasonably promptly applied to the purchase price of such replacement property;

 (d) Dispositions of property by any Subsidiary to the Borrower or to a wholly-owned Subsidiary; 
 (e) Dispositions permitted by Section 7.04; 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 51 

 (f) (i) licenses and sublicenses of IP Rights in the ordinary course of business and
substantially consistent with past practice, and (ii) licenses and cross-licenses of IP Rights in connection with settlements of intellectual property-related disputes with third parties; 
 (g) sales or discounting of delinquent accounts in the ordinary course of business; and 
 (h) Dispositions by the Borrower and its Subsidiaries not otherwise permitted under this Section 7.05; provided that
(i) at the time of such Disposition, no Default shall exist or would result from such Disposition, (ii) no such Disposition or related series of Dispositions shall entail assets having combined book value in excess of the Single
Transaction Limit, and (iii) after giving effect to such Disposition, the Borrower is in compliance, on a projected pro forma basis, with Section 7.11 for the subsequent four fiscal quarters; 
 provided, however, that any Disposition pursuant to clauses (a) through (h) shall be for fair value. 
 7.06 Restricted Payments. Declare or make, directly or indirectly, any Restricted Payment, or incur any obligation (contingent or
otherwise) to do so, except that, so long as no Default shall have occurred and be continuing at the time of any action described below or would result therefrom: 
 (a) each Subsidiary may make Restricted Payments to the Borrower, the Guarantors and any other Person that owns an Equity Interest in such
Subsidiary, ratably according to their respective holdings of the type of Equity Interest in respect of which such Restricted Payment is being made; 
 (b) the Borrower and each Subsidiary may declare and make dividend payments or other distributions payable solely in the common stock or other common Equity Interests of such Person; 
 (c) the Borrower and each Subsidiary may purchase, redeem or otherwise acquire Equity Interests issued by it with the proceeds received
from the substantially concurrent issue of new shares of its common stock or other common Equity Interests; 
 (d) the
Borrower may purchase, redeem or otherwise acquire for cash Equity Interests issued by it pursuant to stock buy-back plans approved by the board of directors of the Borrower and disclosed to the Lender prior to the Original Closing Date in respect
of not more than 1 million shares in the aggregate of the Borrower’s common stock; and 
 (e) the Borrower may
declare or pay cash dividends to its stockholders and purchase, redeem or otherwise acquire for cash Equity Interests issued by it, provided, that after giving effect to such declaration, payment, purchase, redemption or acquisition, the Borrower is
in compliance, on a projected pro forma basis, with Section 7.11 for the subsequent four fiscal quarters. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 52 

 7.07 Change in Nature of Business. Engage in any material line of business substantially
different from those lines of business conducted by the Borrower and its Subsidiaries on the date hereof or any business reasonably related or incidental thereto. 
 7.08 Transactions with Affiliates. Enter into any transaction of any kind with any Affiliate of the Borrower, whether or not in the ordinary course of business, other than on fair and reasonable terms
substantially as favorable to the Borrower or such Subsidiary as would be obtainable by the Borrower or such Subsidiary at the time in a comparable arm’s length transaction with a Person other than an Affiliate, provided that the foregoing
restriction shall not apply to transactions between or among the Borrower and any of its wholly-owned Subsidiaries or between and among any wholly-owned Subsidiaries. 
 7.09 Burdensome Agreements. Enter into any Contractual Obligation (other than this Agreement or any other Loan Document) that (a) limits the ability (i) of any Subsidiary to make Restricted Payments
to the Borrower or any Guarantor or to otherwise transfer property to the Borrower or any Guarantor, (ii) of any Subsidiary to Guarantee the Indebtedness of the Borrower or (iii) of any Domestic Subsidiary to pledge Voting Stock of any
First Tier Foreign Subsidiary, or (b) that requires the grant of a Lien to secure an obligation of another Person if such Voting Stock should be so pledged. 
 7.10 Use of Proceeds. Use the proceeds of any Credit Extension, whether directly or indirectly, and whether immediately, incidentally or ultimately, to purchase or carry margin stock (within the meaning of
Regulation U of the FRB) or to extend credit to others for the purpose of purchasing or carrying margin stock or to refund indebtedness originally incurred for such purpose. 
 7.11 Financial Covenants. 
 (a) Consolidated Leverage Ratio. Permit the Consolidated Leverage Ratio as of the last day of any fiscal quarter of the Borrower (commencing with the fiscal quarter ended September 26, 2008) to be greater than the applicable
amount set forth on Schedule 7.11. 
 (b) Consolidated Fixed Charge Coverage Ratio. Permit the Consolidated
Fixed Charge Coverage Ratio as of the last day of any fiscal quarter of the Borrower (commencing with the fiscal quarter ending January 2, 2009) to be less than the applicable amount set forth on Schedule 7.11. 
 (c) Borrower Assets. Permit at any time the Borrower’s assets (other than Equity Interests issued by its Subsidiaries and
inter-company debt) to be less than the greater of (x) the applicable amount set forth on Schedule 7.11 or (y) the applicable amount set forth on Schedule 7.11. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 53 

 7.12 Capital Expenditures. Make or become legally obligated to make any expenditure in respect of
the purchase or other acquisition of any fixed or capital asset (excluding normal replacements and maintenance which are properly charged to current operations) (“Capital Expenditures”), except for capital expenditures not
exceeding, in the aggregate for the Borrower and it Subsidiaries during any Applicable Period the applicable amount set forth on Schedule 7.11 of Consolidated EBITDA for the relevant Specified Period; provided, however, that so
long as no Event of Default has occurred and is continuing or would result from such expenditure, any portion of any amount set forth above, if not expended in the fiscal year for which it is permitted above, may be carried over for expenditure in
the next following fiscal year. 
 7.13 Fiscal Periods. Change its fiscal quarter or fiscal year end date methodology from that
applicable as of the Original Closing Date. 
 ARTICLE VIII. 
 EVENTS OF DEFAULT AND REMEDIES 
 8.01 Events of Default. Any of
the following shall constitute an Event of Default: 
 (a) Non-Payment. The Borrower or any other Loan Party fails to
pay (i) when and as required to be paid herein, any amount of principal of any Loan or any L/C Obligation, or (ii) within three Business Days after the same becomes due, any interest on any Loan or on any L/C Obligation, or any fee due
hereunder, or (iii) within five Business Days after the same becomes due, any other amount payable hereunder or under any other Loan Document; or 
 (b) Specific Covenants. The Borrower fails to perform or observe any term, covenant or agreement contained in any of Section 6.01, 6.02(b), 6.03, 6.05, 6.10, 6.11
or 6.12 or Article VII; or 
 (c) Other Defaults. Any Loan Party fails to perform or observe any
other covenant or agreement (not specified in subsection (a) or (b) above) contained in any Loan Document on its part to be performed or observed and such failure continues for 45 days; or 
 (d) Representations and Warranties. Any representation, warranty, certification or statement of fact made or deemed made by or on
behalf of the Borrower or any other Loan Party herein, in any other Loan Document, or in any document delivered in connection herewith or therewith shall be incorrect or misleading when made or deemed made; or 
 (e) Cross-Default. (i) Any Loan Party or any Significant Subsidiary (A) fails to make any payment when due (whether by
scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of any Indebtedness or Guarantee (other than Indebtedness hereunder and Indebtedness under Swap Contracts) having an aggregate principal amount (including
undrawn committed or available amounts and including amounts owing to all creditors under any combined or syndicated credit arrangement) of more than the Threshold Amount, or (B) fails to observe or perform any other agreement or condition
relating to any such Indebtedness or Guarantee or contained in any instrument or agreement evidencing, securing or 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 54 

 
relating thereto, or any other event occurs, the effect of which default or other event is to cause, or to permit the holder or holders of such Indebtedness
or the beneficiary or beneficiaries of such Guarantee (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) to cause, with the giving of notice if required, such Indebtedness to be demanded or to become due or
to be repurchased, prepaid, defeased or redeemed (automatically or otherwise), or an offer to repurchase, prepay, defease or redeem such Indebtedness to be made, prior to its stated maturity, or such Guarantee to become payable or cash collateral in
respect thereof to be demanded; or (ii) there occurs under any Swap Contract an Early Termination Date (as defined in such Swap Contract) resulting from (A) any event of default under such Swap Contract as to which the Loan Party or any
Significant Subsidiary is the Defaulting Party (as defined in such Swap Contract) or (B) any Termination Event (as so defined) under such Swap Contract as to which any Loan Party or any Significant Subsidiary is an Affected Party (as so
defined) and, in either event, the Swap Termination Value owed by the Loan Party or such Significant Subsidiary as a result thereof is greater than the Threshold Amount; or 
 (f) Insolvency Proceedings, Etc. Any Loan Party or any of its Significant Subsidiaries institutes or consents to the institution of
any proceeding under any Debtor Relief Law, or makes an assignment for the benefit of creditors; or applies for or consents to the appointment of any receiver, trustee, custodian, conservator, liquidator, rehabilitator or similar officer for it or
for all or any material part of its property; or any receiver, trustee, custodian, conservator, liquidator, rehabilitator or similar officer is appointed without the application or consent of such Person and the appointment continues undischarged or
unstayed for 60 calendar days; or any proceeding under any Debtor Relief Law relating to any such Person or to all or any material part of its property is instituted without the consent of such Person and continues undismissed or unstayed for 60
calendar days, or an order for relief is entered in any such proceeding; or 
 (g) Inability to Pay Debts; Attachment.
(i) Any Loan Party or any Significant Subsidiary becomes unable or admits in writing its inability or fails generally to pay its debts as they become due, or (ii) any writ or warrant of attachment or execution or similar process is issued
or levied against all or any material part of the property of any such Person and is not released, vacated or fully bonded within 30 days after its issue or levy; or 
 (h) Judgments. There is entered against any Loan Party or any Significant Subsidiary (i) a final judgment or order for the
payment of money in an aggregate amount exceeding the Threshold Amount (to the extent not covered by independent third-party insurance or commercial surety as to which the insurer or surety does not dispute coverage), or (ii) any one or more
non-monetary final judgments that have, or could reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect and, in either case, (A) enforcement proceedings are commenced by any creditor upon such judgment or
order, or (B) there is a period of 20 consecutive days during which a stay of enforcement of such judgment, by reason of a pending appeal or otherwise, is not in effect; or 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 55 

 (i) ERISA. (i) An ERISA Event occurs with respect to a Pension Plan or
Multiemployer Plan which has resulted or could reasonably be expected to result in liability of the Borrower under Title IV of ERISA to the Pension Plan, Multiemployer Plan or the PBGC in an aggregate amount in excess of the Threshold Amount,
or (ii) the Borrower or any ERISA Affiliate fails to pay when due, after the expiration of any applicable grace period, any installment payment with respect to its withdrawal liability under Section 4201 of ERISA under a
Multiemployer Plan in an aggregate amount in excess of the Threshold Amount; or 
 (j) Invalidity of Loan Documents.
Any Loan Document, at any time after its execution and delivery and for any reason other than as expressly permitted hereunder or thereunder or satisfaction in full of all the Obligations, ceases to be in full force and effect; or any Loan Party or
any other Person contests in any manner the validity or enforceability of any Loan Document; or any Loan Party denies that it has any or further liability or obligation under any Loan Document, or purports to revoke, terminate or rescind any Loan
Document; or 
 (k) Change of Control. There occurs any Change of Control with respect to the Borrower. 
 8.02 Remedies Upon Event of Default. If any Event of Default occurs and is continuing, the Lender may take any or all of the following
actions: 
 (a) declare the Commitment to be terminated, whereupon the Commitment shall be terminated; 
 (b) declare the unpaid principal amount of all outstanding Loans, all interest accrued and unpaid thereon, and all other amounts owing or
payable hereunder or under any other Loan Document to be immediately due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived by the Borrower; 
 (c) require that the Borrower Cash Collateralize the L/C Obligations (in an amount equal to the then Outstanding Amount thereof); and

 (d) exercise all rights and remedies available to it under the Loan Documents or applicable law; 
 provided, however, that upon the occurrence of an actual or deemed entry of an order for relief with respect to the Borrower under the Bankruptcy Code, the
Commitment shall automatically terminate, the unpaid principal amount of all outstanding Loans and all interest and other amounts as aforesaid shall automatically become due and payable, and the obligation of the Borrower to Cash Collateralize the
L/C Obligations as aforesaid shall automatically become effective, in each case without further act of the Lender. 
 8.03
Application of Funds. After the exercise of remedies provided for in Section 8.02 (or after the Loans have automatically become immediately due and payable and the L/C Obligations have automatically been required to be Cash
Collateralized as set forth in the proviso to Section 8.02), any amounts received on account of the Obligations shall be applied by the Lender in such order as it elects in its sole discretion. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 56 

 ARTICLE IX. 
 MISCELLANEOUS 
 9.01 Amendments; Etc. No amendment or waiver of any provision of this
Agreement or any other Loan Document, and no consent to any departure by the Borrower or any other Loan Party therefrom, shall be effective unless in writing signed by the Lender and the Borrower or the applicable Loan Party, as the case may be, and
each such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. 
 9.02 Notices
and Other Communications; Facsimile Copies. 
 (a) General. Unless otherwise expressly provided herein, all notices
and other communications provided for hereunder shall be in writing (including by facsimile transmission). All such written notices shall be mailed, faxed or delivered to the address, facsimile number or (subject to subsection (c) below)
electronic mail address specified for notices to the applicable party on Schedule 9.02; or to such other address, facsimile number or electronic mail address as shall be designated by such party in a notice to the other party. All
notices and other communications expressly permitted hereunder to be given by telephone shall be made to the telephone number specified for notices to the applicable party on Schedule 9.02, or to such other telephone number as shall be
designated by such party in a notice to the other party. All such notices and other communications shall be deemed to be given or made upon the earlier to occur of (i) actual receipt by the relevant party hereto and (ii) (A) if
delivered by hand or by courier, when signed for by or on behalf of the relevant party hereto; (B) if delivered by mail, four Business Days after deposit in the mails, postage prepaid; (C) if delivered by facsimile, when sent and receipt
has been confirmed by telephone; and (D) if delivered by electronic mail (which form of delivery is subject to the provisions of subsection (c) below), when delivered; provided, however, that notices and other communications
to the Lender pursuant to Article II shall not be effective until actually received by the Lender. In no event shall a voicemail message be effective as a notice, communication or confirmation hereunder. 
 (b) Effectiveness of Facsimile Documents and Signatures. Loan Documents may be transmitted and/or signed by facsimile. The
effectiveness of any such documents and signatures shall, subject to applicable Law, have the same force and effect as manually-signed originals and shall be binding on all Loan Parties and the Lender. The Lender may also require that any such
documents and signatures be confirmed by a manually-signed original thereof; provided, however, that the failure to request or deliver the same shall not limit the effectiveness of any facsimile document or signature. 
 (c) Limited Use of Electronic Mail. Electronic mail and Internet and intranet websites may be used only to distribute routine
communications, such as financial statements and other information as provided in Section 6.02, and to distribute Loan Documents for execution by the parties thereto, and may not be used for any other purpose. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 57 

 (d) Reliance by Lender. The Lender shall be entitled to rely and act upon any
notices (including telephonic Loan Notices) purportedly given by or on behalf of the Borrower even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice
specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof. The Borrower shall indemnify the Lender, its Affiliates, and their respective officers, directors, employees, agents and
attorneys-in-fact from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of the Borrower. All telephonic notices to and other communications with the Lender may be
recorded by the Lender, and the Borrower hereby consents to such recording. 
 9.03 No Waiver; Cumulative Remedies. No failure by the
Lender to exercise, and no delay by the Lender in exercising, any right, remedy, power or privilege hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any
other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by
law. 
 9.04 Expenses; Indemnity; Damage Waiver. 
 (a) Costs and Expenses. The Borrower shall pay (i) all reasonable out of pocket expenses incurred by the Lender and its
Affiliates (including the reasonable fees, charges and disbursements of counsel for the Lender), in connection with the preparation, negotiation, execution, delivery and administration of this Agreement and the other Loan Documents or any
amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii) all reasonable out of pocket expenses incurred by the Lender in connection with
the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all out of pocket expenses incurred by the Lender (including the fees, charges and disbursements of any counsel for the
Lender), in connection with the enforcement or protection of its rights (A) in connection with this Agreement and the other Loan Documents, including its rights under this Section, or (B) in connection with the Loans made or Letters of
Credit issued hereunder, including all such out of pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit. 
 (b) Indemnification by the Borrower. The Borrower shall indemnify the Lender and each Related Party of Lender (each such Person
being called an “Indemnitee”) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses (including the fees, charges and disbursements of any counsel for any Indemnitee),
incurred by any Indemnitee or asserted against any Indemnitee by any third party or by the Borrower or any other Loan Party arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan
Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder, the consummation of the transactions contemplated hereby or thereby, or, in the
case of the Lender and its Related Parties only, the administration of this Agreement and the other Loan Documents, (ii) any Loan or Letter of 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 58 

 
Credit or the use or proposed use of the proceeds therefrom (including any refusal by the Lender to honor a demand for payment under a Letter of Credit if
the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), or (iii) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether
based on contract, tort or any other theory, whether brought by a third party or by the Borrower or any other Loan Party, and regardless of whether any Indemnitee is a party thereto; provided that such indemnity shall not, as to any
Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (x) are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or
willful misconduct of such Indemnitee or (y) result from a claim brought by the Borrower or any other Loan Party against an Indemnitee for breach in bad faith of such Indemnitee’s obligations hereunder or under any other Loan Document, if
the Borrower or such Loan Party has obtained a final and nonappealable judgment in its favor on such claim as determined by a court of competent jurisdiction. 
 (c) Waiver of Consequential Damages, Etc. To the fullest extent permitted by applicable law, the Borrower shall not assert, and
hereby waives, any claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any
other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof. No Indemnitee referred to in subsection (b) above shall be
liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the
other Loan Documents or the transactions contemplated hereby or thereby. 
 (d) Payments. All amounts due under this
Section shall be payable not later than ten Business Days after demand therefor. 
 (e) Survival. The agreements in
this Section shall survive the termination of the Commitment and the repayment, satisfaction or discharge of all the other Obligations. 
 9.05 Payments Set Aside. To the extent that any payment by or on behalf of the Borrower is made to the Lender, or the Lender exercises its right of set-off, and such payment or the proceeds of such set-off or any part thereof is
subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Lender in its discretion) to be repaid to a trustee, receiver or any other party, in connection with
any proceeding under any Debtor Relief Law or otherwise, then, to the extent of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been
made or such set-off had not occurred. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 59 

 9.06 Successors and Assigns. 
 (a) The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Lender and the Lender may not assign or otherwise transfer any of its
rights or obligations hereunder except (i) to an Eligible Assignee in accordance with the provisions of subsection (b) of this Section, (ii) by way of participation in accordance with the provisions of subsection (c) of this
Section, or (iii) by way of pledge or assignment of a security interest subject to the restrictions of subsection (e) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in
this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in subsection (c) of this Section
and, to the extent expressly contemplated hereby, the Indemnitees) any legal or equitable right, remedy or claim under or by reason of this Agreement. 
 (b) The Lender may at any time assign to one or more Eligible Assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of the Commitment, the Loans and L/C Obligations
at the time owing to it) pursuant to documentation acceptable to the Lender and the assignee, it being understood and agreed that with respect to any Letters of Credit outstanding at the time of any such assignment, the Lender may sell to the
assignee a ratable participation in such Letters of Credit. From and after the effective date specified in such documentation, such Eligible Assignee shall be a party to this Agreement and, to the extent of the interest assigned by the Lender, have
the rights and obligations of the Lender under this Agreement, and the Lender shall, to the extent of the interest so assigned, be released from its obligations under this Agreement (and, in the case of an assignment of all of the Lender’s
rights and obligations under this Agreement, shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 3.01, 3.04, 3.05, and 9.04 with respect to facts and circumstances occurring
prior to the effective date of such assignment, and shall continue to have all of the rights provided hereunder to the Lender in its capacity as issuer of any Letters of Credit outstanding at the time of such assignment). Upon request, the Borrower
(at its expense) shall execute and deliver new or replacement Notes to the Lender and the assignee, and shall execute and deliver any other documents reasonably necessary or appropriate to give effect to such assignment and to provide for the
administration of this Agreement after giving effect thereto. 
 (c) The Lender may at any time, without the consent of, or
notice to, the Borrower, sell participations to any Person (other than a natural person or the Borrower or any of the Borrower’s Affiliates or Subsidiaries) (each, a “Participant”) in all or a portion of the Lender’s
rights and/or obligations under this Agreement (including all or a portion of its Commitment and/or the outstanding Letters of Credit and/or the Loans and/or the reimbursement obligations in respect of Letters of Credit); provided that
(i) the Lender’s obligations under this Agreement shall remain unchanged, (ii) the Lender shall remain solely responsible to the Borrower for the performance of such obligations and (iii) the Borrower shall continue to deal
solely and directly with the Lender in connection with the Lender’s rights and obligations under this Agreement. Any agreement or instrument pursuant to which the Lender sells such a participation shall provide that the Lender shall retain the
sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that such agreement or instrument may provide that the Lender will not, without the consent of the
Participant, agree to any amendment, waiver or 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 60 

 
other modification that would (i) postpone any date upon which any payment of money is scheduled to be made to such Participant, (ii) reduce the
principal, interest, fees or other amounts payable to such Participant (provided, however, that the Lender may, without the consent of the Participant, (A) amend any financial covenant hereunder (or any defined term used therein)
even if the effect of such amendment would be to reduce the rate of interest on any Loan or Letter of Credit reimbursement obligation or to reduce any fee payable hereunder and (B) waive the right to be paid interest at the Default Rate), or
(iii) release any Guarantor from the Guaranty. Subject to subsection (d) of this Section, the Borrower agrees that each Participant shall be entitled to the benefits of Sections 3.01, 3.04 and 3.05 to the same extent
as if it were the Lender and had acquired its interest by assignment pursuant to subsection (b) of this Section. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 9.08 as though it
were the Lender. 
 (d) A Participant shall not be entitled to receive any greater payment under Section 3.01 or
3.04 than the Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower’s prior written consent. A
Participant that is not a “United States person” within the meaning of Section 7701(a)(30) of the Code shall not be entitled to the benefits of Section 3.01 unless the Borrower is notified of the participation sold to such
Participant and such Participant agrees, for the benefit of the Borrower, to provide to the Lender such tax forms prescribed by the IRS as are necessary or desirable to establish an exemption from, or reduction of, U.S. withholding tax. 

(e) The Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement (including
under the Note, if any) to secure obligations of the Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank; provided that no such pledge or assignment shall release the Lender from any of its obligations
hereunder or substitute any such pledgee or assignee for the Lender as a party hereto. 
 (f) As used herein, the following
terms have the following meanings: 
 “Approved Fund” means any Fund that is administered or managed by
(a) the Lender or (b) an Affiliate of the Lender. 
 “Eligible Assignee” means (a) an
Affiliate of the Lender; (b) an Approved Fund; and (c) any other Person (other than a natural person) approved by the Borrower (such approval not to be unreasonably withheld or delayed); provided that no such approval shall be
required if an Event of Default has occurred and is continuing. 
 “Fund” means any Person (other than a
natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 61 

 9.07 Treatment of Certain Information; Confidentiality. 
 (a) The Lender agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed
(i) to its Affiliates and to its and its Affiliates’ respective partners, directors, officers, employees, agents, advisors and representatives (it being understood that the Persons to whom such disclosure is made will be informed of the
confidential nature of such Information and instructed to keep such Information confidential), (ii) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as
the National Association of Insurance Commissioners), (iii) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (provided that the Lender shall exercise commercially reasonable efforts,
unless prohibited by applicable law, order or request of a Governmental Authority, to provide prompt prior written notice thereof to the Borrower to enable the Borrower to seek a protective order or otherwise prevent such disclosure), (iv) to
any other party hereto, (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or
thereunder, (vi) subject to an agreement containing provisions substantially the same as those of this Section, to (A) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations
under this Agreement or (B) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (vii) with the consent of the Borrower or (viii) to the
extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Lender or any of its Affiliates on a nonconfidential basis from a source other than the Borrower.

 (b) For purposes of this Section 9.07, “Information” means all information received from the
Borrower or any Subsidiary relating to the Borrower or any Subsidiary or any of their respective businesses, other than any such information that is available to the Lender on a nonconfidential basis prior to disclosure by the Borrower or any
Subsidiary, provided that, in the case of information received from the Borrower or any Subsidiary after the date hereof, such information is clearly identified at the time of delivery as confidential. Any Person required to maintain the
confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person
would accord to its own confidential information. 
 (c) The Lender acknowledges that (i) the Information may include
material non-public information concerning the Borrower or a Subsidiary, as the case may be, (ii) it has developed compliance procedures regarding the use of material non-public information and (c) it will handle such material non-public
information in accordance with applicable Law, including Federal and state securities Laws. 
 9.08 Right of Setoff. If an Event of
Default shall have occurred and be continuing, the Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable law, to set off and apply any and all deposits (general or
special, time or demand, provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by the Lender or any such Affiliate to or for the credit or the account of the Borrower or any other
Loan Party against any and all of the obligations of the Borrower or such Loan Party now or hereafter existing under this Agreement or any other Loan Document to the Lender, irrespective of whether or not the 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 62 

 
Lender shall have made any demand under this Agreement or any other Loan Document and although such obligations of the Borrower or such Loan Party may be
contingent or unmatured or are owed to a branch or office of the Lender different from the branch or office holding such deposit or obligated on such indebtedness. The rights of the Lender and its respective Affiliates under this Section are in
addition to other rights and remedies (including other rights of setoff) that the Lender or its respective Affiliates may have. The Lender agrees to notify the Borrower promptly after any such setoff and application, provided that the failure
to give such notice shall not affect the validity of such setoff and application. 
 9.09 Interest Rate Limitation. Notwithstanding
anything to the contrary contained in any Loan Document, the interest paid or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable Law (the “Maximum Rate”). If
the Lender shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the Borrower. In determining whether the interest
contracted for, charged, or received by the Lender exceeds the Maximum Rate, the Lender may, to the extent permitted by applicable Law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest,
(b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations hereunder. 
 9.10 Counterparts; Integration; Effectiveness. This Agreement may be executed in counterparts (and by different parties hereto in different
counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement and the other Loan Documents constitute the entire contract among the parties relating to the subject
matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been
executed by the Lender and when the Lender shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by
telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 
 9.11 Survival of Representations and
Warranties. All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and
thereof. Such representations and warranties have been or will be relied upon by the Lender, regardless of any investigation made by the Lender or on its behalf and notwithstanding that the Lender may have had notice or knowledge of any Default at
the time of any Credit Extension, and shall continue in full force and effect as long as any Loan or any other Obligation hereunder shall remain unpaid or unsatisfied or any Letter of Credit shall remain outstanding. 
 9.12 Severability. If any provision of this Agreement or the other Loan Documents is held to be illegal, invalid or unenforceable, (a) the
legality, validity and enforceability of the remaining provisions of this Agreement and the other Loan Documents shall not be affected or 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 63 

 
impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid
provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in
any other jurisdiction. 
 9.13 Governing Law; Jurisdiction; Etc. 
 (a) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

 (b) SUBMISSION TO JURISDICTION. THE BORROWER AND EACH OTHER LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR
ITSELF AND ITS PROPERTY, TO THE NONEXCLUSIVE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK SITTING IN THE BOROUGH OF MANHATTAN, NEW YORK CITY AND OF THE UNITED STATES DISTRICT COURT OF THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT
FROM ANY THEREOF, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL
CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY
SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR IN ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT THE LENDER
MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST THE BORROWER OR ANY OTHER LOAN PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION. 
 (c) WAIVER OF VENUE. THE BORROWER AND EACH OTHER LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT REFERRED TO IN PARAGRAPH (B) OF THIS
SECTION. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 64 

 (d) SERVICE OF PROCESS. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF
PROCESS IN THE MANNER PROVIDED FOR NOTICES IN SECTION 9.02. NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW. 
 9.14 Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).

 9.15 USA PATRIOT Act Notice. The Lender hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act
(Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Act”), it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower
and other information that will allow the Lender to identify the Borrower in accordance with the Act. 
 9.16 Time of the Essence.
Time is of the essence of the Loan Documents. 
 9.17 ENTIRE AGREEMENT. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE
FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES. 
 9.18 Effect of Amendment and Restatement. This Agreement is intended to completely amend, restate and replace the Existing Credit Agreement,
without novation. The Borrower hereby acknowledges, certifies and agrees that (i) all “Loans” and “Letters of Credit” as defined in the Existing Credit Agreement and outstanding as of the Closing Date shall automatically, as
of such date, be deemed Loans and Letters of Credit, as the case may be, hereunder and under the Note; (ii) the Borrower’s obligation to repay and any all “Loans” or other “Obligations” as defined in the Existing Credit
Agreement outstanding on the Closing Date to the Lender is not subject to any defense, counterclaim, set-off, right of recoupment, abatement or other claim or determination, and (iii) such Loans shall continue and constitute Borrowings under
and subject to the provisions of this Agreement. The Borrower further reaffirms the validity and binding effect of each Loan Document delivered pursuant to the Existing Credit Agreement. 
 9.19 Post-Closing Matters. 
 (a) By no later than the date that is 90 days after the Closing Date, the Borrower shall deliver to the Lender such documents and perform such acts as may be necessary or appropriate to create a valid charge and pledge under the laws of the
Netherlands in respect of the shares of Varian Medical Systems Nederland B.V., together with an opinion of Borrower’s Netherlands counsel relating thereto, in form and substance satisfactory to the Lender. 
 [Remainder of this page intentionally left blank] 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 65 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the
date first above written. 
  

			
	VARIAN MEDICAL SYSTEMS, INC.
		
	By:	 	/s/ ELISHA W. FINNEY
	Name:	 	Elisha W. Finney
	Title:	 	Senior Vice President, Finance and
Chief Financial Officer
		
	By:	 	/s/ FRANCO N. PALOMBA
	Name:	 	Franco N. Palomba
	Title:	 	Vice President, Finance and Treasurer

  
  

*** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version
of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 S-1 

			
	BANK OF AMERICA, N.A.
		
	By:	 	/s/ JOHN C. PLECQUE
	Name:	 	John C. Plecque
	Title:	 	Senior Vice President

  
  

*** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version
of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 S-2 

 SCHEDULE 5.05 
 SUPPLEMENT TO FINANCIAL STATEMENTS 
 Please see the Borrower’s Annual Report on Form 10-K filed on
November 26, 2007 (the “FY07 10-K”) and the Quarterly Reports on Form 10-Q filed on February 5, 2008, May 6, 2008 and August 5, 2008 (the “Q1, Q2 and Q3 FY08 10-Q’s”). Specifically Part I,
Item 1 (financial statements) and Part II, Item 1 (legal proceedings) in the Q1, Q2 and Q3 FY08 10-Q’s and FY07 10K: Item 3 (legal proceedings), Item 8 (financial statements and supplementary data) in the FY07 10-K.

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 Schedule 5.05 
 1 

 SCHEDULE 5.06 
 LITIGATION 
 None. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 Schedule 5.06 
 1 

 SCHEDULE 5.09 
 ENVIRONMENTAL MATTERS 
 Borrower has concluded that such Environmental Laws and claims and FDA Regulations could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, except as specifically disclosed in the FY07 10-K and Q1, Q2 and Q3 FY08 10-Q’s. Specifically Part I, Item 1 (financial statements) and
Part II, Item 1 (legal proceedings) in the Q1, Q2 and Q3 FY08 10-Q’s and FY07 10K: Item 3 (legal proceedings), Item 8 (financial statements and supplementary data) in the FY07 10-K. 
  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the
Securities and Exchange Commission. 
  

 Schedule 5.09 
 1 

 SCHEDULE 5.13 
 SUBSIDIARIES, OTHER EQUITY INVESTMENTS 
 Part (a) 
  

							
	 Subsidiaries
	  	Material
Subsidiary?	  	Significant
Subsidiary?	  	Exempt
Subsidiary?
	 Accel Instruments GmbH2
	  	No	  	Yes	  	No
	 Cedara Software Services (India) Pvt. Ltd. 6
	  	No	  	No	  	No
	 Centella biotechnologies, Inc. 5
	  	No	  	No	  	No
	 Pan-Pacific Enterprises, Inc.7
	  	No	  	No	  	No
	 Varian Associates Limited7
	  	No	  	No	  	No
	 Varian BioSynergy, Inc.7
	  	No	  	No	  	No
	 Varian China Holdings, Inc.7
	  	No	  	No	  	No
	 Varian Medical Systems Latin America, Ltd.7
	  	No	  	No	  	No
	 Varian Oncology Systems China, Ltd.7
	  	No	  	No	  	No
	 Varian Medical Systems India Pvt. Ltd.7

	  	No	  	No	  	No
	 Varian Medical Systems Pacific, Inc.7

	  	No	  	No	  	No
	 Varian Medical Systems Canada Holdings, Inc.7
	  	No	  	No	  	No
	 Page Mill Corporation7
	  	No	  	No	  	No
	 Mansfield Insurance Company7
	  	No	  	No	  	No
	 Varian Medical Systems Australasia Pty Ltd.7
	  	No	  	Yes	  	No
	 Varian Medical Systems Gesellschaft m.b.H. 1
	  	No	  	No	  	No
	 Varian Medical Systems Belgium N.V. 1

	  	No	  	No	  	No
	 Varian Medical Systems Brasil Limitada7

	  	No	  	No	  	No
	 Varian Medical Systems Canada, Inc. 4

	  	No	  	No	  	No
	 Varian Medical Systems Beijing Co. Ltd. 1

	  	No	  	Yes	  	No
	 Varian Medical Systems Trading (Beijing) Co., Ltd7
	  	No	  	No	  	No
	 Varian Medical Systems Scandinavia AS1

	  	No	  	Yes	  	No
	 Varian Medical Systems Finland OY1
	  	No	  	Yes	  	No
	 Varian Medical France SARL7
	  	No	  	Yes	  	No
	 Varian Medical Systems Deutschland G.m.b.H. 2
	  	No	  	Yes	  	No
	 Varian Medical Systems Haan G.m.b.H. 2

	  	No	  	Yes	  	No
	 Varian Medical Systems Deutschland Holdings GmbH7
	  	No	  	Yes	  	No
	 Varian Medical Systems Italia S.p.A. 1

	  	No	  	Yes	  	No
	 Varian ME Medical Systems K.K.7
	  	No	  	Yes	  	No
	 Varian Medical Systems Mauritius Ltd. 1

	  	No	  	No	  	No
	 Varian FSC B.V.7
	  	No	  	No	  	No
	 Varian Medical Systems Nederland B.V.7

	  	Yes	  	Yes	  	No
	 Varian Medical Systems Iberica S.L. 1

	  	No	  	Yes	  	No
	 Varian Medical Systems International A.G. 1
	  	Yes	  	Yes	  	Yes
	 Varian Medical Systems Imaging Laboratory Gmbh1
	  	No	  	Yes	  	No
	 Varian Medical Systems (RUS) LLC1
	  	No	  	No	  	No
	 Varian Medical Systems UK Holdings Limited7
	  	No	  	Yes	  	No

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 Schedule 5.13 
 1 

							
	 Subsidiaries
	  	Material
Subsidiary?	  	Significant
Subsidiary?	  	Exempt
Subsidiary?
	 Varian Medical Systems UK Ltd. 3
	  	No	  	Yes	  	No
	 Varian TVT Limited (inactive) 3
	  	No	  	No	  	No
	 Varian Philippines, Ltd. (inactive)7
	  	No	  	No	  	No
	 VMS Building E, LLC.7
	  	No	  	No	  	No

 Footnotes: 
  

	 1
	 Owned by VMS Nederland B.V. 

  

	 2
	 Owned by VMS Deutschland Holdings GmbH 

  

	 3
	 Owned by VMS UK Holdings Limited 

  

	 4
	 Owned by VMS Canada Holdings, Inc. 

  

	 5
	 Owned by Varian Biosynergy, Inc. 

  

	 6
	 Owned by VMS India Pvt. Ltd. 

  

	 7
	 Owned by Varian Medical Systems, Inc. 

  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 Schedule 5.13 
 2 

 Part (b) 
  

			
	 Other Equity Investments
	  	Equity Ownership Amounts
	 dpiX
	  	*
		
	 (for description see Footnote 4 to Notes to Consolidated Financial Statements in Borrower’s FY06 10-K)
	  	
		
	 Cryoelectra Gesellschaft fur Kryoelektrische Produkte mbH
	  	EU9,458.90
		
	 (contract manufacturing operation acquired as a part of the ACCEL Instruments GmbH acquisition)
	  	
		
	 *$5,000,000 was invested in a three member consortium
	  	
	 $1,000,000 to acquire another member’s interest in the consortium
	  	
	 $29,553,200 in the manufacturing facility in Colorado
	  	
		
	 Brainlab AG
	  	EU4,999,896
	 (direct investment in business partner)
	  	

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 Schedule 5.13 
 3 

 SCHEDULE 5.16 
 INTELLECTUAL PROPERTY MATTERS 
 None. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 Schedule 5.16 
 1 

 SCHEDULE 7.01 
 EXISTING LIENS 
  

			
	 Lender:
	  	Transamerica Life Insurance Company
		  	c/o AEGON USA Realty Advisors, Inc.

 Secured Promissory Note dated February 29, 2002, secured by a Deed of Trust, due March 1, 2012, interest
rate 7.34%, unpaid principal assumed $4,248,849.64 on September 30, 2005. $3,967,510.41 outstanding as of September 26, 2008. 
  

			
	 Lender:
	  	 Dwyler-Curlett & Co.

 Secured Promissory Note dated October 5, 2001, secured by a Deed of Trust, due November 1, 2011,
interest rate 7.58%, unpaid principal assumed $2,597,528.30 on November 15, 2004. $2,168,830.72 outstanding as of September 26, 2008. 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 75 

 SCHEDULE 7.03 
 EXISTING SUBSIDIARY GUARANTEES 
 None. 
  
  
 *** Confidential
Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 

 

 Schedule 7.01 
 1 

 SCHEDULE 7.11 
 COVENANT INFORMATION 
  

					
	 Section 7.11(a):
	 		  	[****]
	 Section 7.11(b):
	 		  	As set forth below:

  

			
	 Fiscal Quarter
Ending Nearest
	  	Minimum
Amount
	 December 31, 2008
	  	[****]
	 March 31, 2009
	  	[****]
	 Thereafter
	  	[****]

  

					
	 Section 7.11(c):
	  	(x)	  	[****]
		  	(y)	  	[****] of total consolidated assets of the Borrower and its Subsidiaries
			
	 Section 7.12:
	  	[****]	  	

  
  
 *** Confidential Treatment has been requested for portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of
this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 Schedule 7.11 
 1 

 SCHEDULE 9.02 
 NOTICE ADDRESSES AND LENDING OFFICE 
 VARIAN MEDICAL SYSTEMS, INC.: 
 3100 Hansen Way 
 Palo Alto, California 94304 
 Attention: Franco Palomba, Treasurer 
 Telephone: (650) 424-5955

 Facsimile: (650) 842-5080 
 Electronic Mail:
franco.palomba@varian.com 
 Website Address: www.varian.com 
 LENDER 
 Lending Office for Loans, and address for notices: 
 BANK OF AMERICA, N.A. 
 Bank of America 
 Mail Code: CA5-106-01-05 
 530 Lytton Avenue, Suite 101 
 Palo Alto, California 94301 
 Attn: John Plecque, Senior Vice President 
 Telephone: (650) 853-4475 
 Facsimile: (650) 853-4529 
 Electronic Mail: John.Plecque@bankofamerica.com 
 Lending Office for Letters of Credit and 
 payments with respect thereto, including 
 Letter of Credit fees:

 BANK OF AMERICA, N.A. 
 Trade Operations-Los Angeles #22621

 1000 W. Temple Street 
 Mail Code: CA9-705-07-05 
 Los Angeles, CA 90012-1514 
  
  
 *** Confidential Treatment has been requested for
portions of this Exhibit. Confidential portions of this Exhibit are designated by [****]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
  

 Schedule 9.02 
 1Registrant's Amended and Restated 2005 Deferred Compensation Plan

 Exhibit 10.2 
 

 
 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT 
 AMENDMENT AND RESTATEMENT 
 EFFECTIVE
JANUARY 1, 2009 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
			
	ARTICLE 1	  	DEFINITIONS	  	1
			
	ARTICLE 2	  	SELECTION/ENROLLMENT/ELIGIBILITY	  	6
			
	 2.1
	  	 Eligibility
	  	6
	 2.2
	  	 Enrollment Requirements
	  	7
	 2.3
	  	 Commencement of Participation
	  	7
	 2.4
	  	 Termination of Participation and/or Deferrals
	  	7
			
	ARTICLE 3	  	DEFERRAL COMMITMENTS/COMPANY CONTRIBUTIONS/CREDITING/TAXES	  	7
			
	 3.1
	  	 Minimum Deferral
	  	7
	 3.2
	  	 Maximum Deferral
	  	8
	 3.3
	  	 Election to Defer/Effect of Election Form
	  	8
	 3.4
	  	 Withholding of Annual Deferral Amounts
	  	10
	 3.5
	  	 Annual Company Supplemental Contribution Amount
	  	10
	 3.6
	  	 Annual Company Discretionary Contribution Amount
	  	10
	 3.7
	  	 Investment of Trust Assets
	  	10
	 3.8
	  	 Vesting
	  	11
	 3.9
	  	 Crediting/Debiting of Account Balances
	  	12
	 3.10
	  	 Payroll Reductions and Taxes
	  	14
	 3.11
	  	 Distributions
	  	14
	 3.12
	  	 Offset for Obligations to Employer
	  	15
			
	ARTICLE 4	  	SHORT-TERM PAYOUT/UNFORESEEABLE FINANCIAL EMERGENCIES	  	15
			
	 4.1
	  	 Short-Term Payout
	  	15
	 4.2
	  	 Other Benefits Take Precedence Over Short-Term Payout
	  	16
	 4.3
	  	 Withdrawal Payout/Termination of Deferral Election for Unforeseeable Financial Emergencies
	  	16
			
	ARTICLE 5	  	RETIREMENT BENEFIT	  	17
			
	 5.1
	  	 Retirement Benefit
	  	17
	 5.2
	  	 Payment of Retirement Benefit
	  	17
			
	ARTICLE 6	  	SURVIVOR BENEFIT	  	18
			
	 6.1
	  	 Pre-Termination Survivor Benefit
	  	18
	 6.2
	  	 Payment of Pre-Termination Survivor Benefit
	  	18
	 6.3
	  	 Death Prior to Completion of Regular Termination Benefit or Retirement Benefit
	  	18
			
	ARTICLE 7	  	REGULAR TERMINATION BENEFIT	  	18
			
	 7.1
	  	 Regular Termination Benefit
	  	18
	 7.2
	  	 Payment of Regular Termination Benefit
	  	18

					
			
	ARTICLE 8	  	BENEFICIARY DESIGNATION	  	19
			
	 8.1
	  	 Beneficiary
	  	19
	 8.2
	  	 Beneficiary Designation/Change
	  	19
	 8.3
	  	 Acknowledgment
	  	19
	 8.4
	  	 No Beneficiary Designation
	  	19
	 8.5
	  	 Doubt as to Beneficiary
	  	19
	 8.6
	  	 Discharge of Obligations
	  	19
			
	ARTICLE 9	  	TERMINATION/AMENDMENT/MODIFICATION	  	20
			
	 9.1
	  	 Termination
	  	20
	 9.2
	  	 Amendment
	  	21
	 9.3
	  	 Plan Agreement
	  	21
	 9.4
	  	 Effect of Payment
	  	21
			
	ARTICLE 10	  	ADMINISTRATION	  	22
			
	 10.1
	  	 Administrator Duties
	  	22
	 10.2
	  	 Agents
	  	22
	 10.3
	  	 Binding Effect of Decisions
	  	22
	 10.4
	  	 Indemnity of Administrator
	  	23
	 10.5
	  	 Employer Information
	  	23
			
	ARTICLE 11	  	OTHER BENEFITS AND AGREEMENTS	  	23
			
	 11.1
	  	 Coordination with Other Benefits
	  	23
			
	ARTICLE 12	  	CLAIMS PROCEDURES	  	23
			
	 12.1
	  	 Scope of Claims Procedures
	  	23
	 12.2
	  	 Initial Claim
	  	24
	 12.3
	  	 Review Procedures
	  	25
	 12.4
	  	 Calculation of Time Periods
	  	26
	 12.5
	  	 Legal Action
	  	26
			
	ARTICLE 13	  	TRUST	  	27
			
	 13.1
	  	 Establishment of the Trust
	  	27
	 13.2
	  	 Interrelationship of the Plan and the Trust
	  	27
	 13.3
	  	 Distributions from the Trust
	  	27
			
	ARTICLE 14	  	MISCELLANEOUS	  	27
			
	 14.1
	  	 Status of Plan
	  	27
	 14.2
	  	 Unsecured General Creditor
	  	27
	 14.3
	  	 Employer’s Liability
	  	28
	 14.4
	  	 Nonassignability
	  	28
	 14.5
	  	 Not a Contract of Continued Service
	  	28

					
	 14.6
	  	 Furnishing Information
	  	28
	 14.7
	  	 Terms
	  	28
	 14.8
	  	 Captions
	  	28
	 14.9
	  	 Governing Law
	  	28
	 14.10
	  	 Notice
	  	29
	 14.11
	  	 Successors
	  	29
	 14.12
	  	 Spouse’s Interest
	  	29
	 14.13
	  	 Validity
	  	29
	 14.14
	  	 Incompetent
	  	29
	 14.15
	  	 Court Order
	  	30
	 14.16
	  	 Acceleration of Distribution
	  	30
	 14.17
	  	 Delay in Payment
	  	30
	 14.18
	  	 Prohibited Acceleration/Distribution Timing
	  	30
	 14.19
	  	 Insurance
	  	31
	 14.20
	  	 Aggregation of Employers
	  	31
	 14.21
	  	 Aggregation of Plans
	  	31
	 14.22
	  	 USERRA
	  	31

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
 VARIAN MEDICAL SYSTEMS, INC. 
 2005 DEFERRED
COMPENSATION PLAN 
 Amendment and Restatement 
 Effective January 1, 2009 
 Purpose 
 The purpose of this Plan is to provide specified benefits to a select group of management or highly compensated Employees and Directors who contribute materially to the
continued growth, development and future business success of Varian Medical Systems, Inc., a Delaware corporation, and its subsidiaries, if any, that sponsor this Plan. This Plan shall be unfunded for tax purposes and for purposes of Title I of
ERISA. This Plan is intended to comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, as added by the American Jobs Creation Act of 2004 and the final Treasury regulations or any other authoritative
guidance issued thereunder. The purpose of this amendment and restatement of the Plan is to conform the Plan to said final Treasury regulations, issued by the Internal Revenue Service in April 2007. As permitted under guidance issued under
Section 409A, the Plan does not contain provisions retroactive to the effective date of Section 409A, but the Plan has complied with Section 409A and guidance thereunder since the effective date of such legislation. 
 ARTICLE 1 
 Definitions 

 For purposes of this Plan, unless otherwise clearly apparent from the context, the following phrases or terms shall have the following
indicated meanings: 
  

	1.1	“Administrator” shall mean the Committee, or, to the extent provided in Article 10, appropriate management personnel designated by the Committee to perform certain of the
Committee’s duties and responsibilities in respect of the Plan. 

  

	1.2	“Account Balance” shall mean, with respect to a Participant, a credit on the records of the Employer equal to the sum of (i) the Deferral Account balance,
(ii) the Company Supplemental Contribution Account balance and (iii) the Company Discretionary Contribution Account balance. The Account Balance, and each other specified account balance, shall be a bookkeeping entry only and shall be
utilized solely as a device for the measurement and determination of the amounts to be paid to a Participant, or his or her designated Beneficiary, pursuant to this Plan. 

  

	1.3	“Annual Company Discretionary Contribution Amount” shall mean, for the Plan Year of reference, the amount determined in accordance with Section 3.6.

  

 1 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	1.4	“Annual Company Supplemental Contribution Amount” shall mean, for the Plan Year of reference, the amount determined in accordance with Section 3.5.

  

	1.5	“Annual Deferral Amount” shall mean that portion of a Participant’s Base Annual Salary, Incentive Payments and/or Directors’ Fees that a Participant elects to
have, and is deferred, in accordance with Article 3, for any one Plan Year. In the event of a Participant’s Retirement, death or a Regular Termination prior to the end of a Plan Year, such year’s Annual Deferral Amount shall be the
actual amount withheld prior to such event. 

  

	1.6	“Base Annual Salary” shall mean the annual cash compensation relating to services performed during any calendar year, whether or not paid in such calendar year or included
on the Federal Income Tax Form W-2 for such calendar year, excluding bonuses, commissions, overtime, fringe benefits, stock options, relocation expenses, incentive payments, non-monetary awards, Directors’ Fees and other fees, automobile and
other allowances paid to a Participant for employment services rendered (whether or not such allowances are included in the Employee’s gross income). Base Annual Salary shall be calculated before reduction for compensation voluntarily deferred
or contributed by the Participant pursuant to all qualified or non-qualified plans of the Employer and shall be calculated to exclude amounts not otherwise included in the Participant’s gross income under Code Sections 125, 402(e)(3), 402(h),
or 403(b) pursuant to plans established by the Employer. 

  

	1.7	“Beneficiary” shall mean one or more persons, trusts, estates or other entities, designated in accordance with Article 8, that are entitled to receive benefits under this
Plan upon the death of a Participant. 

  

	1.8	“Beneficiary Designation Form” shall mean the form established from time to time by the Administrator that a Participant completes, signs and returns to the Administrator
to designate one or more Beneficiaries (which form may take the form of an electronic transmission, if required or permitted by the Administrator). 

  

	1.9	“Board” shall mean the board of directors of the Company. 

  

	1.10	“Claimant” shall have the meaning set forth in Section 12.2. 

  

	1.11	“Code” shall mean the Internal Revenue Code of 1986, as amended from time to time. 

  

	1.12	“Committee” shall mean the Company’s Compensation and Management Development Committee. 

  

	1.13	“Company” shall mean Varian Medical Systems, Inc. a Delaware corporation, and any successor. 

  

	1.14	“Company Discretionary Contribution Account” shall mean (i) the sum of all of the Participant’s Annual Company Discretionary Contribution Amounts, plus
(ii) amounts credited or debited in accordance with all the applicable crediting provisions of this Plan that relate to the Participant’s Company Discretionary Contribution Account, less (iii) all distributions made to the Participant
or his or her Beneficiary pursuant to this Plan that relate to the Participant’s Company Discretionary Contribution Account. 

  

 2 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	1.15	“Company Supplemental Contribution Account” shall mean (i) the sum of all of the Participant’s Annual Company Supplemental Contribution Amounts, plus
(ii) amounts credited or debited in accordance with all the applicable crediting provisions of this Plan that relate to the Participant’s Company Supplemental Contribution Account, less (iii) all distributions made to the Participant
or his or her Beneficiary pursuant to this Plan that relate to the Participant’s Company Supplemental Contribution Account. 

  

	1.16	“Deduction Limitation” shall mean the following described limitation on a benefit that may otherwise be distributable pursuant to the provisions of this Plan. Except as
otherwise provided, this limitation shall be applied to all distributions that are “subject to the Deduction Limitation” under this Plan. If the Employer reasonably anticipates that, if any distribution hereunder were made as scheduled,
the Employer’s deduction with respect to that distribution would not be permitted by reason of the limitation under Code Section 162(m), then the Employer may delay that distribution, provided that all distributions that could be deferred
in accordance with this Section 1.16 are so deferred, and provided further that the Employer treats payments to all similarly situated Participants on a reasonably consistent basis. Any amounts delayed pursuant to this limitation shall continue
to be credited or debited with additional amounts in accordance with Section 3.9 below, even if such amount is being paid out in installments. The amounts so deferred and amounts credited or debited thereon shall be distributed to the
Participant or his or her Beneficiary (in the event of the Participant’s death) during the Participant’s first taxable year in which the Employer reasonably anticipates, or reasonably should anticipate, that if the distribution is made its
deductibility will not be limited by Code Section 162(m), or, if later, following the Participant’s Separation from Service in accordance with Treasury Regulation Section 1.409A-2(b)(7)(i). 

  

	1.17	“Deferral Account” shall mean (i) the sum of all of a Participant’s Annual Deferral Amounts, plus (ii) amounts credited or debited in accordance with all
the applicable crediting provisions of this Plan that relate to the Participant’s Deferral Account, less (iii) all distributions made to the Participant or his or her Beneficiary pursuant to this Plan that relate to his or her Deferral
Account. 

  

	1.18	“Director” shall mean any member of the Board. 

  

	1.19	“Directors’ Fees” shall mean the fees paid by the Employer, including retainer fees and meetings fees, as compensation for serving on the Board.

  

	1.20	“Effective Date” shall mean the effective date of the Plan and of this amendment and restatement of the Plan, which is January 1, 2009. 

  

	1.21	“Election Form” shall mean the form or forms established from time to time by the Administrator that a Participant completes, signs and returns to the Administrator to
make an election under the Plan (which form or forms may take the form of an electronic transmission, if required or permitted by the Administrator). 

  

	1.22	“Employee” shall mean a person who is an employee of the Employer. 

  

	1.23	“Employer” shall mean the Company and/or any of its subsidiaries (now in existence or hereafter formed or acquired) that have been selected by the Board to participate in
the Plan and have adopted the Plan as a sponsor. For purposes of this Plan, “subsidiary” shall include entities required to be aggregated with the Company pursuant to Section 14.20. 

  

	1.24	“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended from time to time. 

  

 3 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	1.25	“Fiscal Year Compensation” means compensation relating to a period of service coextensive with one or more taxable years of the Company, of which no amount is paid or
payable during the Company’s taxable year or years constituting the period of service. 

  

	1.26	“401(k) Plan” shall mean the Varian Medical Systems, Inc. Retirement Plan, as it may be amended from time to time. 

  

	1.27	“Incentive Payments” shall mean any compensation payable to a Participant under the Annual Incentive Plan, Employee Incentive Plan, Sales Incentive Plan or Service
Incentive Plan. 

  

	1.28	“Measurement Funds” shall have the meaning set forth in Section 3.9(d). 

  

	1.29	“Participant” shall mean any Employee who is selected to participate in the Plan or any Director; provided that such Employee or Director (i) elects to participate in
the Plan, (ii) signs a Plan Agreement, an Election Form(s) and a Beneficiary Designation Form, (iii) has his or her signed Plan Agreement, Election Form(s) and Beneficiary Designation Form accepted by the Administrator, (iv) commences
participation in the Plan, and (v) has not had his or her Plan Agreement terminated. A spouse or former spouse of a Participant shall not be treated as a Participant in the Plan or have an Account Balance under the Plan under any circumstance.

  

	1.30	“Performance-Based Compensation” shall mean that portion of a Participant’s Incentive Payments the amount of which, or the entitlement to which, is contingent on the
satisfaction of pre-established organizational or individual performance criteria relating to a performance period of at least twelve (12) consecutive months, and which satisfies the requirements for “performance-based compensation”
under Section 409A including the requirement that the performance criteria be established in writing by not later than (i) ninety (90) days after the commencement of the period of service to which the criteria relates and
(ii) the date the outcome ceases to be substantially uncertain. 

  

	1.31	“Plan” shall mean this 2005 Deferred Compensation Plan, as evidenced by this instrument and by each Plan Agreement, as they may be amended from time to time.

  

	1.32	“Plan Agreement” shall mean a written agreement (which may take the form of an electronic transmission, if required or permitted by the Administrator), as may be amended
from time to time, which is entered into by and between the Employer and a Participant. Each Plan Agreement executed by a Participant and the Employer shall provide for the entire benefit to which such Participant is entitled under the Plan; should
there be more than one Plan Agreement, the Plan Agreement bearing the latest date of acceptance by the Employer shall supersede all previous Plan Agreements in their entirety and shall govern such entitlement. The terms of any Plan Agreement may be
different for any Participant, and any Plan Agreement may provide additional benefits not set forth in the Plan or limit the benefits otherwise provided under the Plan; provided, however, that any such additional benefits or benefit limitations must
be agreed to by both the Employer and the Participant. In the Plan Agreement, each Participant shall acknowledge that he or she accepts all of the terms of the Plan including the discretionary authority of the Administrator as set forth in Article
10. 

  

	1.33	“Plan Year” shall mean a period beginning on January 1 of each calendar year and continuing through December 31 of such calendar year during which this Plan is
in effect. 

  

 4 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	1.34	“Pre-Termination Survivor Benefit” shall mean the benefit set forth in Article 6. 

  

	1.35	“Regular Termination” shall mean Separation from Service, voluntarily or involuntarily, for any reason other than Retirement or death. 

  

	1.36	“Regular Termination Benefit” shall mean the benefit set forth in Article 7. 

  

	1.37	“Retirement”, “Retire(s)” or “Retired” shall mean, with respect to an Employee, Separation from Service for any reason other than death on or after the
attainment of age fifty-five (55) with ten (10) Years of Service; and shall mean with respect to a Director who is not an Employee, Separation from Service on or after the attainment of age seventy (70). If a Participant is both an
Employee and a Director, Retirement shall not occur until he or she Retires as both an Employee and a Director on or after the attainment of age fifty-five (55) with ten (10) Years of Service. 

  

	1.38	“Retirement Benefit” shall mean the benefit set forth in Article 5. 

  

	1.39	“Sales Commission Compensation” shall mean compensation or portions of compensation earned by a Participant if a substantial portion of the services provided by such
Participant to the Company consist of the direct sale of a product or service to an unrelated customer, the compensation paid by the Company to the Participant consists of either a portion of the purchase price for the product or service or an
amount substantially all of which is calculated by reference to the volume of sales, and payment of the compensation is either contingent upon the Company receiving payment from an unrelated customer for the product or services or, if applied
consistently to all similarly situated service providers, is contingent upon the closing of the sales transaction and such other requirements as may be specified by the Company before the closing of the sales transaction. 

 

	1.40	“Section 409A” shall mean Code Section 409A and the Treasury regulations or other authoritative guidance issued thereunder. 

  

	1.41	“Separation from Service” shall mean the Participant’s separation from service, within the meaning of Section 409A treating as a Separation from Service an
anticipated permanent reduction in the level of bona fide services to twenty percent (20%) or less of the average level of bona fide services performed over the immediately preceding thirty-six (36) month period (or the full period during
which the Participant performed services for the Employer, if that is less than thirty-six (36) months). For this purpose, upon a sale or other disposition of the assets of the Employer to an unrelated purchaser, the Committee reserves the
right to the extent permitted by Section 409A to determine whether Participants providing services to the purchaser after and in connection with the purchase transaction have experienced a Separation from Service. 

  

	1.42	“Short-Term Payout” shall mean the payout set forth in Section 4.1. 

  

	1.43	“Trust” shall mean the trust established pursuant to this Plan, as amended from time to time. The assets of the Trust shall be the property of the Employer.

  

 5 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 1.44
	 “Unforeseeable Financial Emergency” shall mean a severe financial hardship to the Participant resulting from
(i) an illness or accident of the Participant, the Participant’s spouse, the Participant’s dependent (as defined in Code
Section 152(a), without regard to Code Section 152(b)(1), (b)(2) or (d)(1)(B)) or, effective August 17, 2006, the Participant’s Beneficiary, (ii) a loss of the Participant’s property due to casualty (including the need to rebuild a home following damage not otherwise covered by insurance, for example, not as a result of a natural disaster), or
(iii) such other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant (e.g., imminent foreclosure of or eviction from the Participant’s primary residence, the need to pay
for medical expenses, including non-refundable deductibles and prescription drugs, the need to pay funeral expenses of a spouse, dependent or, effective August 17, 2006, the Participant’s Beneficiary), all as determined in the sole
discretion of the Administrator (which discretion the Administrator is bound to exercise, however, within the limitations of Section 409A). 

  

	1.45	“Yearly Installment Method” shall be a yearly installment payment over one of the installment payout alternatives selected by the Participant in accordance with this Plan,
calculated as follows (subject to Section 3.11): The Account Balance of the Participant shall be calculated as of the close of business on the date of reference (or, if the date of reference is not a business day, on the immediately following
business day), and shall be paid during the calendar month containing the date of reference unless otherwise provided herein. The date of reference with respect to the first yearly installment payment shall be the first day of the month provided in
Section 5.2 and the date of reference with respect to subsequent yearly installment payments shall be the anniversary of such date. 

 The installment payout alternative available for election by the Participant with respect to his or her Retirement Benefit is substantially equal annual installments of between two (2) and fifteen
(15) years. The yearly installment shall be calculated by multiplying this Account Balance by a fraction, the numerator of which is one (1), and the denominator of which is the remaining number of yearly payments due the Participant. By way of
example, if the Participant elects a five (5) year Yearly Installment Method, the first payment shall be one-fifth (1/5) of the Account Balance (or applicable portion thereof), calculated as described in this definition. During the
calendar month containing the anniversary of the date of reference for the first yearly installment payment, the payment shall be one-fourth (1/4) of the Account Balance (or applicable portion thereof), calculated as described in this
definition 
  

	1.46	“Years of Service” shall mean the total number of full years in which a Participant has been employed by one or more Employers. For purposes of this definition, a year of
employment shall be a 365 day period (or 366 day period in the case of a leap year) that, for the first year of employment, commences on the Employee’s date of hiring and that, for any subsequent year, commences on an anniversary of that hiring
date. Any partial year of employment shall not be counted. 

 ARTICLE 2 
 Selection/Enrollment/Eligibility 
  

	2.1	 Eligibility. Participation in the Plan shall be limited to Employees whom the Administrator designates, in its sole discretion, for participation,
provided that any Employees may not participate in the Plan unless they are members of a select group of management or highly compensated employees of the Employer, as membership in such group is determined in accordance with Sections 201(2),
301(a)(3) and 401(a)(1) of 

  

 6 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
ERISA (which determination shall be made by the Administrator in its sole discretion). In addition to Employees described in the preceding sentence,
each Director shall become eligible for participation in the Plan upon the date he or she is named as a Director (or upon the Effective Date, if later). 

  

	2.2	Enrollment Requirements. As a condition to participation, each Employee and Director who is eligible for participation shall complete, execute and return to the
Administrator a Plan Agreement, an Election Form(s) and a Beneficiary Designation Form, all within thirty (30) days after he or she first becomes eligible for participation in the Plan. In addition, the Administrator shall establish from time
to time such other enrollment requirements as it determines in its sole discretion are necessary. 

  

	2.3	Commencement of Participation. Provided an Employee or Director who is eligible for participation has met all enrollment requirements set forth in this Plan and
required by the Administrator, that Employee or Director shall commence participation in the Plan immediately following the Employee’s or Director’s timely completion of all enrollment requirements (or as soon as practicable thereafter as
the Administrator may determine). If an Employee or Director fails to meet all such requirements within the specified period required, in accordance with Section 2.2, that Employee or Director shall not be eligible to participate in the Plan
until the first day of the following Plan Year, again subject to timely delivery to and acceptance by the Administrator of the required documents. 

  

	2.4	Termination of Participation and/or Deferrals. If the Administrator determines in good faith that an Employee no longer qualifies as a member of a select group of
management or highly compensated employees of the Employer, the Administrator shall have the right, in its sole discretion, to prevent the Participant from making future deferral elections and/or from being credited with any further Annual Company
Supplemental Contribution Amounts or Annual Company Discretionary Contribution Amounts. 

 ARTICLE 3 

Deferral Commitments/Company Contributions/Crediting/Taxes 
  

	3.1	Minimum Deferral. For each Plan Year, a Participant may elect to defer, as his or her Annual Deferral Amount, Base Annual Salary, Incentive Payments and/or
Directors’ Fees (in the case of a Participant who is also a Director) in the following minimum amounts for each deferral elected: 

  

				
	 Deferral
	  	Minimum
Amount
	 Base Annual Salary
	  	$	2,000
	 Incentive Payments
	  	$	2,000
	 Directors’ Fees
	  	$	2,000

  

 7 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 Notwithstanding the foregoing, the Administrator may, in its sole discretion, establish for any Plan
Year different minimum amount(s). Subject to Section 409A, if an election is made for less than the stated minimum amount, or if no election is made, the amount deferred shall be zero (0). 
  

	3.2	Maximum Deferral. 

 For each Plan Year, a
Participant may elect to defer, as his or her Annual Deferral Amount, Base Annual Salary, Incentive Payments and/or Directors’ Fees (in the case of a Participant who is also a Director) up to the following maximum percentages for each deferral
elected: 
  

				
	 Deferral
	  	Maximum
Amount	 
	 Base Annual Salary
	  	50	%
	 Incentive Payments
	  	100	%
	 Directors’ Fees
	  	100	%

 Notwithstanding the foregoing, the Administrator may, in its sole discretion, establish for any
Plan Year maximum percentage(s) which differ from that set forth above. 
  

	3.3	Election to Defer/Effect of Election Form. 

  

	 	(a)	Timing of Election. Except as provided below, a Participant shall make a deferral election with respect to Base Annual Salary, Incentive Payments and/or
Directors’ Fees, as applicable, to be earned for services performed during an upcoming twelve (12) month Plan Year. Such election must be made during such period as shall be established by the Administrator which ends no later than the
last day of the Plan Year preceding the Plan Year in which the services giving rise to the Base Annual Salary, Incentive Payments and/or Directors’ Fees, as applicable, to be deferred are to be performed. For these purposes, Base Annual Salary
payable after the last day of the Plan Year for services performed during the final payroll period containing the last day of the Plan Year shall be treated as Base Annual Salary for services performed in the subsequent Plan Year. In the case of
Sales Commission Compensation, a Participant earning Sales Commission Compensation is treated as providing services to which such compensation relates only in the calendar year in which the customer remits payment to the Company or, if applied
consistently to all similarly situated service providers, the calendar year in which the sale occurs. 

 Notwithstanding the
preceding, if and to the extent permitted by the Administrator and in accordance with the requirements of Section 409A, a Participant may make an election to defer that portion (if any) of his or her Incentive Payments which qualifies as
Performance-Based Compensation no later than six (6) months prior to the last day of the period over which the services giving rise to the Performance-Based Compensation are performed, provided that the Participant performs services
continuously from the later of the beginning of the performance period or the date the performance 

  

 8 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 
criteria are established through the date of the deferral election, and provided further that in no event may such deferral election be made pursuant to this
paragraph with respect to any portion of the Performance-Based Compensation that has become reasonably ascertainable prior to the making of the deferral election, within the meaning of Section 409A. 
 Notwithstanding the preceding, if and to the extent permitted by the Administrator and in accordance with the requirements of Section 409A, a
participant may make an election to defer that portion (if any) of his or her Incentive Payments which qualifies as Fiscal Year Compensation during such period as shall be established by the Administrator which ends no later than the close of the
Company’s taxable year immediately preceding the first taxable year of the Company in which any services are performed for which such compensation is payable. 
 In addition, notwithstanding the preceding, but subject to Section 14.21, in the case of the first Plan Year in which an Employee or Director first becomes eligible to become a Participant (or again becomes
eligible after having been ineligible for at least twenty four (24) months), if and to the extent permitted by the Administrator, the individual may make an election no later than thirty (30) days after the date he or she becomes eligible
to become a Participant to defer Base Annual Salary, Incentive Payments and/or Directors’ Fees (as applicable) for services to be performed after the election. For this purpose, an election will be deemed to apply to Incentive Payments for
services performed after the election if the election applies to no more than an amount equal to the total Incentive Payments for the performance period multiplied by the ratio of the number of days remaining in the performance period after the
election over the total number of days in the performance period. 
  

	 	(b)	Manner of Election. For any Plan Year (or portion thereof), a deferral election for amount(s) earned during that Plan Year (or portion thereof), and such other elections as
the Administrator deems necessary or desirable under the Plan, shall be made by timely delivering to the Administrator, in accordance with its rules and procedures, by the deadline(s) set forth above, an Election Form, along with such other
elections as the Administrator deems necessary or desirable under the Plan. For these elections to be valid, the Election Form(s) must be completed and signed by the Participant, timely delivered to the Administrator (in accordance with
Section 2.2 above) and accepted by the Administrator. If no such Election Form(s) is timely delivered for a Plan Year (or portion thereof), the Annual Deferral Amount shall be zero (0) for that Plan Year (or portion thereof).

  

	 	(c)	Change in Election. Once the deadline(s) for making a deferral election for a Plan Year (as set forth in Section 3.3(a)) has passed, a Participant may not elect to
change his or her deferral election that is in effect for that Plan Year, except if and to the extent permitted by the Administrator and made in accordance with the provisions of Section 409A specifically relating to a change and/or revocation
of deferral elections (such as, for example, to cancel a deferral election upon the Participant’s disability (as defined in Section 1.409A-3(j)(4)(xii) of the Treasury regulations), or, as provided in Section 1.409A-3(j)(4) of the
Treasury regulations, following an Unforeseeable Financial Emergency or a hardship distribution pursuant to Section 1.401(k)-1(d)(3) of the Treasury regulations). 

  

 9 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	3.4	Withholding of Annual Deferral Amounts. For each Plan Year, the Base Annual Salary portion of the Annual Deferral Amount shall be withheld from each regularly
scheduled Base Annual Salary payroll in equal amounts, as adjusted from time to time for increases and decreases in Base Annual Salary. The Incentive Payments and/or Directors’ Fees portion of the Annual Deferral Amount shall be withheld at the
time the Incentive Payments or Directors’ Fees are or otherwise would be paid to the Participant, whether or not this occurs during the Plan Year itself. 

  

	3.5	Annual Company Supplemental Contribution Amount. For each Plan Year, the Employer, in its sole discretion, may, but is not required to, credit the Company Supplemental
Contribution Accounts of Employee Participants with an Annual Company Supplemental Contribution Amount for that Plan Year equal to the product of (a) the excess, if any, of the Participant’s Base Annual Salary and any applicable Incentive
Payments over the dollar limit on recognizable compensation under Code Section 401(a)(17) for the Plan Year (i.e., $230,000 for 2008, as indexed for future years), and (b) the Company matching contribution rate under the 401(k) Plan
applicable to the Participant for the Plan Year. 

 The Annual Company Supplemental Contribution Amount, if any, shall be
credited no earlier than January 1 and no later than March 15 of the following Plan Year. 
  

	3.6	Annual Company Discretionary Contribution Amount. For each Plan Year, an Employer, in its sole discretion, may, but is not required to, credit any amount it desires to
any Participant’s Company Discretionary Contribution Account under this Plan, which amount shall be for that Participant the Annual Company Discretionary Contribution Amount for that Plan Year. The amount so credited to a Participant may be
smaller or larger than the amount credited to any other Participant, and the amount credited to any Participant for a Plan Year may be zero, even though one or more other Participants receive an Annual Company Discretionary Contribution Amount for
that Plan Year. If a Participant is not employed by the Employer as of the last day of a Plan Year other than by reason of his or her Retirement or death while employed, the Annual Company Discretionary Contribution Amount for that Plan Year shall
be zero. The Annual Company Discretionary Contribution Amount, if any, shall be credited as agreed upon between the Employer and the Participant by no later than the date on which the Participant acquires a legally binding right to have an Annual
Company Discretionary Contribution Amount credited on his or her behalf. 

  

	3.7	Investment of Trust Assets. The trustee of the Trust shall be authorized to invest and reinvest the assets of the Trust in accordance with the applicable Trust agreement,
including the reinvestment of the proceeds in one or more investment vehicles designated by the Administrator. 

  

 10 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	3.8	Vesting. 

  

	 	(a)	A Participant shall at all times be 100% vested in his or her Deferral Account. 

  

	 	(b)	A Participant shall at all times be 100% in his or her Company Discretionary Contribution Account unless a vesting schedule is approved and documented by the Administrator at the
time the Annual Company Discretionary Contribution Amount is credited to the Participant’s Company Discretionary Contribution Account for that Plan Year. 

  

	 	(c)	A Participant shall at all times be 100% vested in his or her Company Supplemental Contribution Account. 

  

	 	(d)	Notwithstanding anything to the contrary contained in this Section 3.8, in the event of a Change in Control, a Participant’s Company Discretionary Contribution Account
shall immediately become 100% vested (if it is not already vested in accordance with a vesting schedule). For purposes of this Section 3.8, a “Change in Control” shall be deemed to have occurred if: 

  

	 	(i)	Any individual or group constituting a “person,” as such term is used in Sections 13(d) and 14(d)(2) of the Exchange Act (other than (A) the Company or any of its
subsidiaries or (B) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of any of its subsidiaries), is or becomes the beneficial owner, directly or indirectly, of securities of the Company
representing thirty percent (30%) or more of the combined voting power of the Company’s outstanding securities then entitled ordinarily (and apart from rights accruing under special circumstances) to vote for the election of Directors; or

  

	 	(ii)	Continuing Directors cease to constitute at least a majority of the Board; or 

  

	 	(iii)	there occurs a reorganization, merger, consolidation or other corporate transaction involving the Company (a “Transaction”), in each case with respect to which the
stockholders of the Company immediately prior to such Transaction do not, immediately after the Transaction, own more than 50% of the combined voting power of the Company or other corporation resulting from such Transaction; or

  

	 	(iv)	all or substantially all of the assets of the Company are sold, liquidated or distributed. 

 Notwithstanding the forgoing a “Change in Control” shall not be deemed to have occurred under this Plan if, prior to the occurrence of a
specified event that would otherwise constitute a Change in Control hereunder, the disinterested Continuing Directors then in office, by a majority vote thereof, determine that the occurrence of such specified event shall not be deemed to be a
Change in Control with respect to an Employee hereunder if the Change in Control results from actions or events in which an Employee is a participant in a capacity other than solely as an officer, employee or Director of the Company. 
 “Continuing Directors” for purposes of the above shall mean the Directors of the Company in office on the date of the adoption of this Plan and
any successor to any such Director who was nominated or selected by a majority of the Continuing Directors in office at the time of the Director’s nomination or selection and who is 

  

 11 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 
not an “affiliate” or “associate” (as defined in Regulation12B under the Exchange Act) of any person who is the beneficial owner,
directly or indirectly, of securities representing ten percent (10%) or more of the combined voting power of the Company’s outstanding securities then entitled ordinarily to vote for the election of Directors. 
  

	3.9	Crediting/Debiting of Account Balances. In accordance with, and subject to, the rules and procedures that are established from time to time by the Administrator, in
its sole discretion, amounts shall be credited or debited to a Participant’s Account Balance in accordance with the following rules: 

  

	 	(a)	Sub-Accounts. Separate sub-accounts shall be established and maintained with respect to each Participant’s Account Balance (together, the
“Sub-Accounts”), each attributable to the portion of the Participant’s Account Balance with respect to which the same time and form of distribution has been elected pursuant to Sections 4.1 and 5.2 hereof. 

  

	 	(b)	Election of Measurement Funds. Subject to Section 3.9(f) below, a Participant, in connection with his or her initial deferral election in accordance with
Section 3.3(a) above, shall elect, on the Election Form(s), one or more Measurement Funds (as described in Section 3.9(d) below) to be used to determine the additional amounts to be credited or debited to each of his or her Sub-Accounts
for the first business day of the Plan Year, continuing thereafter unless changed in accordance with the next sentence. Commencing with the first business day of the Plan Year, and continuing thereafter for the remainder of the Plan Year (unless the
Participant ceases during the Plan Year to participate in the Plan), the Participant may (but is not required to) elect daily, by submitting an Election Form(s) to the Administrator that is accepted by the Administrator (which submission may take
the form of an electronic transmission, if required or permitted by the Administrator), to add or delete one or more Measurement Funds to be used to determine the additional amounts to be credited or debited to each of his or her Sub-Accounts, or to
change the portion of each of his or her Sub-Accounts allocated to each previously or newly elected Measurement Funds. If an election is made in accordance with the previous sentence, it shall apply to the next business day and continue thereafter
for the remainder of the Plan Year (unless the Participant ceases during the Plan Year to participate in the Plan), unless changed in accordance with the previous sentence. 

  

	 	(c)	Proportionate Allocation. In making any election described in Section 3.9(b) above, the Participant shall specify on the Election Form(s), in whole percentage
points, the percentage of each of his or her Sub-Account(s) to be allocated to a Measurement Fund (as if the Participant was making an investment in that Measurement Fund with that portion of his or her Account Balance). 

  

	 	(d)	 Measurement Funds. Subject to Section 3.9(f) below, the Participant may elect one or more of the Measurement Funds set forth on Schedule A
(the “Measurement Funds”), for the purpose of crediting or debiting additional amounts to his or her Account Balance. The Administrator may, in its sole discretion, discontinue, substitute or add a Measurement Fund. Each such action will
take effect as of the first business day that follows by thirty (30) days the day on which the Administrator gives Participants advance written notice of such change. If the Administrator receives an initial or revised Measurement Funds
election which 

  

 12 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
it deems to be incomplete, unclear or improper, the Participant’s Measurement Funds election then in effect shall remain in effect (or, in the case of a
deficiency in an initial Measurement Funds election, the Participant shall be deemed to have filed no deemed investment direction). If the Administrator possesses (or is deemed to possess as provided in the previous sentence) at any time directions
as to Measurement Funds of less than all of the Participant’s Account Balance, the Participant shall be deemed to have directed that the undesignated portion of the Account Balance be deemed to be invested in a money market, fixed income or
similar Measurement Fund made available under the Plan as determined by the Administrator in its discretion. Each Participant hereunder, as a condition to his or her participation hereunder, agrees to indemnify and hold harmless the Administrator,
the Employer and the Company, and their agents and representatives, from any losses or damages of any kind relating to (i) the Measurement Funds made available hereunder and (ii) any discrepancy between the credits and debits to the
Participant’s Account Balance based on the performance of the Measurement Funds and what the credits and debits otherwise might be in the case of an actual investment in the Measurement Funds. 

  

	 	(e)	Crediting or Debiting Method. The performance of each elected Measurement Fund (either positive or negative) will be determined by the Administrator, in its sole
discretion, based on the performance of the Measurement Funds themselves. A Participant’s Account Balance shall be credited or debited on a daily basis based on the performance of each Measurement Fund selected by the Participant, or as
otherwise determined by the Administrator in its sole discretion, as though (i) a Participant’s Account Balance were invested in the Measurement Funds selected by the Participant, in the percentages elected by the Participant as of such
date, at the closing price on such date; (ii) the portion of the Annual Deferral Amount that was actually deferred was invested in the Measurement Funds selected by the Participant, in the percentages elected by the Participant, no later than
the close of business on the third (3rd) business day after the day on which such amounts are actually deferred from the Participant’s Base Annual Salary, Incentive Payments or Directors’ Fees, as applicable, at the closing price on
such date; (iii) any Annual Company Supplemental Contribution Amounts and/or Annual Company Discretionary Contribution Amounts credited to a Participant’s Account Balance were invested in the Measurement Fund(s) selected by the
Participant, in the percentages elected by the Participant, as soon as administratively practicable following the date such amount(s) were credited to the Participant’s Plan Account; and (iv) any distribution made to a Participant that
decreases such Participant’s Account Balance ceased being invested in the Measurement Funds, in the percentages applicable to such calendar day, no earlier than three (3) business days prior to the distribution, at the closing price on
such date. 

  

	 	(f)	 No Actual Investment. Notwithstanding any other provision of this Plan that may be interpreted to the contrary, the Measurement Funds are to be used
for measurement purposes only, and a Participant’s election of any such Measurement Fund, the allocation of his or her Account Balance thereto, the calculation of additional amounts and the crediting or debiting of such amounts to a
Participant’s Account Balance shall not be considered or construed in any manner as an actual investment of his or her Account Balance in any such Measurement Fund. In the event that the Employer or the trustee (as that term is defined in the
Trust), 

  

 13 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
in its own discretion, decides to invest funds in any or all of the Measurement Funds, no Participant shall have any rights in or to such investments
themselves. Without limiting the foregoing, a Participant’s Account Balance shall at all times be a bookkeeping entry only and shall not represent any investment made on his or her behalf by the Employer or the Trust; the Participant shall at
all times remain an unsecured general creditor of the Employer. 

  

	 	(g)	Beneficiary Elections. Each reference in this Section 3.9 to a Participant shall be deemed to include, where applicable, a reference to a Beneficiary.

  

	3.10	Payroll Reductions and Taxes. 

  

	 	(a)	Annual Deferral Amounts. For each Plan Year in which an Annual Deferral Amount is being withheld from a Participant, the Employer shall withhold from that portion of
the Participant’s Base Annual Salary or Incentive Payments that are not being deferred, in a manner determined by the Employer, the Participant’s share of FICA and other employment taxes on such Annual Deferral Amount. If necessary, the
Administrator may reduce the Annual Deferral Amount in order to comply with this Section 3.10. In addition, the Administrator may reduce the Annual Deferral Amount as permitted by Section 409A to the extent necessary to make any other
payroll reductions elected by the Participant or required under any other benefit plan of the Employer (e.g., reductions for contributions to a cafeteria plan (as defined in Code Section 125(d)). 

  

	 	(b)	Annual Company Supplemental Contribution Amounts. When a Participant is credited with Annual Company Supplemental Contribution Amounts, the Employer shall have the
discretion to withhold from the Participant’s Base Annual Salary and/or Incentive Payments that is not deferred, in a manner determined by the Employer, the Participant’s share of FICA and other employment taxes. If necessary, the
Administrator may reduce the Participant’s Annual Company Supplemental Contribution Amounts in order to comply with this Section 3.10. 

  

	 	(c)	Annual Company Discretionary Contribution Amounts. When a Participant becomes vested in his or her Company Discretionary Contribution Account, the Employer shall
withhold from the Participant’s Base Annual Salary, Incentive Payments and/or Directors’ Fees that is not deferred, in a manner determined by the Employer, the Participant’s share of FICA and other employment taxes. If necessary, the
Committee may reduce the vested portion of the Participant’s Company Discretionary Contribution Account in order to comply with this Section 3.10. 

  

	3.11	 Distributions. Notwithstanding anything herein to the contrary, any payments made to a
Participant or Beneficiary under this Plan shall be in cash form, and the Employer, or the trustee of the Trust, shall withhold from any payments made under this Plan all Federal, state and local income, employment and other taxes required to be
withheld by the Employer, or the trustee of the Trust, in connection with such payments, and, subject to Section 3.12, any indebtedness of the Participant to the Employer as of the date(s) of distribution, in amounts and in a manner to be
determined in the reasonable discretion of the Employer and the trustee of the Trust. Any payment made to a Participant or Beneficiary under this Plan shall be made on or during the period after the payment date or event specified herein; provided,
however, such payment 

  

 14 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
shall not be made later than the later of (i) the last day of the calendar year in which the payment date or event occurs, or, if later, the fifteenth
(15th) day of the third (3rd) calendar month following the date of the payment date or event, or (ii) the last day of such other, extended period as the IRS may prescribe, such as in the case of disputed payments or refusals to pay, provided the conditions
of such extension have been satisfied. If a Participant who experiences a Separation from Service is rehired, his or her distributions hereunder may not be suspended. 

  

	3.12	Offset for Obligations to Employer. If, at the time a Participant or his or her Beneficiary becomes entitled to a payment hereunder, the Participant has a debt,
obligation or other liability to the Employer due and owing which has been incurred in the ordinary course of the service relationship, the Employer or trustee of the Trust may offset the amount owed to the Employer against the amount otherwise
payable hereunder, provided that the entire offset in an taxable year does not exceed five thousand dollars ($5,000) and the offset is taken at the same time and in the same amount as the debt otherwise would have been due from the Participant.

 ARTICLE 4 
 Short-Term Payout/Unforeseeable Financial Emergencies 
  

	4.1	 Short-Term Payout. At the same time that a Participant elects to defer an Annual Deferral Amount for a given Plan Year, the Participant may elect to
receive a future “Short-Term Payout” from the Plan. For these purposes, any Incentive Payments deferred pursuant to a deferral election made during a given Plan Year shall be considered as part of the immediately following Plan Year’s
Annual Deferral Amount regardless of when the Incentive Payments would have been payable in absence of the deferral election (e.g., Incentive Payments that are not Performance-Based Compensation and that are deferred pursuant to a deferral election
made in 2008 shall be considered as part of the Participant’s 2009 Annual Deferral Amount). The Participant’s Short-Term Payout election must be made by the deadline(s) set forth in Section 3.3(a) for making a deferral election in
respect of the Base Annual Salary, Incentive Payments and/or Directors’ Fees to which it relates, and is irrevocable after that deadline has passed. Subject to such requirements as may be imposed by the Administrator, a Participant may make
separate Short-Term Payout elections in respect of the Base Annual Salary, Incentive Payments and/or Directors’ Fees portions of his or her Annual Deferral Amount. Subject to the Deduction Limitation and to Section 3.11, the Short-Term
Payout shall be a lump sum payment in an amount that is equal to the Annual Deferral Amount (or applicable portion thereof) and amounts credited or debited thereto in the manner provided in Section 3.9 above, determined at the time that the
Short-Term Payout becomes payable. Subject to the Deduction Limitation and the other terms and conditions of this Plan, each Short-Term Payout elected shall be paid out during a period beginning one (1) day and ending sixty (60) days after
the last day of any Plan Year designated by the Participant that is at least three (3) Plan Years after the Plan Year of the Annual Deferral Amount as specifically elected by the Participant. By way of example, if a three (3) year
Short-Term Payout is elected for 2006 Plan Year Annual Deferral Amounts, the three (3) year Short-Term Payout would become payable during a sixty (60) day period commencing January 1, 2010. Notwithstanding the preceding sentences or
any other provision of this Plan 

  

 15 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
that may be construed to the contrary, a Participant who is in active service with the Employer may, with respect to each Short-Term Payout, on a form
determined by the Administrator, make one (1) or more additional deferral elections (a “Subsequent Election”) to defer payment of such Short-Term Payout to a Plan Year subsequent to the Plan Year originally (or subsequently) elected
in accordance with Treasury Regulation Section 1.409A-2(b); provided, however, any such Subsequent Election will be null and void unless accepted by the Administrator no later than one (1) year prior to the first day of the Plan Year in
which, but for the Subsequent Election, such Short-Term Payout would be paid, and such Subsequent Election provides for a deferral of at least five (5) Plan Years following the Plan Year in which the Short-Term Payout, but for the Subsequent
Election, would be paid. Any amounts credited to the Participant’s Company Supplemental Contribution Account and/or Company Discretionary Contribution Account shall not be eligible for a Short-Term Payout under the Plan.

  

	4.2	Other Benefits Take Precedence Over Short-Term Payout. Should an event occur that triggers a benefit under Article 5, 6 or 7 prior to the occurrence of the Short-Term
Payout Date, any Annual Deferral Amounts, plus or minus amounts credited or debited thereon, that are subject to a Short-Term Payout election under Section 4.1 shall not be paid in accordance with Section 4.1 but shall be paid in
accordance with the other applicable Article. 

  

	 4.3
	 Withdrawal Payout/Termination of Deferral Election for Unforeseeable Financial Emergencies. If a
Participant experiences an Unforeseeable Financial Emergency, the Participant may petition the Administrator to (i) halt any deferrals required to be made by the Participant to the extent permitted by Section 409A and (ii) receive a
partial or full payout from the Plan. The payout shall not exceed the lesser of the Participant’s Account Balance, or the amount reasonably needed to satisfy the Unforeseeable Financial Emergency plus amounts necessary to pay taxes reasonably
anticipated as a result of the payouts, after taking into account the extent to which the Unforeseeable Financial Emergency is or may be relieved through reimbursement or compensation by insurance or otherwise, by liquidation of the
Participant’s assets (to the extent the liquidation of assets would not itself cause severe financial hardship) or by termination of deferrals
hereunder. If, subject to the sole discretion of the Administrator (which discretion the Administrator is bound to exercise, however, within the limitations of Section 409A), the petition for a termination of deferrals and payout is approved,
cessation shall take effect upon the date of approval and any payout shall be made within sixty (60) days of the date of approval. The payment of any amount under this Section 4.3 shall be subject to Section 3.11, but shall not be
subject to the Deduction Limitation. Notwithstanding anything set forth in this Section 4.3, a Participant may not receive a payout pursuant to this Section 4.3 to the extent such payout would not be permitted under Section 409A.

  

 16 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 ARTICLE 5 
 Retirement Benefit 
  

	5.1	Retirement Benefit. Subject to the Deduction Limitation and to Section 3.11, a Participant who Retires shall receive, as a Retirement Benefit, his or her vested
Account Balance (or applicable portion thereof). 

  

	5.2	Payment of Retirement Benefit. At the same time that a Participant elects to defer an Annual Deferral Amount for a given Plan Year, the Participant may elect to
receive that portion of his or her Retirement Benefit attributable to the Annual Deferral Amount in a lump sum, or pursuant to one of the available Yearly Installment Methods. For these purposes, any Incentive Payments deferred pursuant to a
deferral election made during a given Plan Year shall be considered as part of the immediately following Plan Year’s Annual Deferral Amount regardless of when the Incentive Payments would have been payable in absence of the deferral election
(e.g., Incentive Payments deferred pursuant to a deferral election made in 2008 shall be considered as part of the Participant’s 2009 Annual Deferral Amount). Subject to such requirements as may be imposed by the Administrator, a Participant
may make separate Retirement Benefit distribution elections in respect of the Base Annual Salary, Incentive Payments and/or Directors’ Fees portions of his or her Annual Deferral Amount. The lump sum payment shall be made, or installments shall
commence, (i) if the Participant’s Retirement occurs during January through June of any Plan Year, during the January of the Plan Year following the Plan Year of the Participant’s Retirement; (ii) if the Participant’s
Retirement occurs during July through December of any Plan Year, during the July of the Plan Year following the Plan Year of the Participant’s Retirement. 

 The Participant may change his or her election to an allowable alternative payout period date by
submitting a new Election Form to the Administrator in accordance with Treasury Regulation Section 1.409A-2(b), provided that any such Election Form will be null and void unless accepted by the Administrator no later than one (1) year
prior to the date of the Participant’s Retirement and provides for a distribution (or commencement of distributions) date which is at least five (5) years from the distribution (or commencement of distributions) date then in effect.
Subject to the foregoing, the Election Form most recently accepted by the Administrator shall govern the payout of the Retirement Benefit with respect to the portion of the Participant’
s Account Balance to which it pertains. 
 Notwithstanding anything above or elsewhere in the
Plan to the contrary, no change submitted on an Election Form shall be accepted by the Administrator if the change accelerates the time over which distributions shall be made to the Participant (except as otherwise permitted under Section 409A)
and the Administrator shall deny any change made to an election if the Administrator determines that the change violates the requirement under Section 409A that the first payment with respect to which such election is made be deferred for a
period of not less than five (5) years from the date such payment would otherwise have been made. For these purposes, installment payments shall be treated as a single payment, with the result that an election to change from installments to a
lump sum (or to an different Yearly Installment Method) will require that the lump sum (or first installment) be postponed until a date which is at least five (5) years from the previously scheduled payment date of the first installment.

  

 17 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 If the Participant does not make any election with respect to the payment of any portion of the
Retirement Benefit, then such portion shall be paid in a lump sum: (i) if the Participant’s Retirement occurs during January through June of any Plan Year, during the January of the Plan Year following the Plan Year of the
Participant’s Retirement; (ii) if the Participant’s Retirement occurs during July through December of any Plan Year, during the July of the Plan Year following the Plan Year of the Participant’s Retirement. 
 Any payment made shall be subject to Section 3.11 and to the Deduction Limitation. 
 Any amounts credited to the Participant’s Company Supplemental Contribution Account and/or Company Discretionary Contribution Account shall be
payable under the Plan solely in the form of a lump sum (in accordance with the timing rule set forth in the last sentence of the first paragraph of this Section 5.2) and shall not be eligible for installment distribution. 
 ARTICLE 6 
 Survivor
Benefit 
  

	6.1	Pre-Termination Survivor Benefit. The Participant’s Beneficiary shall receive a Pre-Termination Survivor Benefit equal to the Participant’s vested Account
Balance if the Participant dies before he or she experiences a Retirement or a Regular Termination. 

  

	6.2	Payment of Pre-Termination Survivor Benefit. The Pre-Termination Survivor Benefit shall be paid to the Participant’s Beneficiary in a lump sum at the time of the
Participant’s death, provided the Administrator receives proof that is satisfactory to the Administrator of the Participant’s death. Any payment made hereunder shall be subject to Section 3.11, but shall not be subject to the
Deduction Limitation. 

  

	 6.3
	 Death Prior to Completion of Regular Termination Benefit or Retirement Benefit. If a Participant dies
after Regular Termination or Retirement but before the Regular Termination Benefit or Retirement Benefit is paid in full, the Participant’s
unpaid Regular Termination Benefit or Retirement Benefit shall be paid to the Participant’s Beneficiary in a lump sum at the time of the Participant’s death, provided the Administrator receives proof that is satisfactory to the
Administrator of the Participant’s death. Any payment made hereunder shall be subject to Section 3.11, but shall not be subject to the Deduction Limitation. 

 ARTICLE 7 
 Regular Termination Benefit 
  

	7.1	Regular Termination Benefit. Subject to the Deduction Limitation and to Section 3.11, the Participant shall receive a Regular Termination Benefit, which shall be
equal to the Participant’s vested Account Balance if a Participant experiences a Regular Termination prior to his or her Retirement or death. 

  

	7.2	 Payment of Regular Termination Benefit. The Participant’s Regular Termination Benefit shall be paid in a lump sum: (i) if the
Participant’s Regular Termination occurs during January through June of any Plan Year, during the January of the Plan Year following the Plan Year of the Participant’s Regular 

  

 18 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
Termination; (ii) if the Participant’s Regular Termination occurs during July through December of any Plan Year, during the July of the Plan Year
following the Plan Year of the Participant’s Regular Termination. Any payment made shall be subject to Section 3.11 and the Deduction Limitation. 

 ARTICLE 8 
 Beneficiary Designation 
  

	8.1	Beneficiary. Each Participant shall have the right, at any time, to designate his or her Beneficiary(ies) (both primary as well as contingent) to receive any benefits
payable under the Plan upon the death of a Participant. The Beneficiary designated under this Plan may be the same as or different from the Beneficiary designation under any other plan of the Employer in which the Participant participates.

  

	8.2	Beneficiary Designation/Change. A Participant shall designate his or her Beneficiary by completing and signing the Beneficiary Designation Form, and returning it to
the Administrator or its designated agent. A Participant shall have the right to change a Beneficiary by completing, signing and otherwise complying with the terms of the Beneficiary Designation Form and the Administrator’s rules and
procedures, as in effect from time to time. If the Participant names someone other than his or her spouse as a Beneficiary, a spousal consent, in the form designated by the Administrator, must be signed by the Participant’s spouse and returned
to the Administrator. Upon the acceptance by the Administrator of a new Beneficiary Designation Form, all Beneficiary designations previously filed shall be canceled. The Administrator shall be entitled to rely on the last Beneficiary Designation
Form filed by the Participant and accepted by the Administrator prior to his or her death. 

  

	8.3	Acknowledgment. No designation or change in designation of a Beneficiary shall be effective until received and acknowledged in writing by the Administrator or its
designated agent. 

  

	8.4	No Beneficiary Designation. If a Participant fails to designate a Beneficiary as provided in Sections 8.1, 8.2 and 8.3 above or, if all designated Beneficiaries
predecease the Participant or die prior to complete distribution of the Participant’s benefits, then the Participant’s designated Beneficiary shall be deemed to be his or her surviving spouse, or, if the Participant has no surviving
spouse, the benefits remaining under the Plan to be paid to a Beneficiary shall be payable to the executor or personal representative of the Participant’s estate. 

  

	8.5	Doubt as to Beneficiary. Subject to any limitations imposed by Section 409A, if the Administrator has any doubt as to the proper Beneficiary to receive payments
pursuant to this Plan, the Administrator shall have the right, exercisable in its discretion, to cause the Employer to withhold such payments until this matter is resolved to the Administrator’s satisfaction. 

  

	8.6	 Discharge of Obligations. The payment of benefits under the Plan to a person believed in good faith by the Administrator to be a valid Beneficiary
shall fully and completely discharge the Employer and the Administrator from all further obligations under this Plan with respect to the Participant, and that 

  

 19 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
Participant’s Plan Agreement shall terminate upon such full payment of benefits. Neither the Administrator nor the Employer shall be obliged to search
for any Participant or Beneficiary beyond the sending of a registered letter to such person’s last known address. If the Administrator notifies any Participant or Beneficiary that he or she is entitled to an amount under the Plan and the
Participant or Beneficiary fails to claim such amount or make his or her location known to the Administrator within three (3) years thereafter, then, except as otherwise required by law, if the location of one or more of the next of kin of the
Participant is known to the Administrator, the Administrator may direct distribution of such amount to any one or more or all of such next of kin, and in such proportions as the Administrator determines. If the location of none of the foregoing
persons can be determined, the Administrator shall have the right to direct that the amount payable shall be deemed to be a forfeiture, except that the dollar amount of the forfeiture, unadjusted for deemed gains or losses in the interim, shall be
paid by the Employer if a claim for the benefit subsequently is made by the Participant or the Beneficiary to whom it was payable. If a benefit payable to an unlocated Participant or Beneficiary is subject to escheat and/or unclaimed property laws
pursuant to applicable law, neither the Administrator nor the Employer shall be liable to any person for any payment made in accordance with such law. 

 ARTICLE 9 
 Termination/Amendment/Modification 
  

	 9.1
	 Termination. Although the Employer anticipates that it will continue the Plan for an indefinite period of
time, there is no guarantee that the Employer will continue the Plan or will not terminate the Plan at any time in the future. Accordingly, the Employer reserves the right to discontinue its sponsorship of the Plan and/or to terminate the Plan at
any time with respect to any or all of its participating Employees or Directors, by action of the Administrator. Upon a termination of the Plan in accordance with the requirements, restrictions and limitations of Section 1.409A-3(j)(4)(ix) of
the Treasury regulations, the Plan Agreements of the affected Participants shall terminate and they shall be paid in a single lump sum distribution their vested Account Balances (but not to commence before or end after any distribution period
required by Section 409A). If, due to the circumstances surrounding the Plan termination, a distribution of a Participant’s vested Account
Balance upon Plan termination is not permitted by Section 409A, the payment of the Account Balance shall be made only after Plan benefits otherwise become due hereunder. Except by reason of changing the time and form of payment of a
Participant’s benefit under the Plan, the termination of the Plan shall not adversely affect any Participant or Beneficiary who has become entitled to the payment of any benefits under the Plan as of the date of termination.

 Without limiting the generality of the foregoing, the Employer specifically reserves the right to terminate and liquidate
the Plan with respect to all of its participating Employees and Directors, in its discretion and by action of the Administrator, within the thirty (30) days preceding or the twelve (12) months following a “change in control
event” (as defined in Section 409A) in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix); provided, however, that such termination and liquidation must be irrevocable and shall 

  

 20 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 
be permitted only if all arrangements sponsored by the Employer that are required to be aggregated with the Plan pursuant to Section 14.21 are also
irrevocable terminated and liquidated with respect to each participant therein who is employed by the Employer has experienced the change in control event, so that the Employees or Directors participating under the Plan and all participants under
those other arrangements that have experienced the change in control event are required to receive all amounts of compensation deferred under the terminated and liquidated arrangements within twelve (12) months of the date the Employer takes
irrevocable action to terminate and liquidate the arrangements. 
  

	9.2	Amendment. The Employer may, at any time, amend or modify the Plan in whole or in part by the action of the Administrator; provided, however, that no amendment or
modification shall be effective to decrease or restrict the value of a Participant’s vested Account Balance in existence at the time the amendment or modification is made, calculated as if the Participant had experienced a Regular Termination
as of the effective date of the amendment or modification or, if the amendment or modification occurs after the date upon which the Participant was eligible for Retirement, the Participant had Retired as of the effective date of the amendment or
modification. The amendment or modification of the Plan shall not affect any Participant or Beneficiary who has become entitled to the payment of benefits under the Plan as of the date of the amendment or modification. 

  

	9.3	Plan Agreement. Despite the provisions of Sections 9.1 and 9.2 above, if a Participant’s Plan Agreement contains benefits or limitations that are not in this
Plan document, the Employer may only amend or terminate such provisions with the consent of the Participant. 

  

	9.4	Effect of Payment. The full payment of the applicable benefit under Articles 4, 5, 6 or 7 of the Plan shall completely discharge all obligations to a Participant
and his or her designated Beneficiaries under this Plan and the Participant’s Plan Agreement shall terminate. 

 Amendment to Ensure Proper Characterization of the Plan. Notwithstanding the previous Sections of this Article, the Plan may be amended at any time, retroactively if required, if found necessary, in the opinion of the
Employer, in order to ensure that the Plan is characterized as a non-tax-qualified “top hat” plan of deferred compensation maintained for a select group of management or highly compensated employees, as described under ERISA Sections
201(2), 301(a)(3) and 401(a)(1), to conform the Plan to the provisions to Section 409A and to ensure that amounts under the Plan are not considered to be taxed to a Participant under the Federal income tax laws prior to the Participant’s
receipt of the amounts or to conform the Plan and the Trust to the provisions and requirements of any applicable law (including ERISA and the Code). 
  

 21 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 ARTICLE 10 
 Administration 
  

	10.1	Administrator Duties. This Plan shall be administered by the Committee, or, with respect to those duties and responsibilities described below, appropriate management
personnel designated by the Committee to perform such duties and responsibilities. The Administrator shall have the discretion and authority to (i) make, amend, interpret and enforce all appropriate rules and regulations for the administration
of this Plan and (ii) decide or resolve any and all questions including interpretations of this Plan, as may arise in connection with the Plan. Any individual serving as a member of the Administrator who is a Participant shall not vote or act
on any matter relating solely to himself or herself. When making a determination or calculation, the Administrator shall be entitled to rely on information furnished by a Participant or the Employer. 

 Any of the duties and responsibilities of the Administrator under the Plan, including, but not limited to those listed below, may be performed by
appropriate management personnel designated by the Committee to perform such duties and responsibilities, except that any decision, interpretation, calculation or other action which would materially increase the Employer’s liability and/or
costs associated with the Plan must be approved by the Committee: 
  

	 	(a)	the appropriate management personnel may designate those Employees of the Employer who are eligible to participate in the Plan in accordance with Section 2.1;

  

	 	(b)	the appropriate management personnel may make all discretionary decisions under the Plan with respect to Annual Company Discretionary Contribution Amounts; provided, however, that
the appropriate management personnel may only credit an Annual Company Discretionary Contribution Amount under the Plan on behalf of a Participant without Committee approval if, but for the decision to so credit, the appropriate management personnel
could otherwise have directed, without Committee approval, that the Participant receive an amount equal to the Annual Company Discretionary Contribution Amount in cash; 

  

	 	(c)	the appropriate management personnel may administer the claims procedure requirements of the Plan set forth in Article 12; 

  

	 	(d)	the appropriate management personnel may make Plan amendments under Article 9, but only to the extent such amendments do not materially increase the Employer’s liability and/or
costs associated with the Plan; 

  

	 	(e)	the appropriate management personnel may change service providers used in connection with the Plan; 

  

	 	(f)	the appropriate management personnel may allocate expenses associated with the Plan’s administration among Participants’ Account Balances; 

  

	 	(g)	the appropriate management personnel may change the deemed investment alternatives available under the Plan. 

  

	10.2	Agents. In the administration of this Plan, the Administrator may, from time to time, employ agents and delegate to them such administrative duties as they see fit
(including acting through a duly appointed representative) and may from time to time consult with counsel who may be counsel to the Employer. 

  

	10.3	Binding Effect of Decisions. The decision or action of the Administrator with respect to any question arising out of or in connection with the administration,
interpretation and application of the Plan and the rules and regulations promulgated hereunder shall be final and conclusive and binding upon all persons having any interest in the Plan. 

  

 22 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	10.4	Indemnity of Administrator. The Employer shall indemnify and hold harmless the members of the Administrator, and any individuals to whom the duties of the
Administrator may be delegated, against any and all claims, losses, damages, expenses or liabilities arising from any action or failure to act with respect to this Plan, except in the case of willful misconduct by the Administrator or any of its
members or any such individuals. This indemnification shall be in addition to, and not in limitation of, any other indemnification protections of the Administrator. 

  

	10.5	Employer Information. To enable the Administrator to perform its functions, the Employer shall supply full and timely information to the Administrator on all matters
relating to the compensation of the Participants, the date and circumstances of the Retirement, death or Regular Termination of the Participants, and such other pertinent information as the Administrator may reasonably require.

 ARTICLE 11 
 Other Benefits and Agreements 
  

	11.1	Coordination with Other Benefits. The benefits provided for a Participant or a Participant’s Beneficiary under the Plan are in addition to any other benefits
available to such Participant under any other plan or program for Employees or Directors of the Employer. The Plan shall supplement and shall not supersede, modify or amend any other plan or program except as may otherwise be expressly provided.

 ARTICLE 12 
 Claims Procedures 
  

	12.1	Scope of Claims Procedures. This Article is based on final regulations issued by the Department of Labor and published in the Federal Register on November 21,
2000 and codified at 29 C.F.R. section 2560.503-1. If any provision of this Article conflicts with the requirements of those regulations, the requirements of those regulations will prevail. 

 For purposes of this Article, references to disability benefit claims are intended to describe claims made by Participants in connection with a revocation
of a deferral election pursuant to Section 3.3(c), but only if and to the extent that such claims require an independent determination by the Administrator that the Participant is or is not suffering from a disability, within the meaning
Section 1.409A-3(j)(4)(xii) of the Treasury regulations. If the Administrator’s determination is based entirely on a disability determination made by another party, such as the Social Security Administration or another federal or state
agency or an insurer with respect to a disability insurance policy covering the Participant, the Participant’s claim shall not be treated as a disability claim for purposes of the special provisions of this Article that apply to claims for
which an independent determination of disability is required. 
  

 23 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	12.2	Initial Claim. A Participant or Beneficiary who believes he or she is entitled to any benefit under the Plan (a “Claimant”) may file a claim with the
Administrator. The Administrator shall review the claim itself or appoint an individual or an entity to review the claim. 

  

	 	(a)	Benefit Claims that do not Require a Determination of Disability. If the claim is for a benefit other than one that requires a determination by the Committee of a
Participant’s disability, the Claimant shall be notified within ninety (90) days after the claim is filed whether the claim is allowed or denied, unless the Claimant receives written notice from the Administrator or appointee of the
Administrator prior to the end of the ninety (90) day period stating that special circumstances require an extension of the time for decision, such extension not to extend beyond the day which is one hundred eighty (180) days after the day
the claim is filed. 

  

	 	(b)	Disability Benefit Claims. In the case of a benefits claim that requires an independent determination by the Administrator of a Participant’s disability status,
the Administrator shall notify the Claimant of the Plan’s adverse benefit determination within a reasonable period of time, but not later than forty-five (45) days after receipt of the claim. If, due to matters beyond the control of the
Plan, the Administrator needs additional time to process a claim, the Claimant will be notified, within forty-five (45) days after the Administrator receives the claim, of those circumstances and of when the Administrator expects to make its
decision but not beyond seventy-five (75) days. If, prior to the end of the extension period, due to matters beyond the control of the Plan, a decision cannot be rendered within that extension period, the period for making the determination may
be extended for up to one hundred five (105) days, provided that the Administrator notifies the Claimant of the circumstances requiring the extension and the date as of which the Plan expects to render a decision. The extension notice shall
specifically explain the standards on which the determination of a disability is based, the unresolved issues that prevent a decision on the claim and the additional information needed from the Claimant to resolve those issues, and the Claimant
shall be afforded at least forty-five (45) days within which to provide the specified information. 

  

	 	(c)	Manner and Content of Denial of Initial Claims. If the Administrator denies a claim, it must provide to the Claimant, in writing or by electronic communication:

  

	 	(i)	The specific reasons for the denial; 

  

	 	(ii)	A reference to the Plan provision or insurance contract provision upon which the denial is based; 

  

	 	(iii)	A description of any additional information or material that the Claimant must provide in order to perfect the claim; 

  

	 	(iv)	An explanation of why such additional material or information is necessary; 

  

	 	(v)	Notice that the Claimant has a right to request a review of the claim denial and information on the steps to be taken if the Claimant wishes to request a review of the claim denial;
and 

  

 24 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	(vi)	A statement of the participant’s right to bring a civil action under ERISA Section 502(a) following a denial on review of the initial denial. 

 In addition, in the case of a denial of benefits on the basis of the Administrator’s independent determination of the Participant’s disability
status, the Administrator will provide a copy of any rule, guideline, protocol, or other similar criterion relied upon in making the adverse determination (or a statement that the same will be provided upon request by the Claimant and without
charge). 
  

	12.3	Review Procedures. 

  

	 	(a)	Benefit Claims that do not Require a Determination of Disability. Except for claims requiring an independent determination of a Participant’s Disability status, a
request for review of a denied claim must be made in writing to the Administrator within sixty (60) days after receiving notice of denial. The decision upon review will be made within sixty (60) days after the Administrator’s receipt
of a request for review, unless special circumstances require an extension of time for processing, in which case a decision will be rendered not later than one hundred twenty (120) days after receipt of a request for review. A notice of such an
extension must be provided to the Claimant within the initial sixty (60) day period and must explain the special circumstances and provide an expected date of decision. 

 The reviewer shall afford the Claimant an opportunity to review and receive, without charge, all relevant documents, information and records and to submit
issues and comments in writing to the Administrator. The reviewer shall take into account all comments, documents, records and other information submitted by the Claimant relating to the claim regardless of whether the information was submitted or
considered in the initial benefit determination. 
  

	 	(b)	Disability Benefit Claims. In addition to having the right to review documents and submit comments as described in (a) above, a Claimant whose claim for benefits
requires an independent determination by the Administrator of the Participant’s disability status has at least one hundred eighty (180) days following receipt of a notification of an adverse benefit determination within which to request a
review of the initial determination. In such cases, the review will meet the following requirements: 

  

	 	(i)	The Plan will provide a review that does not afford deference to the initial adverse benefit determination and that is conducted by an appropriate named fiduciary of the Plan who
did not make the initial determination that is the subject of the appeal, nor by a subordinate of the individual who made the determination. 

  

	 	(ii)	The appropriate named fiduciary of the Plan will consult with a health care professional who has appropriate training and experience in the field of medicine involved in the medical
judgment before making a decision on review of any adverse initial determination based in whole or in part on a medical judgment. The professional engaged for purposes of a consultation in the preceding sentence shall not be an individual who was
consulted in connection with the initial determination that is the subject of the appeal or the subordinate of any such individual. 

  

 25 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	(iii)	The Plan will identify to the Claimant the medical or vocational experts whose advice was obtained on behalf of the Plan in connection with the review, without regard to whether the
advice was relied upon in making the benefit review determination. 

  

	 	(iv)	The decision on review will be made within forty-five (45) days after the Committee’s receipt of a request for review, unless special circumstances require an extension of
time for processing, in which case a decision will be rendered not later than ninety (90) days after receipt of a request for review. A notice of such an extension must be provided to the Claimant within the initial forty-five (45) day
period and must explain the special circumstances and provide an expected date of decision. 

  

	 	(c)	Manner and Content of Notice of Decision on Review. Upon completion of its review of an adverse initial claim determination, the Administrator will give the Claimant,
in writing or by electronic notification, a notice containing: 

  

	 	(i)	its decision; 

  

	 	(ii)	the specific reasons for the decision; 

  

	 	(iii)	the relevant Plan provisions or insurance contract provisions on which its decision is based; 

  

	 	(iv)	a statement that the Claimant is entitled to receive, upon request and without charge, reasonable access to, and copies of, all documents, records and other information in the
Plan’s files which is relevant to the Claimant’s claim for benefits; 

  

	 	(v)	a statement describing the Claimant’s right to bring an action for judicial review under ERISA Section 502(a); and 

  

	 	(vi)	if an internal rule, guideline, protocol or other similar criterion was relied upon in making the adverse determination on review, a statement that a copy of the rule, guideline,
protocol or other similar criterion will be provided without charge to the Claimant upon request. 

  

	12.4	Calculation of Time Periods. For purposes of the time periods specified in this Article, the period of time during which a benefit determination is required to be made
begins at the time a claim is filed in accordance with the Plan procedures without regard to whether all the information necessary to make a decision accompanies the claim. If a period of time is extended due to a Claimant’s failure to submit
all information necessary, the period for making the determination shall be tolled from the date the notification is sent to the Claimant until the date the Claimant responds. 

  

	12.5	 Legal Action. If the Plan fails to follow the claims procedures required by this Article, a Claimant shall be deemed to have exhausted the
administrative remedies available under the Plan and shall be entitled to pursue any available remedy under ERISA Section 502(a) on the basis that the Plan has failed to provide a reasonable claims procedure that would yield a decision on the
merits of the claim. A Claimant’s compliance with the foregoing 

  

 26 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
provisions of this Article is a mandatory prerequisite to a Claimant’s right to commence any legal action with respect to any claims for benefits under
the Plan. However, notwithstanding anything herein that may suggest otherwise, with respect to any claim pertaining to a Participant who is not subject to ERISA, following the Claimant’s exhaustion of the foregoing provisions of this Article,
all disputes in connection with such claim shall be resolved by binding arbitration in accordance with the commercial arbitration rules of the American Arbitration Association. 

 ARTICLE 13  
 Trust
 
  

	13.1	Establishment of the Trust. The Company has established the Trust, and the Employer intends, but is not required, to transfer over to the Trust at least annually such
assets as the Employer determines, in its sole discretion, are necessary to provide for its respective future liabilities created with respect to the Annual Deferral Amounts, Annual Company Supplemental Contribution Amounts and Annual Company
Discretionary Contribution Amounts for the Participants. 

  

	13.2	Interrelationship of the Plan and the Trust. The provisions of the Plan and the Plan Agreement shall govern the rights of a Participant to receive distributions
pursuant to the Plan. The provisions of the Trust shall govern the rights of the Employer, Participants and the creditors of the Employer to the assets transferred to the Trust. The Employer shall at all times remain liable to carry out its
obligations under the Plan. 

  

	13.3	Distributions from the Trust. The Employer’s obligations under the Plan may be satisfied with Trust assets distributed pursuant to the terms of the Trust, and any
such distribution shall reduce the Employer’s obligations under this Plan. 

 ARTICLE 14 
 Miscellaneous 
  

	14.1	Status of Plan. The Plan is intended to be a plan that is not qualified within the meaning of Code Section 401(a) and that “is unfunded and is maintained by
an employer primarily for the purpose of providing deferred compensation for a select group of management or highly compensated employees” within the meaning of ERISA Sections 201(2), 301(a)(3) and 401(a)(1). The Plan shall be administered and
interpreted to the extent possible in a manner consistent with that intent. 

  

	14.2	Unsecured General Creditor. Participants and their Beneficiaries, heirs, successors and assigns shall have no legal or equitable rights, interests or claims in any
property or assets of the Employer. For purposes of the payment of benefits under this Plan, any and all of the Employer’s assets shall be, and remain, the general, unpledged unrestricted assets of the Employer. The Employer’s obligation
under the Plan shall be merely that of an unfunded and unsecured promise to pay money in the future. 

  

 27 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	14.3	Employer’s Liability. The Employer’s liability for the payment of benefits shall be defined only by the Plan and the Plan Agreement, as entered into between
the Employer and a Participant. The Employer shall have no obligation to a Participant under the Plan except as expressly provided in the Plan and his or her Plan Agreement. 

  

	14.4	Nonassignability. Subject to Sections 3.11 and 3.12, neither a Participant nor any other person shall have any right to commute, sell, assign, transfer, pledge,
anticipate, mortgage or otherwise encumber, transfer, hypothecate, alienate or convey in advance of actual receipt, the amounts, if any, payable hereunder, or any part thereof, which are, and all rights to which are expressly declared to be,
unassignable and non-transferable. Subject to Sections 3.12 and 14.15, no part of the amounts payable shall, prior to actual payment, be subject to seizure, attachment, garnishment or sequestration for the payment of any debts, judgments, alimony or
separate maintenance owed by a Participant or any other person, be transferable by operation of law in the event of a Participant’s or any other person’s bankruptcy or insolvency or be transferable to a spouse as a result of a property
settlement or otherwise. 

  

	14.5	Not a Contract of Continued Service. The terms and conditions of this Plan shall not be deemed to constitute a contract of continued service by the Participant to the
Employer and a Participant, whether in an employee or independent contractor capacity. Such service is hereby acknowledged, subject to applicable state law, to be an “at will” service relationship that can be terminated at any time for any
reason, or no reason, with or without cause, and with or without notice, unless expressly provided in a written employment, consulting or like agreement. Nothing in this Plan shall be deemed to give any Participant the right to be retained in the
service of the Employer either as an Employee or Director, or to interfere with the right of the Employer to discipline or discharge the Participant at any time. 

  

	14.6	Furnishing Information. A Participant or his or her Beneficiary will cooperate with the Administrator by furnishing any and all information requested by the
Administrator and take such other actions as may be requested in order to facilitate the administration of the Plan and the payments of benefits hereunder, including, but not limited to, taking such physical examinations as the Administrator may
deem necessary. 

  

	14.7	Terms. Whenever any words are used herein in the masculine, they shall be construed as though they were in the feminine in all cases where they would so apply; and
whenever any words are used herein in the singular or in the plural, they shall be construed as though they were used in the plural or the singular, as the case may be, in all cases where they would so apply. 

  

	14.8	Captions. The captions of the articles, sections and paragraphs of this Plan are for convenience only and shall not control or affect the meaning or construction of
any of its provisions. 

  

	14.9	Governing Law. Subject to ERISA, the provisions of this Plan shall be construed and interpreted according to the internal laws of the State of California without
regard to its conflicts of laws principles. 

  

 28 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	14.10	Notice. Any notice or filing required or permitted to be given to the Administrator under this Plan shall be sufficient if in writing and hand-delivered, or sent by
registered or certified mail, to the address below: 

 Vice President, Human Resources 
 3100 Hansen Way 
 Palo Alto, California 94304

 With Copy To: 
 General Counsel

 3100 Hansen Way 
 Palo Alto,
California 94304 
 Such notice shall be deemed given as of the date of delivery or, if delivery is made by mail, as of the date shown on the
postmark on the receipt for registration or certification. 
 Any notice or filing required or permitted to be given to a Participant under
this Plan shall be sufficient if in writing and hand-delivered, or sent by mail, to the last known address of the Participant. 
  

	14.11	Successors. The provisions of this Plan shall bind and inure to the benefit of the Participant’s Employer and its successors and assigns and the Participant and
the Participant’s designated Beneficiaries. 

  

	14.12	Spouse’s Interest. The interest in the benefits hereunder of a spouse of a Participant who has predeceased the Participant shall automatically pass to the
Participant and shall not be transferable by such spouse in any manner, including but not limited to such spouse’s will, nor shall such interest pass under the laws of intestate succession. 

  

	14.13	Validity. In case any provision of this Plan shall be illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining parts hereof, but
this Plan shall be construed and enforced as if such illegal or invalid provision had never been inserted herein; except to the extent that Section 409A requires that this Section 14.13 be disregarded because it purports to nullify Plan
terms that are not in compliance with Section 409A. 

  

	14.14	Incompetent. If the Administrator determines in its discretion that a benefit under this Plan is to be paid to a minor, a person declared incompetent or to a person
incapable of handling the disposition of that person’s property, the Administrator may direct payment of such benefit to the guardian, legal representative or person having the care and custody of such minor, incompetent or incapable person.
The Administrator may require proof of minority, incompetence, incapacity or guardianship, as it may deem appropriate prior to distribution of the benefit. Any payment of a benefit shall be a payment for the account of the Participant and the
Participant’s Beneficiary, as the case may be, and shall be a complete discharge of any liability under the Plan for such payment amount. 

  

 29 

	14.15	Court Order. The Administrator is authorized to make any payments otherwise distributable here under as directed by court order in any action in which the Plan or the
Administrator has been named as a party. In addition, if a court determines that a spouse or former spouse of a Participant has an interest in the Participant’s benefits under the Plan in connection with a property settlement or otherwise, the
Administrator, in its sole discretion but solely if and to the extent permitted by Section 409A, shall have the right, notwithstanding any election made by a Participant, to immediately distribute the spouse’s or former spouse’s
interest in the Participant’s benefits under the Plan to that spouse or former spouse. 

  

	14.16	Acceleration of Distribution. 

  

	 	(a)	In General. The Employer may, in its discretion (without any direct or indirect election on the part of any Participant), accelerate the date of distribution or
commencement of distributions hereunder, or accelerate installment payments by paying the vested Account Balance in a lump sum or pursuant to a Yearly Installment Method using fewer years, to the extent permitted under Section 409A (such as,
for example, as provided in Section 1.409A-3(j)(4) of the Treasury regulations, to comply with domestic relations orders or certain conflict of interest rules, to pay employment taxes, to make a lump sum cashout of certain de minimus amounts
that are less than the applicable dollar amount under Code Section 402(g)(1)(B), or to make payments upon income inclusion under Section 409A). 

  

	 	(b)	Trust. If the Trust terminates in accordance with the provisions of the Trust and benefits are distributed from the Trust to a Participant in accordance with such
provisions, the Participant’s benefits under this Plan shall be reduced to the extent of such distributions. 

  

	14.17	Delay in Payment. If the Employer reasonably anticipates that any payment scheduled to be made hereunder would violate securities laws (or other applicable laws) or
jeopardize the ability of the Employer to continue as a going concern if paid as scheduled, then the Administrator may defer that payment, provided the Employer treats payments to all similarly situated Participants on a reasonably consistent basis.
In addition, the Employer may, in its discretion, delay a payment upon such other events and conditions as the IRS may prescribe, provided the Employer treats payments to all similarly situated Participants on a reasonably consistent basis. Any
amounts deferred pursuant to this Section shall continue to be credited or debited with additional amounts in accordance with Section 3.9 above, even if such amount is being paid out in installments. The amounts so deferred and amounts credited
or debited thereon shall be distributed to the Participant or his or her Beneficiary (in the event of the Participant’s death) at the earliest possible date on which the Administrator reasonably anticipates that such violation or material harm
would be avoided or as otherwise prescribed by the IRS. 

  

	14.18	Prohibited Acceleration/Distribution Timing. This Section shall take precedence over any other provision of the Plan or this Article 14 to the contrary. If the timing
of any distribution election would result in any tax or other penalty (other than ordinarily payable Federal, state or local income or payroll taxes), which tax or penalty can be avoided by payment of the distribution at a later time, then the

  

 30 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

	 	 
distribution shall be made (or commence, as the case may be) on (or as soon as practicable after) the first date on which such distributions can be made (or
commence) without such tax or penalty; except to the extent that Section 409A requires that this Section be disregarded because it purports to nullify Plan terms that are not in compliance with Section 409A. 

 

	14.19	Insurance. The Employer, on its own behalf or on behalf of the trustee of the Trust, and, in its sole discretion, may apply for and procure insurance on the life of
the Participant, in such amounts and in such forms as the Trust may choose. The Employer or the trustee of the Trust, as the case may be, shall be the sole owner and beneficiary of any such insurance. The Participant shall have no interest
whatsoever in any such policy or policies, and at the request of the Employer shall supply such information and execute such documents as may be required by the insurance company or companies to whom the Employer has applied for insurance.

  

	14.20	Aggregation of Employers. If the Employer is a member of a controlled group of corporations or a group of trades or business under common control (as described in Code
§414(b) or (c), but substituting a fifty percent (50%) ownership level for the eighty percent (80%) level set forth in those Code Sections), all members of the group shall be treated as a single Employer for purposes of whether there
has occurred a Separation from Service and for any other purposes under the Plan as Section 409A shall require. For purposes of Section 9.1, in the case of a change in control event, the entities to be treated as a single Employer shall be
determined immediately following the change in control event. 

  

	14.21	Aggregation of Plans. If the Employer offers other account balance deferred compensation plans in addition to the Plan, those plans together with the Plan shall be
treated as a single plan to the extent required under Section 409A for purposes of determining whether an Employee or Director may make a deferral election pursuant to Section 3.3(a) within thirty (30) days of becoming eligible to
participate in the Plan, for purposes of cashing out de minimus amounts pursuant to Section 14.16 and for any other purposes under the Plan as Section 409A shall require. 

  

	14.22	USERRA. Notwithstanding anything herein to the contrary, any deferral or distribution election provided to a Participant as necessary to satisfy the requirements of
the Uniformed Services Employment and Reemployment Rights Act of 1994, as amended, shall be permissible hereunder. 

  

 31 

 VARIAN MEDICAL SYSTEMS, INC. 
 PLAN DOCUMENT CONTINUED... 
  

 IN WITNESS WHEREOF, the Employer has adopted this amended and restated Plan document effective as of
January 1, 2009. 
  

			
	VARIAN MEDICAL SYSTEMS, INC
		
	By:	 	 
	Print Name:	 	 
	Title:	 	 
	Date:	 	 

  

			
	OTHER SPONSORING EMPLOYERS:
	
	 
		
	By:	 	 
	Print Name:	 	 
	Title:	 	 
	Date:	 	 
	
	 
		
	By:	 	 
	Print Name:	 	 
	Title:	 	 
	Date:	 	 

  

 32

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}]]